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Abstract 
Background: 
Patient recruitment to trials is problematic; many fail to achieve targets, leaving them 
underpowered and unable to address their hypothesis. Few solutions have been identified in 
existing literature. This thesis aimed to: identify factors associated with recruitment; and 
understand clinicians’ experiences of recruiting patients to a primary care based randomised 
controlled trial (RCT). This was explored using The Birmingham Atrial Fibrillation 
Treatment of the Aged (BAFTA) trial as a case study. 
Methods: 
Mixed methods were used: a systematic review to identify factors influencing recruitment to 
primary care based RCTs; quantitative analysis of BAFTA data to identify factors associated 
with recruitment; and qualitative interviews with General Practitioners involved with 
BAFTA, to understand their experience of participation. 
Results: 
Existing literature demonstrated that influences on recruitment include: study workload; study 
question; concerns about patients. Recommendations to address these issues are not based on 
strong empirical evidence. BAFTA identified factors associated with patient recruitment 
(practice size; GP age; recruitment year); and patterns over time. Interviews identified 
differences in attitude between high and low recruiters, including risk perception and 
motivation. 
Conclusions: 
This thesis demonstrates how practitioners can influence patient recruitment. Revised 
recruitment methods need testing in prospective trials.
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Chapter 1: Introduction 
1.1 Structure of the Thesis 
This thesis consists of four separate studies which all examine the issue of recruitment of 
patients to primary care based randomised controlled trials (RCTs). The four studies include: 
 A systematic review of the literature pertaining to the recruitment of patients to 
primary care based RCTs; 
 Two separate analyses of recruitment patterns to a large, multi-centred primary care 
based RCT which examined the optimum way to prevent stroke in older people with 
atrial fibrillation (AF), the Birmingham Atrial Fibrillation Treatment of the Aged 
(BAFTA) Study; 
 A qualitative study using semi-structured interviews with general practitioners (GPs) 
who recruited their patients to BAFTA. 
Each study will be presented in a separate chapter. The thesis will start with an overview of 
the aims and objectives of the project. Chapter two will provide a general background, 
discussing the literature on the influence of practitioner factors on patient recruitment to RCTs 
in a variety of settings. Chapter three will present the systematic review of literature 
specifically pertaining to RCTs in a primary care setting, and will conclude with a description 
of the BAFTA study.  
Chapter four will provide justification for the choice of a mixed methodology approach to the 
thesis. Chapters five and six will present the two separate analyses of patient recruitment to 
BAFTA and chapters seven, eight and nine will present the qualitative interview study. The 
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thesis concludes with an overall discussion of the findings of the studies and 
recommendations for how to optimise recruitment to primary care based trials. 
1.2 Aims and Objectives 
The overall aim is to look at practice and/or practitioner factors that influence the recruitment 
of patients to primary care based RCTs, using BAFTA as a case study. BAFTA is an ideal 
trial on which to base this analysis for a number of reasons:  
 BAFTA was a multi-centred RCT involving a large number of sites located 
throughout England and Wales. This allows for investigation into the impact of a 
variety of site factors on recruitment; 
 Each site had a separate GP acting as local investigator with responsibility for patient 
recruitment. This allows for investigation into the impact of a variety of clinician 
factors on recruitment; 
 The trial was initially failing to reach accrual targets, but through the introduction of a 
number of procedural and protocol amendments managed to enhance the recruitment 
rate to become ultimately successful. This allows for investigation into changes that 
may have influenced recruitment. 
The main focus of this thesis is practice and/or practitioner factors that impact on patient 
recruitment. Patient or procedural issues are discussed where they are relevant to clinician 
considerations. For example, patient perception of trial drugs may influence their decision 
about participation.  However, in this thesis, this would be discussed in the context of how the 
GP explanation of the trial drugs may influence a patient’s attitude to them. It is important to 
examine the practitioner effect on recruitment because much of the existing literature 
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considers recruitment from the patient perspective. While important, this may only be part of 
the story. There is a small but growing body of literature considering practitioner effects 
which indicates that clinician factors may have a significant influence on a patient’s 
willingness to participate, and is a potentially important aspect of the problems faced by 
trialists when trying to recruit patients. However, this body of literature is in its infancy, and 
studies that add to understanding in this area remain vital. 
1.3 Specific Objectives  
There are five specific objectives for this thesis: 
1. To determine what practice or GP factors influence the recruitment of patients to 
primary care based RCTs, through the identification and assessment of the existing 
literature pertaining to this issue; 
2. To identify whether patient and/or practitioner factors predict the likelihood of a 
patient giving consent to BAFTA; 
3. To identify whether there were any patterns of recruitment to BAFTA that may have 
been influenced by the protocol or procedural changes that were introduced 
throughout the course of the trial; 
4. To understand the experience of GPs who recruited to BAFTA; 
5. To make recommendations for optimal recruitment to trials in primary care, drawing 
both on the original work described in this thesis, and on the findings of the literature 
review; and to highlight areas that would benefit from further research. 
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Chapter 2: General Background 
The purpose of this chapter is to set the context in which this study took place. It begins by 
providing a background to the need for RCTs, explaining their importance to the advancement 
of health care interventions. The chapter goes on to highlight a significant problem often 
encountered when conducting RCTs, namely poor patient recruitment, and explains why it is 
important that this issue is addressed. The chapter will then discuss the general literature 
search that was carried out to identify the factors that influence recruitment to trials, and how 
these factors have been addressed.  
2.1 Randomised Controlled Trials 
Randomised controlled trials are widely accepted as being the best way of evaluating the 
effects of treatment1 and health care interventions.1,2,3 This is because well designed and 
executed trials are the most appropriate way to minimise bias4,5 by controlling for both known 
and unknown confounding factors that may affect outcomes.5 It is important that an RCT has 
internal validity (e.g. how was randomisation conducted; was the trial blinded; how was the 
analysis carried out?) and that its results are clearly presented, clinically relevant and 
generalisable to an individual clinician’s own patient population (e.g. was the trial carried out 
in primary or secondary care; what were the characteristics of included patients?). It is also 
important that it has sufficient power to detect any differences between the interventions in 
question and that adequate numbers of patients enrol. (See Table 1). 
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Table 1: Key Aspects of the Design of RCTs6,7  
Feature Considerations 
Randomisation of 
participants  
How was the randomisation carried out? Was the 
allocation schedule concealed from patients and study 
personnel in advance of study inclusion? 
Blinding Were patients and study personnel blind to the treatment 
allocation (double blind)? If not, were the outcome 
assessors blind to the treatment allocation (single blind)? 
Trial analysis Was intention to treat analysis used (maintaining the 
randomisation by ensuring that groups do not differ 
systematically)?  
Study power  Was a power calculation carried out? Was the sample 
size large enough to detect differences between trial 
arms? Were adequate numbers of patients enrolled? 
Trial setting Which country/healthcare system was the trial carried out 
in? Was it in primary or secondary care? How were 
participating centres/clinicians recruited?  
Study Population How restrictive were the inclusion/exclusion criteria? 
What proportions of eligible patients declined 
randomisation? How were patients identified/diagnosed? 
What were the baseline clinical characteristics? What 
was the severity of their disease? What co-morbidities 
did patients have? Were patients at high risk of 
complications excluded? 
 6 
 
Feature Considerations 
Follow up How often/long were the follow-ups? How complete was 
the follow up? Who carried out the follow ups? 
Clinical relevance How does the trial protocol compare with routine 
practice? What trial interventions were used? What 
outcome measures were used? How clinically relevant 
were they? How do the trial patients compare with my 
patients? 
2.2 Recruitment to Randomised Controlled Trials 
Regardless of how well designed trials are, their execution is often difficult and fraught with 
problems. One of the most problematic areas is the enrolment of an adequate number of 
eligible patients. This is a key success criterion for any trial, as it ensures that sufficient 
participants are recruited in a reasonable timescale.8,9 It is also a high level performance 
criteria on which the research networks will be judged in 2011/12.10  If a trial fails to recruit to 
target, it will not meet its power requirement, thus reducing its ability to detect significant 
effects and resulting in potentially misleading information.5,11 Slow recruitment may lead to 
the broadening of inclusion criteria, potentially reducing study validity12,13 and also causes 
delays which may affect the generalisability of the study if standard care changes over time.11 
If slow recruitment is due to physician selection of patients, generalisability may be further 
reduced, as it is possible that only a healthier or more approachable sub-section of the target 
population is being included14 (See Table 1). An additional significant problem that arises 
when studies recruit too slowly is that of cost. Properly conducted RCTs are expensive, and 
recruitment delays can lead to increased costs.15,16 Funders may opt to extend the recruitment 
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period, but they may also decide that the recruitment problems are of such magnitude that the 
trial should be halted.4 In a world with limited funding for research, resources spent on failed 
studies may mean that many important questions may never be adequately addressed, leaving 
unanswered scientific questions.15 Despite the importance of adequate recruitment, there is 
only a limited evidence base on which to base recruitment strategies.2,4,16 Existing guidance, 
while useful, is based more on the opinions of experienced researchers than on evidence.17 
Although it is not easy to quantify the number of trials that experience difficulties, it is 
estimated that around two thirds never achieve their recruitment targets.3,18,19 It is likely that 
how a trial is carried out will influence the success or otherwise of the recruitment. For 
example, some trials employ researchers to travel to sites to carry out patient recruitment, 
other trials rely on independent clinicians to enrol patients. Studies with the latter design may 
be less likely to recruit successfully. One review found that only 12.5% of such studies 
completed recruitment, even when their timeframe had been extended by 50%.18 It is possible 
that, in reality, more trials recruited successfully than is indicated in this paper, because of the 
problem of publication bias (when reporting trial results, successful trials are more likely to be 
published; case studies examining recruitment to trials which fail to achieve targets may be 
more likely to be published than those relating to those recruiting successfully, as the interest 
is in how to learn from a failure).18 However, these estimates do give an indication of the 
potential scale of the problem.  
Having established the importance of RCTs and identified that patient recruitment is a major 
barrier to their successful completion, this chapter will now focus on the existing evidence 
that addresses this issue, and will ascertain what actions trialists take to improve their 
recruitment rates. 
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2.3 General Review of Literature Pertaining to Trial Recruitment 
A general literature search was carried out that had two aims: 
 Identification of any clinician factors that impact on patient recruitment to RCTs, 
regardless of disease type or trial setting;   
 Identification of interventions that may help to improve recruitment. 
The search terms used were: 
 Patient recruit* OR accrual OR enrol* AND randomised controlled trial. 
Initially the search also included the term OR RCT, but this returned approximately 500,000 
hits, most of which were not relevant. No date restrictions were applied, but only studies 
published in English were included, as the resources needed for translation were not available.  
As the subject being addressed is very general and is not a narrow clinical question, it was 
difficult to achieve specificity without losing sensitivity. The Pubmed, Medline and Cochrane 
databases were searched using the above terms. The titles of all identified papers were looked 
at, and the abstract of any potentially relevant articles were read; full text was obtained for 
anything that appeared to be applicable. Papers discussing recruitment to study designs other 
than RCTs were excluded. Those looking at particularly vulnerable patient groups, for 
example, children, prisoners or those unable to give informed consent on their own behalf 
were also excluded. In these cases there are extra requirements for obtaining consent which is 
likely to add a further layer of complexity to the recruitment issue that is only relevant to 
studies of this type. Additionally, studies that were confined to looking at recruitment of 
minority groups were not considered; interventions that are tailored to the particular patient 
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group in question are not likely to be generalisable to less specific populations. Individual 
papers have not been listed, but will be discussed in relation to the issues they raise. 
2.3.1 The Process of Recruiting Patients to RCTs 
When looking at the recruitment procedure throughout a trial as a whole, it is apparent that 
there are a number of phases that need to be carried out before a patient can be successfully 
enrolled; factors which impact on any of these steps can result in poor recruitment. (See 
Figure 1, page 10)   
The literature identifies a variety of causes of poor recruitment that can potentially affect any 
point in this process. These can be divided into three main categories: patient orientated 
factors; clinician orientated factors and practical considerations.20 (See Table 2, page 14) As 
the focus of this thesis is on practitioner factors influencing recruitment, patient and practical 
considerations will be discussed only when they overlap with clinician orientated issues.  
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Figure 1: Process for Recruitment of Patients to RCTs 
 
Clinician factors and practical considerations can influence both the clinician’s decision to 
participate in a trial (thus impacting upon site recruitment), and once the decision to take part 
has been made, can affect their ability to recruit patients. Some factors may impact upon both 
areas. The remainder of this chapter will focus on these two areas. 
Identification of sites / individual 
clinicians willing to participate
 
Identification of potentially eligible 
patients 
Training of site personnel 
Initial screening for eligibility 
Possibly eligible, attend baseline 
Discuss trial with patients/obtain 
informed consent 
Enter patient into the trial 
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2.3.2 Influences on Practitioner Willingness to Participate 
Identification of sufficient sites and the recruitment of adequate numbers of clinicians are 
important elements of successful study completion. In fact, a survey of oncologists reported 
that 76% of responders thought that the reluctance of clinicians to participate was a greater 
barrier to successful trial completion than the reluctance of patients.21 An understanding of 
what motivates clinicians to take part in a trial, or what barriers they face when making that 
decision, may help trialists to ensure that they can maximise site recruitment.  
2.3.2.1 Factors that Promote Participation 
The literature cites a number of reasons why physicians are motivated to participate in trials. 
These are summarised in table two (Page 13). 
Interest in the study question 
Interest and enthusiasm for the study question is something that clinicians will take into 
account when considering trial participation. A survey of physicians who were recruiting 
patients to a hypertension trial found that 34% of them stated that interest in the agents being 
compared in the study was an important factor in their decision to take part,22 while 17% of 
surveyed oncologists felt that scientifically uninteresting questions would deter them from 
participation.23 In order to encourage participation, the question also needs to have an 
important scientific aim,4,16,24,25,26,27 and should be relevant to their clinical practice 
(conditions that they see regularly would be especially relevant).28 GPs for example, are less 
likely to be involved in cancer treatment trials, as these patients are usually cared for in a 
specialist setting.  
 12 
 
This is a difficult area in which to make changes that could have an impact on clinician 
participation rates; a trial is funded to look at a specific question and practitioners will either 
be interested in it or they will not. It may be that different ways of approaching clinicians to 
participate influences their perception of the study question, although there are few studies 
looking at whether this is the case. Ward et al reported that 78% of clinicians were 
encouraged to take part to some extent by having a telephone call from the chief investigator 
prior to receiving an invitation letter,29 so it is possible that how the initial approach is carried 
out could affect clinician participation rates. The literature also advises trialists to place 
emphasis on the benefits, both to the clinician and to future patients, of their involvement.15,30 
However, this advice is based on anecdotal evidence, and there are no studies that have tested 
whether this is the case, and if so, the optimum way of achieving this.  
Ability to carry out the study 
An ability to actually carry out the work involved in participation is also a prime 
consideration of clinicians contemplating involvement.  Many centres will not agree to take 
part if they feel that they do not have adequate numbers of staff. A study of reasons for 
declining participation in a trial looking at modes of delivery for pre-term breech babies found 
almost 50% of non-participating centres cited insufficient staff to obtain properly informed 
consent as a major barrier.31 Furthermore, the time commitment necessary for trial 
involvement deters some. A survey of research active clinicians found that for 83%, time 
available to them to undertake the extra duties associated with trials was a major barrier to 
their participation.32 Trialists are advised to minimise workload and to keep the protocol and 
data collection forms as simple as possible in order to encourage involvement.17 Although this 
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is intuitive advice, there is no clear evidence that simplicity or minimisation of workload 
actually improves clinician recruitment.  
Table 2: Clinician Reasons for Participating in an RCT 
Interest in the study question 
 Scientifically interesting question 
 Interest in the agents under investigation 
 Relevance to clinical practice 
Ability to carry out the study 
 Time constraints 
 Adequate numbers of suitably trained staff 
Other reasons for participation 
 Participation of an academic research group or clinical research organisation 
 Personal relationships 
o Personal acquaintance with the researchers 
o Colleague who agreed to participate 
 Personal appeal by the research team 
 Professional obligation 
 Corporate decision to participate 
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Other reasons for participation 
A number of other motivators to participate were cited in the literature. These included: 
professional or personal relationships with the researchers or other participating colleagues;33 
personal appeal by the research team;34 professional obligation;34 or involvement of an 
academic research group.34 However, these findings all came from surveys of clinicians who 
participated in trials. They were asked to indicate which factors influenced their decision, or 
to rank them in order of their perceived importance. It is not clear from the articles how the 
questionnaires were designed, so it is possible that these factors are assumed by researchers to 
be important, but are not actually relevant in practice. Not all participating clinicians express 
interest in the study. Some are involved purely because a corporate decision by the Trust to 
take part has been made.35 
2.3.3 Clinician Factors that Influence Patient Recruitment 
This section will look at clinician factors that may impact on their ability to recruit patients. 
2.3.3.1 Impact of Clinician Motivation to Participate on Patient Recruitment 
Rates 
Having examined the different considerations that play a part in the decision to participate, the 
relative importance of each factor is not clear. It may be, for example, that a clinician may not 
express an interest in the question, but feels strongly enough about their professional 
obligation that they will still agree to participation. Simple involvement, however, does not 
necessarily lead to good patient recruitment. Csimma et al stated that an enthusiastic lead 
investigator at each site was the most important factor associated with recruitment, although 
no detail was given about how they came to this conclusion.36 It remains unclear what makes 
some physicians enrol more patients than others. If it were possible to identify this, then it 
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may be possible for trialists to target their practitioner recruitment efforts at those clinicians 
most likely to recruit successfully. 
A number of studies have looked at whether a physician’s reasons for participation influences 
their ability to recruit successfully, and these have been summarised in a Cochrane Review of 
incentives and disincentives to clinician participation.35 This review found three studies that 
considered whether there was an association between factors that motivated clinicians to 
participate, and their subsequent recruitment activity.33,34,37 All three studies were postal 
surveys of physicians who had recruited to an RCT, asking them what motivated them to 
participate, or to rank a number of factors in order of their perceived importance. The results 
of these studies are equivocal. There was an association with better patient recruitment for 
those ranking involvement of an academic research group highly against those who did not 
(adjusted OR 2.9, 95% CI 1.2-6.9),34 whereas, for clinicians who became involved because of 
professional relationships with the researchers or other participating colleagues, there was a 
higher percentage who recruited no patients when compared with clinicians who cited other 
motivations to participate (50% versus 15.5%).33 There was also a negative association with 
patient recruitment for those who ranked personal appeal by the research team as an important 
motivator (OR 0.4, 95% CI 0.2-0.9).34 There was no association with recruitment for those 
who ranked professional obligation as important (OR 1.7, 95% CI 0.7-3.7).34 This evidence is 
slightly at odds with the current advice; involvement of a local ‘champion’ in a trial, with the 
aim of encouraging clinician participation is an approach that is recommended.17 These 
findings point to the fact that, while this advice may increase the number of doctors willing to 
take part, using personal appeals or contacts may ultimately result in the participation of 
clinicians that are poor recruiters of study patients. 
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Interest in the specific study question was also found to have no association with recruitment 
(OR 1.0, 95% CI 0.5-2.2),34 which may mean that those without an interest will opt to not 
participate rather than agree but fail to recruit. However, those expressing an interest in 
learning about research per se, were found to have a positive association with recruitment 
(74.8% of recruiters cited interest in learning about research versus 63.8% of non-recruiters, 
p<0.02).37 It may, therefore, be worthwhile for researchers to identify how to ‘sell’ their trial 
in such a way as to maximise interest amongst clinicians, or to identify those doctors who are 
interested enough in research to participate despite having little interest in the topic area.  
For some clinicians, regardless of their reasons for taking part, the study question may raise 
issues further down the recruitment stream: some factors will have an influence at more than 
one point. As discussed, clinician agreement to participate does not ensure that they will 
successfully recruit adequate numbers of patients. The same factors that deter some from 
participation may not deter others, and their concerns may only come to light when actively 
recruiting patients. This is demonstrated by the many trials that highlight discrepancies 
between the number of practitioners who agree to participate and the number of those who 
actually recruit.14,35 
2.3.3.2 Other Clinician Factors that may Impact on Patient Recruitment Rates 
Once they have agreed to enrol their patients into a trial, clinicians need to identify and 
approach their eligible patients, and carry out the informed consent process with each one 
before they can be included in the study. (See Figure 1, page 10) There are many factors that 
can affect any point in the process (See Table 3, page 18) and result in poor recruitment. Each 
factor will now be considered in turn. 
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2.3.3.2.1 Ethical Considerations of RCTs 
All studies carried out in the United Kingdom are required to have prior approval from a 
designated Ethics Committee, and to conform to the standards of Good Clinical Practice 
(GCP) as laid down by the International Conference of Harmonisation Guideline for Good 
Clinical Practice (ICHGCP).38 This guidance has its origins in the Declaration of Helsinki 
(1964) and its aim is to safeguard the safety and well-being of any human subject. Prior to any 
patient being approached, ethics committees look at all aspects of a trial to ensure that it is not 
likely to cause undue harm. They consider the treatments in question and whether there is an 
imbalance of risks between the treatment arms on offer; whether there is a genuine clinical 
question that has not already been answered, thus justifying the exposure of patients to 
potential risk; and aspects of the informed consent process, including who will be obtaining 
consent and what is included in the patient information sheet.  There are two central ethical 
tenets to RCTs that can influence recruitment: clinical equipoise and fully informed consent. 
Clinical Equipoise 
Clinical equipoise provides the ethical basis for all randomised trials involving humans, and 
means that there is genuine medical uncertainty as to which treatment is best.  In addition, 
clinicians who recruit patients to trials also need to consider the ethics of the trial in relation to 
their own personal viewpoint. They need to be happy with all of the treatments on offer as 
part of the study and, for each individual patient that they enrol they need to be in equipoise:39 
this is known as personal equipoise. Ethical concerns may arise when investigators begin to 
favour one treatment arm over another, and where this is the case, they should not be offering 
trial entry to their patients. Even if the clinician is in equipoise over the aim of the study, for 
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patients where they are not in personal equipoise, they should treat as they feel most 
appropriate and not consider them eligible for the trial. 
Table 3: Clinician Factors that Impact on Accrual 
Ethical Considerations 
 Equipoise 
 Informed Consent 
o Process of obtaining informed consent 
Impact on the doctor/patient relationship 
 Discussion of uncertainty 
 Dual role of physician and researcher 
 Loss of clinical autonomy 
Structural barriers 
 Time constraints 
 Staff shortages 
 Research experience and training 
Despite agreeing to take part, some clinicians express concerns about disparities between the 
treatment arms or find that they prefer one of the treatments over the other14 and this may 
impact on their ability to recruit. Those who have a strong preference may not recruit as many 
of their eligible patients as those who have none,4,24 although whether or not this is the case 
remains unclear: de Witt et al’s survey of participating clinicians, found no differences in 
recruitment according to views about trial interventions (OR 1.0, 95% CI 0.5-2.2).34 Concerns 
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about treatment arms can depend upon whether there is a big divergence between them. In 
trials where the balance of risk is not distributed evenly across both arms, clinicians become 
less comfortable with involving their patients.26 For example, including a placebo arm in a 
trial can have a detrimental impact on recruitment: 37% of surveyed oncologists would recruit 
to a trial with a placebo arm versus 68% who would recruit to a trial with two active 
treatments.40 Conversely, the authors of an observational study of interactions between 
patients and oncologists concluded that there was a reluctance to recruit patients with a poor 
prognosis to a trial in which they may be randomised to a standard treatment; they would 
rather choose to give the patient the non-standard treatment.41 
This situation begs the question, why do clinicians agree to participate if they are not in 
clinical equipoise about the study treatments? It may be that, while they are happy with the 
trial in principle, they find it more difficult when actually faced with making the choices with 
regard to one of their patients, and concerns about treatments come to the fore.35 While they 
are actually in clinical equipoise over the study question, they may not be in personal 
equipoise with individual patients, and so are selective about whom they consider for trial 
entry. 
This may also influence how they discuss the trial with their patients. One study that audio 
recorded trial discussions found that most clinicians presented general uncertainty about the 
treatment options.42 Some clinicians, as well as communicating their clinical equipoise, were 
also explicit about personal equipoise and explained that they were happy with: 
Either arm of treatment to (name of child) … if I wasn’t I’d be 
giving you the one that I thought was better 42 (p6) 
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Byrne-Davis et al demonstrate that clinicians discuss the trial with their patients in different 
ways. They describe how some clinicians distance themselves from the trial, by contrasting 
between the trial perspective (e.g. they’re looking to see if the leukaemia is above a certain 
level) and the clinical team’s perspective (e.g. from our point of view s/he is in remission), 
while others use pronouns that imply they are allied with the trial (e.g. we’re running a trial).42 
It has previously been demonstrated that the order in which information about trial treatment 
arms is given43 and patient acceptance of equipoise44 both impact upon patient willingness to 
participate; how clinicians communicate with their patients is therefore likely to influence 
patient understanding and acceptance of trial concepts. Given this, it would be useful to 
determine whether the kind of communication differences highlighted by Byrne-Davis et al 
resulted in differential recruitment rates between recruiters. Unfortunately, this was not 
reported42 and the full impact of equipoise on recruitment remains unknown.  
Informed Consent  
Although ICHGCP covers all aspects of how a trial is run, one of the central tenets of GCP is 
the process of gaining fully informed consent from any person who may be offered entry to a 
research study. GCP details six main requirements that need to be fulfilled before it can be 
assumed that fully informed consent has been given. These are: 
 Prior written approval from a medical ethics committee of the written consent form 
and any other written information to be provided to a subject; 
 Subjects must not be coerced or unduly influenced to participate; 
 The investigator should fully inform the subject of all pertinent aspects of the trial. 
There are 21 points that need to be conveyed to the subject. (See Table 4, page 21); 
 21 
 
 Language used, both written and oral, should be as non-technical as possible and 
should be understandable by the subject; 
 Subject should be given ample time to decide whether or not to participate and be 
given the opportunity to have any questions they may have answered; 
 The written informed consent form should be signed and dated by both the 
investigator and the subject prior to trial entry. A copy of this should be given to the 
subject. 
Practical aspects for obtaining informed consent need to be considered during the protocol 
design phase. They need to balance the requirements of GCP and pragmatic considerations 
relating to how patients are identified and approached. The minutiae are likely to be study 
specific. However, most trials would aim to include as many of the GCP required points as 
possible in the patient information sheet, and follow this up with a study appointment with the 
recruiter who will address any concerns or queries that the patient may have. Trials where 
patients are recruited during routine consultations need to carefully consider how they will 
fulfil the requirement for giving subjects adequate time to make their decision.   
Table 4: Areas to be Explained During the Informed Consent Procedure38 
 The trial involves research 
 The purpose of the trial 
 The trial treatment (s) and the probability for random assignment for each 
treatment 
 The trial procedures to be followed, including all invasive procedures 
 The subject’s responsibilities 
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 Those aspects of the trial that are experimental 
 The reasonably foreseeable risks or inconveniences to the subject 
 The reasonable expected benefits. When there is no intended clinical benefit to 
the subject, the subject should be made aware of this 
 The alternative procedure(s) or course(s) of treatment that may be available, and 
their important benefits and risks 
 The compensation and/or treatment available in the event of a trial related injury 
 The anticipated payment, if any, to the subject for trial participation 
 The anticipated expenses, if any, to the subject for trial participation 
 That the subjects involvement in the trial is voluntary and that they may refuse 
trial entry, or withdraw at any time without any penalty or impact on their 
medical care 
 That regulatory authorities will have access to the subject’s original medical 
records for verification of trial procedures 
 Records identifying the subject will be kept confidential. If trial results are 
published the individual’s identity will remain confidential 
 The subject will be informed if information becomes available that may be 
relevant to their willingness to continue participation 
 The person to contact for further information about the trial and whom to contact 
in the event of a trial related injury 
 The foreseeable circumstances under which the subject’s participation may be 
terminated 
 The expected duration of their participation 
 The approximate number of subjects involved in the trial 
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The process of obtaining fully informed consent from patients has often been cited as a barrier 
to accrual, and was listed as one of the five most difficult areas of discussion during the 
oncology consultation.45 It has been identified by physicians as a reason for failing, or for 
making it difficult, to recruit patients;4 There is a significant body of literature that examines 
informed consent from the patient perspective. Much of this focuses on patient understanding 
of the trial, and whether they fully appreciate what they have consented to. Although the 
literature produces some mixed evidence, the general consensus is that patients have a poor 
understanding of trials, often do not understand the reason for randomisation and experience 
the ‘therapeutic misconception’ (the belief that their doctor has chosen the best treatment for 
them).46 It would be logical to assume that improved understanding of trial concepts would 
result in an increased number of people willing to participate. However, it seems that this may 
not be the case. One study tested two different methods of information giving: ‘passive’ 
receipt of information via brochures; and interactive information receipt via computer. The 
mean understanding score for agreers and refusers were calculated. They found that improved 
understanding of trials seems to have had a detrimental effect on willingness to consent (mean 
understanding score, agreers 13.19, refusers 14.06, p=0.03).47  Another study randomised 
patients to receive standard trial entry invitation, or to receive standard invitation plus a 
questionnaire about their medical condition. They found that people receiving the 
questionnaire were more likely to participate (RR1.37, 95% CI 1.13-1.65) and concluded that 
increased awareness about their condition could have been responsible for the increased 
willingness to participate.48 While it is vital to ensure that a patient understands and accepts 
what they are agreeing to when considering trial participation, it may be that placing greater 
emphasis on the understanding of their medical condition during the consent process would 
be beneficial to recruitment rates. 
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It is probable that how trials are discussed with patients can have an influence on their 
willingness to enrol. One qualitative interview project demonstrated that the order in which 
the treatment arms of a trial for prostate cancer were explained influenced the recruitment 
rate; re-ordering the presentation of treatment options contributed to the increase in 
recruitment rates from 40% to 70%.43 A Cochrane review of strategies to improve recruitment 
to RCTs examined 27 studies that evaluated the effects of nine different categories of 
recruitment interventions. Eighteen of these studies modified how information was given to 
potential participants, including: amended information sheets; video information versus 
written information or use of interactive computer programmes to present trial information.49 
None of the studies in this Cochrane review provided conclusive evidence that the 
modifications to the way information is given improved accrual, although the use of an 
interactive computer programme to present trial information ‘probably slightly’ improved 
recruitment to a hypothetical cancer trial when compared with an audio tape presentation (RR 
1.48, 95% CI 1.00-2.18).47,49 
The literature often focuses on the need to determine patient levels of understanding to ensure 
that patients have given fully informed consent. Whilst it is imperative that people are fully 
informed before they give consent to participation, consideration also needs to be given to 
ensuring that patients also give fully informed refusal, as those who do not understand the 
process may be those who do not wish to take part.46 It could be argued that patients should 
be given the information in such a way that those who decline participation have made as 
much of an informed decision as those who accept, rather than refusing consent because they 
have not understood the trial or have not received the information that they need. This is an 
important issue if researchers are to achieve their targets whilst ensuring that the right patients 
both enter and decline trial participation. If it is true that how a clinician discusses the trial 
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with a patient influences their decision to participate, consideration of factors that impact on 
this process is important.  
Factors influencing the informed consent discussion 
The appropriateness of the informed consent process has been questioned by a number of 
clinicians. 40% of oncologists who enrol patients onto trials believe that consent is not 
designed to protect patients.4,16,50 Surgeons in one study felt that obtaining informed consent 
was an arduous process, stating that, while they may ‘vigorously support’ the trial, they 
cannot bring themselves to ask their patients to sign up: ‘I look at the informed consent sheet 
which is far in excess of what is appropriate and that’s it.51 (p1365) If there was not the need for 
written informed consent, 87% of 484 surveyed clinicians stated that they would enter more 
patients in trials.4,52 
Investigators were often uncomfortable with some aspects of the informed consent 
consultation; one of the reasons given is that they were not comfortable explaining trials to 
their patients,41 and some were too embarrassed to introduce the subject with their patients.37 
Many clinicians are uncomfortable with admitting to uncertainty, a central aspect of the 
consent process (discussed in detail in section 2.3.3.2.2). Many other reasons for having 
problems with consent have also been cited. 38% of surgeons recruiting to a cancer trial said 
that they had trouble with the informed consent process, specifically, the need to disclose 
information to patients that they would usually discuss as part of the usual consultation in a 
more flexible manner. Respondents appeared concerned that the informed consent form 
regulates formerly flexible decisions.53 Clinicians often found it difficult to initiate the clinical 
trial discussion,45 or to assess the level of information that patients want to be given.52 They 
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worried that too much information may frighten patients31 or even lead to increased morbidity 
or mortality.52  
In addition to these general concerns about the consent discussion, many cite difficulties with 
discussion of the specific terms used as part of a trial, for example, randomisation or 
placebo.54 Recruiters often feel ill prepared for carrying out consent and feel that they do not 
have adequate training or skills for the role.4 These concerns may lead to sub-optimum patient 
recruitment, encouraging clinicians to select the patients that they feel best able to 
communicate with. The literature recommends that clinicians consider that they will need to 
explain these terms, but there is little that discusses how this would be best achieved. 
Despite the wealth of literature examining informed consent, and the assumption that it 
impacts negatively on patient recruitment, there is no clear evidence about whether this is 
actually the case. The evidence rarely links clinician feelings about consent, or how they 
conduct the process to recruitment rates. Three survey studies did try to link these factors, but 
their findings were inconclusive. For example, one small survey of 40 oncologists found no 
significant difference in referral rates between those comfortable with explaining trials and 
those who were not, but potentially important differences could not be excluded given the 
small sample size (OR 5.05, 95% CI 0.85-29.91).55 Another study reported that there was a 
significant difference in recruitment between oncologists that have, and oncologists who do 
not have issues with obtaining informed consent (0% of those reaching recruitment targets 
cited problems with consent versus 37% of those who did not reach targets, p<0.005).52 
Conversely, a higher proportion of GPs who said that they were ‘too embarrassed’ to initiate 
trial discussions recruited than those who were not embarrassed (39.5% versus 22.7%, 
p<0.02).37 This finding seems counter-intuitive, and the authors offer no explanation for this 
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result. It may be that clinicians from different specialities have different concerns about 
consent, for example, oncologists and GPs, and that this accounts for the conflicting evidence. 
However, these findings do highlight the continued uncertainty around the subject. 
2.3.3.2.2 Impact on the Doctor/Patient Relationship 
In addition to the factors already discussed, a number of other issues have been identified that 
exacerbate the recruitment problem. Clinician concerns about the impact of trial inclusion on 
the doctor/patient relationship have a negative impact on recruitment,26,35 and may influence 
clinicians to select which patients they approach about participation. A systematic review of 
factors that limit the progress of RCTs found that, out of 84 primary research papers 
(qualitative and quantitative) reporting findings related to the recruitment of clinicians or 
patients, 12 discussed how the doctor/patient relationship may have acted as a barrier to 
recruitment.4 There are a number of possible reasons for this (See Table 3, page 18) and these 
will now be considered in turn. 
Discussion of uncertainty 
Studies of the doctor/patient relationship indicate that the main drivers of the relationship are 
patient’s trust in the doctor’s expert knowledge, individualised decision making power and a 
belief that a doctor will do their best for an individual patient.56 A concern is that the 
discussion of uncertainty disrupts that dynamic and has a negative impact on the 
relationship.25,52 The change in image from confident clinician to one with an attitude of 
uncertainty raises instinctive resistance amongst clinicians.27 Many are concerned that this 
would necessitate a major shift in the usual doctor/patient interaction and that patient morale 
may be reduced if they were exposed to the implicit indecision of a trial.50,52 In an interview 
study, many clinicians cited concerns with the need to admit uncertainty, typically saying: 
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For the trial, I guess I’ll have to start to learn to say ‘I don’t know 
which is best.’ I’m not sure I will be very comfortable doing that for 
too long.56 (p220) 
In one survey, this worry was found to have a negative impact on recruitment.57 Richardson et 
al found that those expressing difficulties with recruitment consultations were less likely to 
have recruited than those who did not (90 participants, p= 0.04). Another survey supported 
this finding. They reported that none of the 25 surgeons who recruited to target cited concerns 
with the discussion of uncertainty, while eight out of 32 who failed to recruit any patients 
perceived it as a problem (p<0.025).51 
Dual role of physician and researcher 
Another factor that leads to concerns about the doctor/patient relationship is the difficulty 
faced by clinicians when they are trying to fulfil the dual role of physician and researcher.4,41 
A traditional characteristic of the medical profession is its high social status, which is mainly 
derived from patients’ trust in their doctor’s knowledge and skills.56 When faced with a 
clinician’s uncertainty, the shift in this perception results in conflict between the roles of 
researcher and clinician.15 A clinician’s main priority is the well-being of patients. However, 
participation in a trial brings a competing priority, that of advancing scientific knowledge, and 
there is a perceived difficulty in balancing these two aims. Most focus more on fulfilling their 
patient needs than offering patients the opportunity to take part in research.15 This conflict can 
lead to the situation where, despite agreeing with the trial in principle, there is a subsequent 
failure to enrol patients.31 
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Clinical autonomy 
The final consideration that may impact on the doctor/patient relationship is the potential loss 
of clinical autonomy. Clinicians are reluctant to relinquish the power to make individual 
decisions about their patients;14,52,53,56 82% of clinicians cited this loss of independence as a 
barrier to recruitment.14 Clinicians also did not like the loss of flexibility implicit with 
following a study protocol 51,52,56 and wanted to retain the ability to act on their clinical 
judgement even where it conflicted with published data.53 Concerns about this loss of 
autonomy seem to have a negative impact on recruitment, as doctors select which patients 
they approach about the trial.4 However, despite the fact that this is often reported to be a 
barrier to recruitment, it must be noted that much of the evidence for this comes from one 
main author, and each project uses similar methodology, namely surveys of physicians 
recruiting to oncology trials.14,51,52,53,56 Prior assumptions of the authors that loss of autonomy 
is a barrier to recruitment may have influenced the questions asked, and therefore shaped the 
findings. Details of questions asked were also not given. Caution, therefore, must be applied 
to this conclusion. 
Logically it would be expected that concerns about the doctor/patient relationship would have 
a negative impact on accrual. As discussed, the evidence is mixed, with contradictory findings 
and no RCTs that test the theory. However, these areas have the potential to impact on many 
of the recruitment steps. They may influence the decision whether or not to participate, affect 
which patients are selected for trial entry, alter the informed consent discussion and create 
concerns about the generalisability of the study.  
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2.3.3.2.3 Structural Barriers to Recruitment 
Time constraints 
Even after a clinician has agreed to participate, the time it takes to enrol and follow up trial 
patients may still be a significant barrier to accrual.16 Time spent on research often has to sit 
within usual clinical practice and many clinicians do not have adequate time within the 
constraints of their current workloads to enrol patients into trials. The time demands of patient 
identification and obtaining consent are cited as particular barriers.16,58 These problems are 
exacerbated by complex protocols and poorly designed data collection forms. Trialists need to 
consider ways of providing appropriate support to clinicians to ensure lack of time will not 
deter them from taking part or inhibit their ability to carry out study procedures.4 One way is 
to ensure that trial processes are as streamlined as possible; paperwork should be succinct and 
uncomplicated, and identification of potential patients should be straightforward.17 Once 
again the advice, whilst intuitive, is not based on evidence. In fact, the evidence about 
whether time constraints adversely affect accrual is mixed. Oncologists who consider that 
‘trials involve extra work’ were more likely to have recruited than those who did not (OR 
92.94, 95% CI 4.54-1902.11), but those that thought paperwork time consuming were less 
likely to have done (OR 0.0011, 95% CI 0.00002-0.06): recruitment by surgeons was not 
affected by their views on the practical aspects of a trial.55 
Staff Shortages 
The lack of support staff is also cited as a barrier to trial recruitment.4,35 Some sites will not 
participate if they feel that they do not have enough staff to enable them to take fully informed 
consent4 whereas other sites may participate, but leave the majority of the work to be carried 
out by the recruiting doctor. Lack of support staff, (i.e. research nurses), may have a 
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detrimental impact on patient recruitment, although again the evidence is not clear cut. For 
example, GPs who had assistance with a trial from a practice nurse were found to be more 
likely to recruit than those recruiting alone (56% of GPs who had help from a nurse recruited 
versus 33% of GPs who recruited alone, p=0.02).57 On the other hand, there were no 
significant differences in recruitment between oncologists who had support staff, and those 
who did not, though the study was not powered to exclude a possible effect (OR 4.99, 95% CI 
0.64 – 38.63).55 Some trials have sufficient funding to allow researchers to ‘parachute’ into 
sites to carry out study tasks, thus minimising work for clinicians. This may help to overcome 
the barriers caused by time constraints. An examination of site factors affecting recruitment to 
the Cardiac Arrhythmia Suppression Trial (CAST) found a positive correlation between 
accrual and the availability of CAST nurse clinicians on site. Recruitment was better where 
there were more full time equivalent CAST nurses on site and where they were involved in 
fewer competing trials.59 Unfortunately it was unclear from the published report whether the 
nurses were employed by CAST and sent to sites to recruit, or whether they were nurses who 
worked on site anyway and were devoting some of their time to the trial. Although this 
example adds weight to the argument that increased support for investigators leads to 
improved recruitment, prospective studies examining this area could determine the optimum 
way that support with staffing could maximise recruitment.  
Research Experience and Training 
Prescott et al, in their systematic review of factors that limit the progress of RCTs, found 12 
studies that highlighted problems encountered with the lack of trained staff.4 Five of these 
found that clinicians were often inadequately prepared for the role;14,27,32,52,56 that training is 
often inadequate59 and that there is a perception amongst clinicians that there is a diminished 
number and calibre of researchers due to reduced career opportunities.32 Taylor et al suggest 
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that physicians need to be better educated on the rationale of RCTs in order to improve 
accrual.56 It would seem logical that better understanding of trials on behalf of recruiters 
would translate into better explanation of studies, reduced patient selection, and therefore, 
improved recruitment. 
Recruiters also need to be well informed about the aims of any study they are involved with, 
and to have a good understanding of the treatment arms and study processes.60 This is 
highlighted by the findings of a failed study looking at an intervention to enable people with 
mental health issues to return to work. Interviews were conducted with recruiters to determine 
why patient accrual was so poor. They found that recruiters, despite having received 
instruction about the study protocol, had a poor understanding of both general RCT tenets, 
including randomisation and equipoise, and a lack of knowledge about the study protocol. 
Many recruiters were confused about the treatment arms, and felt that the control arm was no 
treatment at all. In fact, the control arm was standard practice. This confusion communicated 
itself to the patients, and they in turn refused trial participation.15 
Three articles state that lack of research experience on behalf of the investigator is also a 
barrier to recruitment,32,61,62 but not all studies came to the same conclusion. De Witt et al 
found that prior research experience had no association with recruitment rates (OR 1.5, 95% 
CI 0.6-3.6).34 In the United Kingdom, research networks are now used to identify sites that are 
suitable for recruiting patients to trials. They ensure that clinicians are well prepared to carry 
out research, offering training and support for research processes and ensuring that sites are 
able to carry out all study procedures.63 However, anecdotally, it seems that some research 
networks place emphasis on larger sites, and prioritise sites that are research experienced for 
involvement in trials. While this approach may reduce generic training requirements (e.g. 
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GCP), paradoxically it may have a detrimental effect on recruitment. Investigators that have 
no prior experience of research may recruit as well as, or better than, those who have had 
involvement with other trials, as prior research experience has not been shown to be 
associated with recruitment.34  
2.3.4 Problems with the Existing Evidence 
There are a number of limitations to the current literature. Many of the publications are 10 
years old or more and there have been significant changes to how trials are conducted since 
this time, especially with regard to informed consent, so it is not clear how relevant the 
findings remain. Many articles are observational or descriptive studies of individual projects, 
and do not relate their findings to recruitment rates. While they provide a useful insight into 
the subject, they do not provide any evidence that their procedures were linked to their 
recruitment. No articles were found that examined recruitment to a trial that was failing to 
recruit patients but which introduced changes that improved accrual, which might provide 
useful insight into strategies that may work.2 A large number of studies are surveys of 
recruiting clinicians and as such they may suffer from biases inherent in such study designs. 
Surveys are cross sectional studies, generally carried out at one point in time, and as such 
provide a snapshot of a situation and give no indication of the sequence of events under 
investigation. Therefore, they can imply association but cannot determine whether the 
outcome is as a result of the exposure.64 Furthermore, surveys can suffer from bias, for 
example non-response bias, where a low response rate is obtained. This is especially 
problematic where responders differ systematically from non-responders. They may also 
suffer from recall bias, where respondents can be misclassified during analysis due to an error 
in their memory of the situation under question.64 Few RCTs were found that actually tested 
any interventions to improve recruitment, and although a few studies have found various 
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factors that are associated with recruitment rates, there were none that looked at potential 
interventions to overcome the issue. Furthermore, the evidence that is available is often 
conflicting, which may be due to specific features (for example, the impact of 
inclusion/exclusion criteria) of the individual trials.  
Another major limitation of the literature is the fact that many of the papers relate to 
secondary care based cancer trials, and as such, may have issues specific to their setting or 
disease area. For trialists looking to carry out RCTs in a primary care setting, the relevance of 
this evidence is unclear. Therefore, the next chapter will look specifically at the evidence 
relating to primary care based RCTs to establish how far the factors already identified remain 
relevant when recruiting to trials in this setting. 
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Chapter 3: Review of Literature Pertaining to Primary 
Care Based RCTs 
As discussed in section 2.1, it is important for external validity that trials are carried out in an 
appropriate setting. For GPs to be willing to rely on the evidence from trials, they need to be 
sure that it is relevant for their patients. Therefore, GPs are looking for evidence from trials 
carried out in a primary care setting. As discussed, one of the problems with the literature is 
that much of it relates to issues of recruitment to secondary care based cancer trials: there 
seems to be little discussion about RCTs carried out in the primary care setting. While some 
of the issues may be generic, it is likely that there are a different set of considerations to take 
into account. In primary care, for example, the nature of the disease being studied is likely to 
be different: clinicians may find it less difficult to introduce the concept of randomisation 
when they are not discussing a potentially terminal illness such as cancer.   
For trials carried out in a primary care setting, the steps leading to patient recruitment are 
likely to be identical (See Figure 1, page 10) and some of the central issues (for example, 
clinical equipoise and the need to follow GCP guidance on obtaining informed consent) will 
remain the same as those described in section 2.3.3.2. However, it is possible that the factors 
that affect these steps in primary care based trials differ from those in other settings. Primary 
care based trials, for example, often involve higher numbers of smaller sites than are needed 
when carrying out hospital based studies. These sites are often very diverse, both 
geographically and in their structure, and may have very different population mixes or disease 
types to those found in secondary care: all of these considerations could mean that recruitment 
problems at any step in the process are magnified in primary care based studies.   
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This chapter will look at the literature pertaining to primary care based trials, determine 
whether or not the issues that have already been identified remain relevant when specifically 
considering trials in this setting, and whether there are any issues that apply only to these 
studies. Interventions to overcome any issues raised will also be discussed.  
A review of the literature was carried out that had two objectives: 
 To determine how far the recruitment issues that have already been identified apply to 
RCTs carried out in a primary care setting; 
 To identify interventions that impact on recruitment to primary care based RCTs 
One of the problems when carrying out searches for methodological papers is that it is not a 
clearly defined clinical question that is being asked, and as such it is difficult to narrow the 
search down without losing too many relevant articles.4 The search strategies employed here 
aimed to maximise the number of relevant articles while keeping the numbers of papers to 
manageable levels.  
3.1 Methods 
The Pubmed and Pubmed Central (PMC) databases were searched, as was the Cochrane 
Library.  The searches run in the Pubmed database allowed simultaneous searching of 
Pubmed, Medline and PMC. These databases were selected as it was felt that many of the 
relevant articles would be identified through them. The Cochrane database was included to 
identify any Cochrane Reviews that may be relevant to the question. As it is not possible to 
conduct very sensitive searches for such a non-specific question, the databases of two journals 
were also searched (Trials and Biomed Central Methodology) in order to identify any further 
articles that had not been picked up through the initial searches. Finally, the reference lists of 
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all relevant studies were examined to try to ensure that no important papers had been 
overlooked. 
3.1.1 Search Criteria 
The search criteria chosen aimed to cover the commonly used terms both for patient 
recruitment and primary care; similar terms have been used in prior reviews4,35,11 (See Table 
5). Initially the Pubmed and PMC databases were searched with RCT as RCT*: this approach 
returned 640,000 references, so the wild card was removed and the search re-run. This 
reduced the number of papers returned to more manageable levels, hopefully without 
removing any of relevance. Date ranges were applied to the searches, with publications prior 
to 1990 being excluded. It was felt that those prior to 1990 may not be relevant to current 
practice as many changes both to general practice and approaches towards the conduct of 
research had taken place since that time. The searches were carried out in March 2011, so 
articles published post March were also not included. 
Table 5: Search Criteria 
Database Search Criteria Restrictions 
Pubmed 
Random* control* trial OR RCT AND 
primary care OR family practice OR GP OR 
family physician OR community AND 
recruit* OR accru* OR enrol* 
 
English papers 
Articles with abstracts 
Humans 
From 1990 – March week 
1 2011. 
Pubmed 
Central 
Random* control* trial OR RCT AND 
primary care OR family practice OR GP OR 
family physician OR community AND 
recruit* OR accru* OR enrol* 
 
English papers 
Articles with abstracts 
Humans 
From 1990 – March week 
1 2011. 
Cochrane recruitment AND “random and trial” AND 
“consent or accrual” and “primary care” 
None 
Trials Random* control* trial AND primary care 
AND recruit*.   
None 
BMC 
Methodology 
Random* control* trial AND primary care 
AND recruit*.   
None 
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The criteria used across different databases were kept as similar as possible. The process of 
building searches differs between databases: those run on the Cochrane and the individual 
journal databases were less flexible than Pubmed and PMC, and there was less scope for 
including alternative terms for primary care or recruitment. 
3.1.2 Selection Criteria 
Papers were eligible if there was discussion of the practice or practitioner issues influencing 
patient recruitment, although articles not available in English were excluded as there were no 
resources available to carry out translation. Papers were also excluded if they looked only at 
the recruitment of potentially vulnerable patient groups, for example, children or prisoners, as 
there are likely to be specific issues with recruiting these populations that are not relevant to 
primary care based trials in general. Similarly, those restricted to the recruitment of ethnic 
minority populations were excluded. Finally, papers discussing the recruitment of patients to 
studies with designs other than individually randomised RCTs were not considered.  
3.1.3 Quality Assessment 
No formal assessment of the quality of included articles was carried out, for two reasons: 
 The aim of the review was to determine whether the factors found to influence 
recruitment to trials in general were relevant to those carried out in primary care so 
any relevant articles were considered regardless of their methodology 
 Very few trials of recruitment processes have been carried out, and none of these were 
specific to primary care 
All articles of any study type were eligible as long as they discussed recruitment to primary 
care based RCTs.  
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All search results were imported into Reference Manager (version 11) and duplicates were 
removed. The titles of all remaining articles were screened, and any irrelevant titles were also 
deleted. Of the remaining titles, where there was any uncertainty about the relevance, the 
abstract was reviewed for eligibility and irrelevant papers were again excluded. For all 
remaining potentially relevant studies, full text articles were obtained and assessed for 
inclusion. 
3.2 Results 
From 6083 unique titles, 99 articles were retrieved and 35 eligible publications identified. A 
further 19 papers were identified from the search of reference lists of relevant studies, giving 
a total of 54 applicable articles. (See Figure 2, page 40) 
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Figure 2: Primary Care Literature Review 
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54 
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3.3 Discussion of the Evidence Pertaining to Primary Care Based 
Trials  
Factors influencing recruitment to primary care based trials are broadly similar to those 
affecting trials in all settings (see Tables 3 (page 18) and 4 (page 21). 
3.3.1 Physician Willingness to Participate 
When looking at trials in general, the recruitment of adequate numbers of physicians or sites 
was identified as a particular problem for trialists: a number of factors influencing their 
willingness to involve themselves with trials were identified. (See Table 2, page 13) This 
issue is also problematic for primary care based trials. In fact, it is possible that it is an even 
more acute issue in primary care,65 as these trials typically involve a larger number of sites 
than trials carried out in a hospital setting. There are a number of articles that have highlighted 
this issue. (See Table 6, page 42) 
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Table 6: Summary of Publications included in the Systematic Review  
Study Design Relevance Methods and Results 
Allsup et 
al. 200266 
Retrospective analysis of 
recruitment to an RCT of 
influenza vaccination; 
questionnaire survey of 1173 
patients who refused to 
participate 
Identification of 
eligible patients; 
impact of 
information given 
to patients on 
their willingness 
to participate 
Patient Identification: Only 7/20 (35%) of practices had the necessary skills 
to identify patients using computers, manual identification of patients in 
remaining practices was difficult and time consuming. 
Questionnaire response rate: 1173/2583 (45.4%). 
Impact of information given on patient willingness to participate: 25.2% of 
responders objected to the use of the word geriatric, causing sufficient offence 
to be sole reason for non-participation.  
Asch et al 
200065 
Systematic Review of studies 
recruiting large numbers of 
community based physicians 
where their burden of work is 
greater than completion of a 
survey 
Physician 
willingness to 
participate in 
research 
Sixteen studies identified with GP participant rates ranging from 2.5%-91%. 
Barriers: time pressures; GPs show less interest in research than specialists; 
incentives (i.e. payment) did not influence recruitment rates.  
Facilitators: affiliation with academic institutions; personal contact by peers; 
friendship networks. 
Askew et 
al. 200267 
Postal Survey of 467 GPs and 
qualitative semi-structured 
interviews with 18 GPs 
GP attitudes 
towards research 
389/463 (84%) of GPs had a positive attitude to research; only 29% of these 
wanted more involvement. 
Barriers: general practice environment and culture.  
Enablers: academic mentors; reputable established research relevant to 
general practice; access to information resources, i.e. MEDLINE. 
Bell-Syer et 
al. 200825 
Postal survey of 124 GPs 
participating in 2 RCTs of 
management of low back pain 
(one exercise trial and one 
acupuncture trial) 
 
Identification of 
factors 
influencing GP 
referral of 
patients 
Response rates: Exercise trial, 64/87 (73%). Acupuncture trial, 27/37 (73%) 
Reasons for non-referral: patients already had other treatments; time 
constraints; concern for patients (not all patients would get the intervention; 
patients travelling to classes/clinics); remembering inclusion criteria. 
Reasons for referral: belief in the benefits of exercise/acupuncture; desire to 
support research; research gave extra treatment option; positive feedback 
from existing trial patients. 
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Study Design Relevance Methods and Results 
Bower et 
al. 200718 
Email questionnaire of 70 
corresponding authors who 
carried out an RCT in UK 
primary care that were published 
in the BMJ, Family Practice or 
BJGP. 
Identification of: 
extent of 
recruitment 
difficulties; 
responses to 
problems; 
relationship 
between trial 
characteristics 
and recruitment 
Response rate: 39/70 (56%).  
Extent of difficulties: Ten trials (29%) recruited to time; 12 (35%) required up 
to 50% more time than planned; 12 (35%) required over 50% additional time. 
Responses to problems: Extension of recruitment period (56%); seeking 
additional funds (31%); alternative recruitment methods (18%); recruitment 
of more sites (44%); recalculating power (21%); completion with insufficient 
patients (18%). 
Relationship: Only 12.5% trials where GPs were responsible for gaining 
consent recruited within 50% extra time, compared with 61.5% where GPs 
were not responsible (P = 0.04). 
Bower et 
al. 200968 
Narrative literature review Factors impacting 
on recruitment; 
key areas for 
further research 
Successful recruitment strategies (tested in trials): Open versus placebo 
controls; lay advocates/recruiters; alternative patient contact strategies; paper 
versus electronic data recording. 
Further research: should follow the framework for development of complex 
interventions; use infrastructure (i.e. Clinical Research Networks) to carry out 
research on recruitment strategies; evaluation of this infrastructure; 
development of public and professional engagement with research. 
Brealey et 
al. 200769 
Comparison of different 
randomisation procedures in an 
RCT of early access MRI versus 
referral to orthopaedic specialist 
for suspected internal 
derangement of the knee 
Recruitment rate 
when using postal 
randomisation 
procedure instead 
of telephone 
randomisation 
Randomisation procedure did not affect GP willingness to participate. 
(155/359 (43%) postal versus 130/288 (45%) telephone)  
Patients recruited per practice: telephone, median 2.5, range 0 -23; postal, 
median 1.5, range 0-9. 122 (43%) practices recruited no patients. 
Factors associated with more patients: 12% increase with more GPs in 
practice (p=0.001). 
Factors associated with fewer patients: decrease in 2% with increased 
practice distance from hospital (p=0.001). 
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Study Design Relevance Methods and Results 
Carr et al. 
201070 
Direct head to head comparison 
of methods to improve 
awareness of and recruitment to 
Alzheimer Disease (AD) trials.  
Comparison of 
Continuing 
medical education 
(CME) based 
event for primary 
care physicians 
(PCP arm) versus 
a grass roots 
outreach event 
(COE arm)  
Post PCP course: PCPs were more likely to: view trial participation for 
patients as useful (p=0.02); and refer patients to AD trials (p=0.032). They 
were less likely to see trials as increasing their workload (p=0.0003). There 
was no influence on the perception of potential risk to patients or fear of 
losing patients to other healthcare providers. 
Post COE course: no before and after comparison made. 187/250 (75%) 
attendees agreed to future contact from trials. 
Long term outcome: (4 months post event, defined as enrolment in any 
clinical research activity): PCP arm = 0 patients; COE arm = 69 patients 
(p<0.0001). 
Davey et 
al. 200371 
Comparison of two recruitment 
methods to an RCT examining 
cost effectiveness of water 
therapy for elderly people with 
lower limb osteoarthritis 
Comparison of 
GP recruitment 
versus 
recruitment using 
the media  
Recruitment methods: All patients aged 60+ within participating practices 
were sent a screening questionnaire to determine eligibility. An advert for the 
trial was printed alongside an article in a local newspaper about the benefits 
of exercise for osteoarthritis. 
Results: 66 eligible patients recruited during 1 month period via newspaper; 
242 recruited via general practice in a 6 month period (40 per month). 
Recruitment via media yielded fewer patients but was more cost effective 
(£2.72 per patient versus £27.66 per patient) and more efficient (1 month 
versus 6 months). 
De Witt et 
al. 200134 
Survey of 165 GPs recruiting to 
an RCT of drug treatment for 
dyspepsia 
GP reasons for 
participation and 
association of 
reasons with 
patient 
recruitment 
128/165 (80%) response rate 
Reasons for participation: research topic (59%); involvement of academic 
research group (63%); professional obligation (39%); financial incentive 
(15%) 
Factors associated with recruitment rate: participation of an academic 
research group (adjusted OR 2.9; 95% CI 1.2-6.9). 
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Study Design Relevance Methods and Results 
Dormandy 
et al. 
200872 
Qualitative semi-structured 
interviews with 20 GPs 
recruiting to an RCT of sickle 
cell screening. 
Physician 
willingness to 
participate in 
research 
Factors important in recruitment: research topic; invitation method; interest 
in research.  
Ellis et al 
200773 
Retrospective analysis of yield 
and cost of 10 recruitment 
strategies used to involve 
practices in a trial of 
cardiovascular disease risk factor 
management. 
 
 
Physician 
willingness to 
participate in 
research 
Recruitment strategies: Opt in (i.e. mass advertising; practice meetings; non-
personalised mailings; emails from opinion leaders). Opt out (i.e. repeated 
cold calling; exploitation of professional relationships). Combined opt in opt 
out (physicians sent an interest survey). 
Response rates: Overall recruitment 68/13823 (0.49%). Opt-in replies 
53/13290 (0.40%), recruited 18/53 (34%); opt-in portion of opt-in – opt-out 
response 90/176 (51%), recruited 19/90 (21%). No results given for opt-out 
approaches. 
Best approaches: practice meetings (42%); professional relationships (33%). 
Foy et al. 
200274 
Survey of trial organisation of 
seven clinical trials of dyspepsia 
management, followed by a 
Delphi technique to reach 
consensus on quality of evidence 
to support recruitment 
interventions 
Determination of 
whether 
commonly 
employed 
recruitment 
strategies are 
evidence based 
Methods: Recruitment methods used in the dyspepsia trials were categorised 
and deemed to be evidence based if they met criteria I (value established in 
RCT or systematic review) or II (sufficient face validity that RCT deemed 
unnecessary) with agreement by 7 out of 9 investigators.  
Results:  56 interventions were identified (median 8 per trial, range 6-9). 
35/56 interventions were judged evidence based (interactive educational 
approaches, educational outreach; dissemination of educational materials). 
2/10 organisational characteristics that may influence recruitment were 
deemed evidence based (eligibility criteria and practitioner workload). 
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Study Design Relevance Methods and Results 
Fransen et 
al. 200775 
Case study of recruitment to an 
RCT of dyspepsia treatment 
Description of 
recruitment 
strategies 
GP recruitment: a letter, trial information and recommendation from College 
of General Practitioners were sent to all GPs. Non-responders were called, 
and interested practices were visited. 312 GPs participated; 162 (52%) failed 
to recruit any patients. 
Patient recruitment: by GPs during routine consultation.  
Interventions to improve recruitment: monthly newsletter reminders, 
minimisation of GP workload; extension of recruitment period (only GPs 
expected to recruit continued). Recruitment rate did not fall, implying that 
inclusion of the ‘right’ GPs may lead to more effective recruitment. 
Frayne et al 
200176 
Focus group with a convenience 
sample of seven primary care 
providers  (PCPs) 
Practitioner, 
attitude and 
beliefs regarding 
their role in 
recruitment to 
cancer prevention 
trials 
PCP concerns: dual role of patient advocate and researcher; threats to 
primary care relationship (loss of clinical autonomy); general philosophy 
towards prevention (support for lifestyle interventions, less support for cancer 
prevention medications); distrust of the research process (research goals may 
take precedence over optimal patient care); influence of PCP trust for a 
particular investigator. 
Galvin et 
al. 200977 
A postal survey of 226 GPs to 
determine attitudes towards 
Alzheimer disease (AD) clinical 
trials 
Factors affecting 
likelihood of a 
physician to refer 
patients to trials 
Benefits of referral: patient benefits from participation; patient interested in 
participation; participation may enhance care; practitioner may gain helpful 
feedback to guide care decisions.  
Barriers: perception of risk; patient inability to consent; patient exposure to 
procedures or extra risk; participation overly burdensome; distance from 
research site; patient expressed no interest in research; lack of awareness 
about studies; lack of time during consultations. 
Predictors of referral: close proximity of AD research centre (OR: 4.0, 95% 
CI: 1.1-15.6).  
Barriers to referral: concerns about procedures or extra risk (OR: 4.7, 95% 
CI: 1.2-18.7); lack of time (OR: 6.8, 95% CI: 1.4-32.3). 
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Study Design Relevance Methods and Results 
Geraets et 
al. 200678 
Evaluation of two recruitment 
strategies to an RCT of a 
behavioural treatment for 
patients with chronic shoulder 
complaints 
Comparison of 
GP recruitment 
versus 
recruitment using 
the media; 
comparison of 
patient outcomes 
Results: 83 patients recruited by GP, 93 by advertisement. Media recruitment 
was more efficient (4 month recruitment period by advert versus 14 month 
recruitment by GP). 
Outcomes: those recruited via GP had greater mean improvements at 52 
weeks (p=0.001) irrespective of treatment allocation, indicating that 
recruitment strategy was a confounding factor. 
Graffy et al 
201079 
Telephone interviews with 20 
stakeholders (funders, principal 
investigators, trial managers, 
ethics committee chairs) 
Exploration of 
practicality and 
acceptability of 
undertaking 
nested trials of 
recruitment 
methods 
Barriers: challenges of implementation (increased complexity and 
management burden; compatibility between host and nested studies; impact 
of nested study on trial design and relationships with collaborators; who has 
control over nested projects and sample sizes). 
Enablers: nested studies should be planned from the outset; good 
communication between teams; and adequate resources. 
Graffy et al 
200880 
Iterative series of 3 workshops, 
the final one using a modified 
nominal group technique 
Identification of 
what research 
staff consider 
important in 
successful 
recruitment 
Research staff opinions: building and maintenance of relationships (most 
important factor); primary care teams having positive attitude to research; 
minimisation of workload and compatibility with practice processes. 
Grundmeier 
R et al. 
200781 
Description of two methods for 
supporting recruitment using 
electronic health records (EHR) 
Use of electronic 
health records to 
improve 
recruitment 
Strategy one: GP recruitment during consultations using computer ‘pop-up’ 
prompts as a reminder – clinicians would indicate that the research team had 
permission to contact the patient. 
Strategy two: on-site research assistants working from lists of potential 
subjects derived from the EHR. 
The use of on-site research assistants to directly enrol subjects generally 
resulted in enrolment of more subjects. 
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Hahn et al. 
200482 
Case study of recruitment to a 
pilot RCT of azithromycin for 
use in adult asthma 
Feasibility of GPs 
recruiting patients 
to a practical 
clinical trial of 
asthma 
3/11 (27%) participating GPs recruited no patients.  
Reasons for non-recruitment:  protocol was too difficult; and patients would 
not consent.  
Reasons for sub-optimal recruitment: eligible patients sometimes overlooked 
because of busy surgeries (GPs forgot or decided not to discuss the study). 
Herber et 
al. 200983 
Investigation of the success of 
different strategies employed to 
recruit GPs to an RCT of leg 
ulcer care. Reasons for non-
participation collected via 
telephone. 
Physician 
willingness to 
participate in 
research 
Phase 1 recruitment: Practices contacted by phone with a follow up fax; 
practices completed questionnaire to determine eligibility (26/1549 (1.7%) 
participation).  
Phase 2 recruitment: Practice eligibility assessed on the telephone, no need 
for questionnaire completion (12/273 (4.4%) participation). 
Facilitators: GPs affiliated to universities; use of physician recruiters. 
Barriers: Concern about study workload; disruption to practice routine; 
general lack of interest in research. 
Hummers-
Pradier et 
al 200884 
Postal survey of 96 German GPs 
and qualitative interview study 
of 21 GPs (12 telephone 
interviews and 9 face to face 
interviews)  
Identification of 
GPs’ motives for 
non-participation 
in research and 
subjective 
barriers to 
primary care 
research 
Survey results: Research considered important by 88/96 (92%) but 60 (64%) 
would not take part. 47 (49%) of responders would not allow researchers to 
have access to their electronic health records, or to allow their patients to be 
examined by study nurses on their premises. 
Qualitative results: GPs reservations towards participating in research are not 
merely a matter of time or workload. Concerns include: relevance of the 
question; not in professional remit of GPs; little value to GP career structure; 
distrust and negativity towards research and researchers (lack of recognition 
in the research process, fear of being measured by researchers or concerns 
about researcher access to data or practice computers), conflict between 
patient care and participating in research.  
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Study Design Relevance Methods and Results 
Hunt et al. 
200185 
Case study of a failed RCT of 
structured problem solving and 
selective serotonin reuptake 
inhibitor medication for patients 
with mild depression 
Identification of 
reasons why GPs 
failed to recruit 
patients to the 
trial 
Methods: The trial followed advice to minimise recruitment problems 
(recruited GPs with an interest in depression; involved GPs in protocol 
development; minimised GP workload; exploited CI relationships with 
participating GPs; amendment of inclusion/exclusion criteria).  
GP reasons for non-referral: lack of equipoise (1 in 6 excluded because of 
GP treatment preference); restrictive exclusion criteria (protocol amendments 
did not increase referrals).  
Author conclusions: there needs to be a fundamental shift in ethos and 
knowledge of principles that underlie research to improve recruitment. 
Johnston et 
al. 20109 
Mixed qualitative (interview) 
and quantitative (survey) 
methods to gather data about 
practice recruitment from five 
research teams.  
Physician 
willingness to 
participate in 
research 
GP recruitment rate ranged from 20-49% 
Barriers: Gaining rapport with front office to gain access to the decision 
makers.  
Facilitators: Recruitment by physicians (but is not explained by differences 
in recruitment rates); recognition and reward; perceived interest and 
relevance; effective communication with GPs. 
Recommendations: GP buy-in and effective communication with GPs are felt 
to be most important aspects of successful GP recruitment. 
Jones et al. 
200986 
Systematic review of trials 
published in four primary care 
journals 
Identification of 
the proportions of 
eligible patients 
recruited into 
RCTs to 
determine the 
external validity 
of trials 
Results: The median eligibility fraction (proportion eligible of those screened) 
was 83% (IQR 40%-100%); the median enrolment fraction (proportion 
randomised of those eligible) was 74% (IQR 49%-92%). Number needed to 
screen (NNS) to randomise one patient was 2.43 (range 1-484).  
Author’s conclusions:  patients deemed eligible after screening are likely to 
be randomised, though this may be due to inadequate identification or 
reporting of the eligible population.  
  
  
 
50 
Study Design Relevance Methods and Results 
Leathem et 
al. 200987 
Description of strategy used to 
recruit GPs to an RCT of an 
intervention to improve 
secondary prevention of 
coronary heart disease; 
Qualitative interviews with 
practitioners to explore 
perceptions of the recruitment 
process 
Physician 
willingness to 
participate in 
research 
GP recruitment rate: 48/165 (33.9%) 
Recruitment methods: Initial telephone contact by Research Nurse (RN) to 
determine practice eligibility and interest. Interested practices were then 
visited by nurse.  
Barriers: workload/time; staff issues; interest in question or research in 
general; insufficient number of eligible patients; realistic information about 
workload may harm recruitment but aids retention. 
Facilitators: Personal contact, avoiding unsolicited letters. 
Margitic et 
al. 199988 
Case study of recruitment to the 
Activity Counselling (ACT) 
Trial 
Relative success 
of different GP 
recruitment 
methods 
Methods: GPs at only 1 site were directly involved in recruitment but this was 
discontinued due to lack of recruitment. Patients were otherwise recruited by 
study personnel. 
Results: Direct mailing was the most successful, yielding 43.4% of 
randomised patients; questionnaires handed out in practice yielded 32.5%; 
direct telephone contact yielded 21.6%. 
Conclusions: multiple strategies should be utilised, monitored carefully and 
adapted as necessary. 
Mason et al 
200789 
Qualitative semi structured 
interviews with 41 GPs 
participating in an RCT 
recruiting patients with 
depression 
Practitioner 
factors affecting 
patient 
recruitment 
Themes identified: concerns about the impact on the doctor/patient 
relationship and protecting vulnerable patients; perceived lack of skill and 
confidence introducing the subject of research; the priority given to clinical 
and administrative tasks over research. 
Conclusions: patients are not always given the chance to participate in 
research in the same way they are encouraged to participate in treatment 
decision making. A radical change in clinician attitudes and policy may be 
needed to give research a higher priority in primary care. Lack of skills 
should be addressed with increased training for GPs. 
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Study Design Relevance Methods and Results 
McKinstry 
et al 200790 
Case study of an RCT of 
management of Bell’s Palsy 
Physician 
willingness to 
participate in 
research 
Recruitment methods: Invitation letters highlighted benefits of participation 
(benefits to patients; reduction of GP workload due to participation; 
remuneration). The letters were signed by local ‘champions’. 
Maintaining interest: Regular feedback and newsletters. 
Monaghan 
et al. 
200791 
Single blind RCT of the effects 
on recruitment of 
communication, involving 167 
clinical sites in 19 countries.  
Impact on 
recruitment of 
increased 
communication 
strategy between 
the central trial 
co-ordinators and 
the clinical sites 
Methods: Sites were randomised to either additional (85 sites) or usual (82 
sites) communication strategies. The additional group received a 
communication package comprising additional, individually tailored feedback 
about recruitment in addition to the usual correspondence.  
Results: there was no significant difference in the median number of 
participants recruited between the additional and usual groups (37.5 vs. 37.0, 
p=0.68). The median time to reaching half the randomisation target was lower 
in the additional group than the usual group but this did not achieve statistical 
significance (4.4 months vs. 5.8 months, p=0.08).  
Mosis et al. 
200692 
Use of software to allow 
automated patient identification 
and recruitment in an RCT of 
tolerability of celecoxib and 
diclofenac in patients with 
osteoarthritis; qualitative 
interviews with recruiting GPs 
Use of computers 
to identify 
patients, 
identification of 
barriers to using 
this approach 
Methods: The software was incorporated into the practice clinical computer 
systems. Patients with osteoarthritis were identified and an electronic 
reminder was added to the patient records. When the patient record was 
opened a study reminder was displayed, and the GP was guided through the 
recruitment process.  
Results: 170/7127 (2.4%) patients were eligible, and 20/170 (11.8%) were 
randomised. Reasons for non-inclusion after prompt: seen by a non-study GP 
(20%); GPs too busy to recruit (20%); GP forgot to recruit the patient (7%). 
36% were excluded due to patient related issues. 
Qualitative results: GPs liked the automated process, but specified lack of 
eligible patients, high number of false positive reminders, and difficulties 
recruiting patients during routine consultation as barriers to recruitment. 
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Nelson et 
al. 200693 
Qualitative interview study with 
13 practitioners (9 GPs and 4 
practice nurses) who recruited 
patients to an RCT of obesity 
management 
Practitioner 
factors affecting 
patient 
recruitment 
The intervention was a weight management model; this was implemented 
with few patients in the trial.  
Barriers to recruitment: substantial misunderstanding about who was 
responsible for implementation of the intervention; unmet training needs 
(many forgot about the treatment algorithm or expressed confusion about the 
mathematical formula they were required to calculate); high expectations 
about the intervention which became disillusionment as many felt it was 
merely a refresher of current knowledge. (these practitioners dismissed the 
study as a ‘waste of time’).  
Paine et al. 
200894 
Analysis of the effectiveness of 
conducting group seminars with 
patients prior to screening for a 
double blind RCT of hormone 
therapy  
Comparison of 
recruitment rates 
between patients 
who did and did 
not attend 
seminar groups  
Methods: Women were invited to attend a group seminar conducted by the 
research team prior to individual screening for study eligibility. The seminars 
aimed to increase knowledge about and understanding of the trial.  
Results: women who attended a group seminar were twice as likely to attend 
screening and enter the trial than those who did not (p<0.001). Additionally it 
was estimated that the time and the number and duration of telephone calls 
required to recruit were reduced for the seminar group. 
Pearl et al. 
200395 
Comparison of characteristics of 
recruiting and non-recruiting 
GPs in an RCT to determine 
usefulness of brain natriuretic 
peptide in diagnosis of heart 
failure. 
Characteristics of 
recruiting and 
non-recruiting 
clinicians 
GP recruitment rate: 186/294 (63%). 
Recruitment methods: Early involvement of GPs in protocol design; detail 
given about benefits of participation (reimbursement and CPD equivalent 
points); invitation letters; personal visits to practices. 
Results: Only 49% of participating GPs referred eligible patients (92/186). No 
differences in sociodemographic characteristics between referring and non-
referring GPs were found. The main reason given for non-referral was lack of 
eligible patients. 
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Perkins et 
al. 200896 
Telephone interviews with staff 
from practices which expressed 
interest, took part or withdrew 
from a trial of a complex 
intervention for caring for 
patients with chronic disease. 
Physician 
willingness to 
participate in 
research 
Results: 155 practice expressed interest, and 87 went on to participate. Of 
those 87, 30 (34%) subsequently withdrew.  
Reasons for non-participation: practice workload; delays between expressing 
interest and start of involvement (caused loss of interest or involvement in 
other activities); inability for one person to convince the rest of the staff to 
participate. 
Reasons for subsequent withdrawal: frustration caused by delays between 
provision of data and implementation of intervention; realisation of the actual 
workload; changing practice circumstances (i.e. Loss of key staff). 
Practices remaining in the trial: more likely to see an opportunity to improve 
chronic disease management and to perceive research as important to improve 
quality of care in the practice. 
Prout et al 
200397 
Qualitative semi-structured 
interviews with 9 GPs recruiting 
to a double blind placebo 
controlled RCT of treatments for 
upper respiratory tract infections 
in children 
Practitioner 
experience of 
participating in an 
RCT 
Themes identified: difficulties with recruitment and concerns about safety of 
study medication; insufficient time to recruit during consultations; ideas for 
successful trial implementation (including good organisation; simple 
documentation (especially for patients) and study procedures; ability to allay 
concerns about patient safety).  
Raftery et 
al 200998 
Review of guidelines governing 
payments to clinicians for 
recruiting to trials. Qualitative 
semi-structured interviews with 
a range of NHS clinical trial 
leaders 
Motivators to GPs 
to participate in 
research 
Participants agreed that research expenses should be covered but that payment 
in excess of expenses may increase participation but risks reduction of 
quality. Motivators such as interest in the topic, scope for patient benefit and 
intellectual curiosity were considered more important. Reduction of 
bureaucracy and delay are important facilitators. 
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Raina Elley 
et al 200799 
Comparison of two recruitment 
strategies to an RCT of a 
multifactorial falls prevention 
programme 
Effectiveness of 
different 
recruitment 
strategies 
Methods:  Patients received study information and a simple study 
questionnaire asking if they had a fall or trip in the preceding 12 months. In 
recruitment strategy one, the information and questionnaire were handed to 
the patient by the receptionist when they entered their practice. In strategy 
two, the information was mailed to all those in the age group (75+) on the 
practice register.  
Results: 312 patients were recruited in total. There was a statistically 
significant difference between the proportion of those screened in the waiting 
room who participated, and the proportion of those who were screened via 
post (90/729 (12.3%) versus 222/2705 (8.2%) respectively) (p<0.001). 
Reid et al. 
2001100 
Case study of recruitment to an 
RCT of the treatment of 
hypertension in the elderly 
Physician 
willingness to 
participate in 
research 
Peer to peer recruitment was the most successful strategy. Multifactorial 
approaches seem to work including: targeting of GPs working in areas with 
high proportion of relevant population (relevance to their practice 
demographics); minimisation of workload; face to face meetings and personal 
contact with GP. 
Richardson 
et al. 
200257 
Cross sectional postal survey of 
98 GPs who had agreed to 
recruit patients for an RCT of 
breath testing for H. Pylori in 
patients with dyspepsia.  
Identification of 
factors associated 
with patient 
recruitment by 
GPs 
Response rate: 95/98 (97%). 53 (56%) of participating GPs recruited no 
patients.   
Factors associated with recruitment: GPs who had help from practice nurses 
were more likely to recruit than those who did not. Of the 46 GPs who had 
nurse help, 26 (56%) recruited, while 16 (33%) without help recruited 
(p=0.02).  
Factors not associated with recruitment: Age, sex, number of GPs in the 
practice, and number of half days worked. 
Ried et al 
2008101 
Cross sectional postal survey of 
five groups of general practice 
registrars who participated in a 
‘Registrar Research Workshop’ 
(RRW) 
Impact of training 
on GP skills, 
confidence, 
participation and 
interest in 
research 
Response rate: 77/121 (64%). 
Results: Self-reported research skills increased for the whole group 
(p=0.047), most significantly for those with little prior research experience 
(p<0.001). 
Two thirds of respondents had been research active, while 84% indicated a 
high degree of interest in taking part in research in the future. The RRW 
provides a model for effective training for interested GP trainees. 
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Rollman et 
al. 2007102 
Cross sectional comparison of 
recruitment data from two trials 
to treat anxiety disorders 
Comparison of 
electronic 
medical record 
reminder versus 
waiting room case 
finding strategy 
Waiting room recruitment: study recruiter was stationed in waiting room and 
administered a questionnaire to determine patient eligibility. 
Electronic medical record reminder: Electronic prompt to remind GP about 
the trial during routine consultations for anxiety disorders.  
Results: Electronic medical record reminders resulted in 176/794 (22%) 
patients; waiting room recruitment resulted in 193/8095 (2.4%) patients. 
Authors’ conclusions: Electronic reminders may increase efficiency by 
reducing the burden imposed on practice staff and study personnel. 
Rosemann 
et al 
2004103 
Cross sectional study using 
semi-structured interviews with 
a random sample of 76 GPs who 
are involved in the teaching of 
medical students 
GP attitudes to 
research and 
reasons for 
participation/non-
participation 
85% of GPs appreciated research in their field. 
Barriers: scepticism about research (perceived gap between theoretical 
research and practical work of GPs; and the domination of research by 
specialists); clinical workload; Disease Management Programmes and 
administrative overload.  
Biggest motivator: substantiation of their quality of care with solid research 
data.  
Salmon et 
al 2007104 
Qualitative interviews with 23 
GPs who declined to participate 
in a research trial to manage 
medically unexplained 
symptoms 
Interpretation of 
significance and 
interrelationship 
of barriers to GP 
participation 
Reasons for non-participation: lack of time; protection of their patients from 
researchers (concerns about unethical research, confidentiality, coercion, risk 
to patients); lack of research skills; research has no professional status (seen 
as irrelevant to GP careers and they feel that they don’t have responsibility to 
do it); they place little value on research because it is uninteresting; concerns 
about loss of clinical autonomy.  
Authors’ conclusions: Lack of time is given as a reason for not participating, 
but that is justification rather than explanation. The underlying concerns are 
what really deter GPs from participation. It is possible that payment will 
release more time, as GPs are more likely to use their own time if payments 
are made. 
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Sanders et 
al. 2009105 
Case study of recruitment to an 
RCT of vitamin D3 versus 
placebo for older women at risk 
of hip fracture 
Comparison of 
recruitment 
strategies 
Recruitment strategies: Doctor referral; presentations at clubs; church/club 
newsletter; word of mouth; media; targeted mail outs. 
Results: 1716/2317 (74%) of patients were recruited in the last 5 months 
following a targeted mail out. Prior to this, only 541 women were recruited 
over an 18 month period. Targeted mail out recruited 1629 (70%) of patients; 
GPs recruited 116 (5%) of patients. 
Sherber et 
al 2009106 
Questionnaire study of patients 
to determine whether their 
willingness to participate in a 
trial is influenced by whether 
their personal physician rather 
than an unfamiliar physician was 
study investigator 
Influence of 
relationship 
between the 
patient and the 
physician 
Response rate: 789/1132 (70%) with 666 having complete data. 
Results: Patients were likely/very likely to participate 56% of the time if 
asked by their personal physician compared to 36% of the time if asked by an 
unfamiliar physician (p<0.0001). 
Authors’ conclusions: this finding could relate to the importance of 
communication, trust and familiarity with the health care system. 
Sibthorpe 
et al 
2002107 
Interviews with health care 
professionals recruiting to a 
failed RCT of the effectiveness 
of a brief intervention for 
hazardous alcohol use. 
Reasons why 
patients were not 
recruited 
Results: Project processes did not fit with clinic processes and was seen as a 
‘hassle’; alternative processes favoured by clinic staff did not fit study 
protocol; health workers uncomfortable approaching people about their 
drinking and uncomfortable about implementing the intervention; health 
workers considered randomisation unethical on one hand, and ‘like telling 
people what to do’ on the other hand. 
Stuardi et 
al 2010108 
Discussion of advantages and 
disadvantages of identifying 
potential participants using 
database recruitment 
Identification of 
participants 
Advantages: Identification of large numbers of potential patients quickly and 
easily (computer search); quick delivery of study materials via bulk mail out; 
can be scheduled to take place at a time convenient to the practice; 
elimination of subjectivity that may accompany GP referral. 
Disadvantages: Restricted to identifying patients with chronic conditions; 
may include patients who do not meet inclusion criteria; may include people 
inappropriate to contact (i.e. recently deceased). 
  
  
 
57 
Study Design Relevance Methods and Results 
Van der 
Windt et al 
2000109 
Illustration of problems related 
to patient recruitment to an RCT 
comparing corticosteroid 
injections and physiotherapy for 
painful stiff shoulder 
Reasons for non-
referral and 
efforts to 
overcome poor 
recruitment 
Reasons for non-referral: busy surgeries; forgetfulness; conviction that a 
patient would benefit more from a specific intervention; lack of eligible 
patients; restrictive trial procedures. 
Interventions to improve recruitment: monthly newsletters; reminders; six 
monthly practice visits; prompt and adequate feedback to queries about trial 
procedures. 
Authors’ conclusions: As not all participating GPs recruit it may be more 
useful to identify GPs motivations to participate and target those interested 
and experienced in research rather than recruit as many GPs as possible. 
Wadland et 
al 199062 
Comparison of recruitment to an 
RCT of smoking cessation in 
two primary care sites, and a 
randomised trial of how consent 
was gained in one of the sites 
Comparison of 
different ways of 
recruiting and 
gaining consent 
Site one: private family practice with 5 physicians (ages 35-62) and 15,000 
patients. All patients were given a screening questionnaire on entry to the 
practices and smokers were informed about the trial. 
Site two: academic general internal medicine practice with 6 physicians (aged 
32-58) and 16,000 patients. Interested smokers were randomly assigned to 
having the form explaining the study read to them by the study co-ordinator 
(actively informed group) or the patient reading the information alone (self-
informed group). 
Results: The rate of enrolment was 3.3 times greater in the private practice 
than the academic practice (45% versus 14%). There were no difference in 
recruitment rate between the actively and the self-informed groups (27/51 
(53%) actively informed versus 25/52 (47%) self-informed) 
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Ward et al 
199429 
Follow up study (using self-
administered questionnaires) of 
134 GPs participating in the 
Men’s Health Study to elicit 
their feedback about the study 
GP perceptions 
about 
participating in 
research 
Factors influencing decision to participate: research topic; telephone call 
from PI prior to written information; co-ordinator visit; GP interest in 
research. Decisions to participate influenced more by topic and personal visits 
than by names and track record of research team. 
Positive aspects of study: prompt to remind GPs to talk about urological 
problems; quick and easy protocol; increasing patient awareness about 
urological problems; patients liked practice to take part in research. 
Negative aspects of the study: negative reactions of some patients; age 
restriction of the protocol; demands on time; extra workload; inappropriate 
timing of the study. 
Wilson I et 
al 200037 
Postal questionnaire of 636 GPs 
who participate in clinical trials 
Differences 
between 
recruiters and 
non-recruiters 
Response rate: 636/1518 (41.9%). Of these 169 (26.6%) had not recruited 
any patients to any study. 
Differences between recruiters and non-recruiters: wish to learn more about 
research (74.8% versus 63.8%); desire a good relationship with staff (63.9% 
versus 53.1%); involvement worthwhile (83.1% versus 54%); too 
embarrassed to ask (39.5% versus 22.7%); patient refusal (81.2% versus 
63.2%). All findings are statistically significant (all p<0.02). 
Yeomans 
Kinney et 
al 1998110 
Survey of 175 women at 
increased risk of breast cancer 
who discussed the possibility of 
their inclusion in a trial with 
their GP 
Impact of GP 
recommendation 
for involvement 
in a trial 
Women who reported that their GP advised them to participate in a trial were 
13 times more likely to participate than women who reported that their GP 
advised them not to participate (OR 13.09, 95% CI 2.64-64.77). 
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3.3.1.1 Interest in the Study Question 
One factor cited as an issue that impacts on the willingness of clinicians to participate in trials 
is interest in the study question, and this remains true for GPs. Seven papers reported that 
interest in the question encouraged them to take part, or cited lack of interest as a reason for 
declining participation.9,29,72,83,84,87,90 One of the main aspects of a trial that will encourage GP 
interest in a question is its perceived relevance to their everyday practice: relevance 
encourages personal interest in the topic83 and is a ‘cornerstone for the GPs decision’ to 
participate.84 GPs will consider the population mix of their practice and will consider the 
relevance to their patients when considering participation. In an interview study, one GP 
stated that one of the reasons they took part was because ‘we have a very high proportion of 
people from the relative… ethnic minorities, so it seemed sensible for us to do it’.72 Although 
this finding is true to all trials, there seems to be an extra hurdle to overcome when recruiting 
GPs rather than specialists and this may be reflected in the fact that there are lower 
participation rates amongst GPs than other specialities.65 GPs seem to have less interest in 
research in general, with some questioning the relevance of research at all:67,83 these 
practitioners were unlikely to become involved with trials.67 Eight papers67,72,80,83,84,87,103,104 
cited a general lack of interest in research as a problem that needs to be overcome in order to 
improve GP participation, and they put forward a number of reasons to explain why they 
place little importance on it. (See Table 7, page 60) 
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Table 7: Reasons given for GP Lack of Interest in Research 
Value of Research from GPs Perspectives 
Relevance to a primary care career  
 A different career structure to that of specialists means that there is no need for 
GPs to carry out research or to publish papers104 
 Research is outside the professional remit of a GP84  
 In a hierarchy of activities for GPs, research was low in its clinical or professional 
value84,104 
Relevance to general practice 
 Preference for using clinical experience over research evidence for clinical 
decision making67,104 
 Clinical practice is unscientific, so it is not possible to base everything on 
evidence104 
 Evidence based medicine is incompatible with person-centred care83 
 Researchers are interested in the wrong things. The question does not always 
relate to problems in general practice104 and can be perceived as being only of 
academic interest and to benefit the researcher’s career103 
 General practice is inherently not researchable104 
Personal feelings 
 Ambivalence or negative attitude to research84  
 Sense of entitlement not to be involved in research104 
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Despite a number of articles having identified lack of research interest as a reason for non-
involvement, it remains unclear what impact this has. The 3 papers that seemed to cite the 
most negative attitudes towards research in general come from Germany,83,84,103 so it is 
possible that there is something specific to the German health system that promotes this 
outlook. In their case study discussing reasons for GP non-participation in a trial to treat leg 
ulceration, Herber et al describe a health care system where GPs feel that they have a lower 
status in the community care sector than specialists, and do not perceive that research activity 
helps to enhance their professional standing.83 Two qualitative interview studies carried out in 
the UK demonstrate that this attitude towards research is not unique to Germany: they found 
that some British GPs also place little value on research.89,104 Some were sceptical about its 
value89 while others contrasted research with the ‘real work of clinical practice’, feeling that it 
was not professionally relevant and they ‘don’t have the responsibility to do it’.104  
It is possible that this negative outlook exists in other health systems, although the extent of 
this problem must be kept in perspective. Rosemann et al interviewed 76 GPs who were 
involved in the teaching of medical students: while the negative views some German GPs 
have towards research is discussed, this study also found that 85% of GPs appreciate research 
in their field.103 They also conclude that a positive attitude towards research was the most 
important motivation for a GP to participate; only those who were research active said that 
participation ‘improves the reputation of GPs and documents our quality of care’.103 However, 
as they only interviewed GPs who carry out undergraduate teaching at the University of 
Heidelberg, it is not clear whether these findings would relate to other GPs. Given that a 
number of studies found that GP affiliation with a university was an important facilitator for 
participation,34,65,83 it is possible that the interviewed GPs may have atypical attitudes towards 
research.   
 62 
 
In contrast to the findings of Rosemann et al, two survey studies found that many GPs have a 
positive attitude towards, or an interest in research. A postal survey of 96 German GPs found 
that 92% of them have an interest in research,84 while a survey of 463 Australian GPs found 
that 84% of them had a positive attitude towards research.67 Unfortunately their interest did 
not translate into willingness to participate (only 36% of interested German GPs and 29% of 
interested Australian GPs would become personally involved) so the impact of lack of interest 
on involvement remains unclear. 
This is a difficult area for trialists to introduce interventions that may improve site recruitment 
rates. Graffy et al carried out a number of workshops that consisted of a group of experienced 
trialists. The aims were: to identify factors that they consider important in successful 
recruitment; and their confidence in achieving them. 72% of workshop attendees considered 
that primary care team positive attitude was important, and most were fairly confident about 
how to address this. However, in order to raise the profile of research and to ensure that it is a 
normal part of everyday activity, they felt that there need to be changes to the organisational 
culture of the health service: trialists were less sure about how to achieve this.80 It would 
appear that research needs to be made an integral and rewarded part of primary care culture 
and to achieve this, changes would need to be introduced at a national level: individual 
research teams are therefore unlikely to have a significant impact on this problem. 
3.3.1.2 Ability to Carry out the Study 
Even when a GP is interested in research and believes the question is important enough to 
consider taking part, there are a number of practical considerations that are also taken into 
account when deciding whether or not to participate. As was found when looking at trials in 
all settings, these centre around their ability to carry out the work involved.  Time constraints 
are often felt to be a major barrier to involvement: Five articles were found that cited this as a 
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reason for non-participation.65,87,100,103,104 In one case 100% of interviewed GPs cited it as a 
reason for not taking part104 while 50% of GPs invited to take part in a trial of coronary heart 
disease prevention also stated they did not have enough time to carry out the study.87 A 
number of surveyed GPs stated that they were already overworked by their daily routine, and 
the administrative workload place on practices on a daily basis contributed to this.103 Given 
the relatively low importance placed on primary care based research, it is therefore 
unsurprising that many GPs are unwilling to take on this extra workload.  
In an attempt to address this problem, trialists often aim to encourage participation through 
minimisation of practice workload by streamlining data collection techniques,65 or keeping 
protocols simple.83,87,90,103 To further minimise workload, two trials required GPs only to 
identify patients and then refer them to the study team who will determine eligibility and gain 
informed consent.87,90 Both of these trials met or exceeded their expected recruitment targets, 
but it is not clear whether this minimisation of GP workload actually encouraged their 
involvement. Having interviewed 23 GPs who declined participation in a trial to manage 
medically unexplained symptoms, Salmon et al concluded that GPs cite lack of time as a 
reason for non-participation, but this actually masks other concerns.104 For example, while it 
would seem logical to reduce workload by providing research nurses who parachute into 
practices to carry out the bulk of study work, this may introduce other concerns: a number of 
GPs expressed fears about being measured by researchers, or about giving research nurses 
access to their patients or computer systems and cited this as a reason for not being involved 
in research.84,104 It is entirely possible therefore, that removal of one barrier is simply replaced 
with another. 
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3.3.1.3 Other Factors  
When looking at trials in all settings a number of other factors were cited as being influences 
on participation to research, and these too, seem to remain relevant when looking at primary 
care specifically. Again, the evidence is not clear cut. 
Personal relationships 
Exploitation of professional relationships through the use of a local ‘champion’ to encourage 
participation is cited as a motivator to participation.90 No studies have tested the impact of this 
approach so it is not clear whether or not this actually works. Use of peer to peer recruitment 
is also thought to increase GPs willingness to participate and is cited in a number of papers: 
GPs are thought to be more likely to participate if they receive an invitation to take part by 
one of their peers.9,65,83,100 Once again the success of this is unclear. Reid et al, when 
recruiting practices to the Second Australian Blood Pressure Study (ANBP2) found it to be 
their most successful strategy.100 Herber et al used research nurses to telephone clinicians to 
invite them to participate, but found it difficult to get past the barrier of reception staff. They 
concluded that use of physicians to contact GPs would allow them easier access to the doctors 
who would make the decision about participation. Unfortunately they were unable to test this 
theory due to financial constraints.83 Another study used mixed qualitative and quantitative 
methods to examine physician recruitment to five trials.9 They found that, although the 
projects using physician to physician recruitment believed that this was a key factor in 
successful recruitment, this did not explain differences in participation rates. For example, the 
Cardiovascular Health Awareness (CHAP) study employed local physician opinion leaders as 
one approach to practitioner recruitment. They recruited 49% of approximately 700 invited 
GPs. In contrast, the Improved Delivery of Cardiovascular Care (IDOCS) study, which used 
similar recruitment methods, recruited only 19% of 1077 eligible GPs.9 Johnston et al 
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conclude that the mixed flexible approach employed by CHAP was a more important factor 
than use of peers for successful GP recruitment.9 
Participation of academic research groups 
Impact of the involvement of an academic research group on site recruitment in primary care 
based trials is unclear.  Trust in the researchers carrying out the trial may influence 
participation. For example, affiliation with a respected research institution is said to be 
associated with successful GP participation.83 However, in another study, some GPs 
expressed suspicion that a covert aim of the institution was to divert patients away from them 
and to the University in question,65 and as a consequence were reluctant to participate. GPs 
cite a general mistrust of researchers and their motivations as a barrier to participation;84 the 
research can be seen as unethical, with GPs citing concerns around coercion and 
confidentiality.104 Development of good working relationships may help overcome some of 
these problems.80 
3.3.2 Interventions to Improve GP Participation 
The use of incentives has been used in an attempt to improve GP participation in research. 
Although financial gain is not cited as an important reason for taking part, GPs do report that 
the lack of remuneration is a barrier to participation.95,104 It seems that, while GPs do not wish 
to make a profit from research, they do need to be reimbursed for the time spent working on 
the study.95,98 Payment may encourage them to use otherwise free time for taking part in 
research or may be used to buy locum time to cover the loss of the GP from usual practice.104 
Other incentives include access to specialists that would not form part of routine care;90 the 
attainment of Continuous Professional Development (CPD) points;96 invitations to 
presentations of the findings;96 or access to information resources not otherwise available.67 
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However, whilst incentives are often employed, none of these studies examined the 
effectiveness of these measures. 
A number of articles have reported different approaches to site recruitment.83,87 These are 
mainly focussed on the initial approach to practices. Many studies utilise a Dillman or 
Modified Dillman approach to recruitment.111,112 This typically involves an initial mailout, 
followed by a second mailout and then a telephone call. Herber et al tried two slightly 
different approaches. In the first, practices were initially contacted by telephone, and those 
expressing an interest in the study were sent a fax and were asked to complete and return a 
questionnaire; the response rate for this questionnaire was very low (only 105/741 (14%) of 
those expressing an interest during the telephone call returned a completed questionnaire). 
This approach resulted in a 1.7% practice participation rate in the trial. Their second method 
was to remove the requirement for questionnaire completion; all other aspects remained the 
same. This resulted in a 5.1% practice participation rate in the trial. It is not clear why the 
need to complete a questionnaire seems to have had some impact on physician recruitment 
rates. It may be that this requirement deters some because it gives them the impression that 
the study will involve large amounts of paperwork completion.83 Another survey of recruiting 
GPs found that initial telephone contact from a clinician associated with the study encouraged 
some GPs to take part, with 48/134 (36%) of them stating that ‘this encouraged me a lot’.29 
While these findings suggest that telephone contact may be a useful approach when recruiting 
practices, the experience of Herber et al implies that the benefits of initial telephone contact 
can be easily undone by the requirements of the study.83  
A trial to improve cardiovascular disease (CVD) risk management employed 10 different 
approaches to clinician recruitment which included opt-in and opt-out strategies, and a 
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combination of both.73 A number of approaches used a professionally designed colour flyer. 
The poster was either posted alone or with a covering letter, or was faxed to practices with a 
covering fax; the fax produced the best absolute response accounting for 13 (19%) of their 
recruited sample (fax recruitment rate 13/3882, <1%). There were other small differences 
between the approaches (for example, the covering letter sent with the fax was signed by the 
Principal Investigator (PI), while the letter accompanying the postal invitation was sent on the 
headed paper of the local NorthWest Area Health Education (AHEC) network of primary care 
practices, and was signed by their director) so it is not possible to determine whether it was 
the fax approach alone that accounted for its apparent success.73 Furthermore, the fax 
invitation was one of the more expensive methods of recruiting sites, so may not be the most 
cost-effective approach. However, it is difficult to interpret these findings as the authors state 
that individual sites may have received multiple opportunities to participate via a variety of 
approaches. 
3.3.3 Clinician Factors that Influence Patient Recruitment 
As discussed in section 2.3.3.1, not all participating clinicians go on to actually recruit 
patients successfully. This also seems to be pertinent to primary care based trials69,95 and this 
next section will focus on practitioner factors that may influence recruitment. It is 
acknowledged that concerns about any of the following factors may also deter a GP from 
participation, but the literature focuses on how they influence the recruitment of participants 
once a practitioner has agreed to involvement. Therefore, these factors will be discussed in 
relation to how they impact further down the recruitment flow, primarily on the identification, 
selection and enrolment of eligible patients. (See Figure 1, page 10) 
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3.3.3.1 Impact of Clinician Motivation to Participate on Patient Recruitment 
Only one article was found that looked at whether motivation to participate impacted on 
patient recruitment rates once a decision to become involved had been taken.34 The authors 
surveyed 128 GPs (response rate 128/165, 80%) who participated in an RCT of drug 
treatment for dyspepsia. They asked questions about personal and practice characteristics, and 
about reasons for taking part. Eight motivators (topic; academic research group; sponsor; 
clinical research organisation; financial incentive; trial presentation; personal appeal; 
professional obligation) were compared with patient recruitment and they found that only 
‘motivation (for involvement) by the academic research group’ was independently associated 
with the number of patients recruited (adjusted OR 2.9, 95%CI, 1.2-6.9).34 It remains unclear 
whether a GP’s initial attitude to the study is reflected in their success or otherwise of 
recruitment: identification of those clinicians most likely to recruit well would allow trialists 
to focus their resources more effectively. 
3.3.3.2 Equipoise 
As detailed in section 2.3.3.2, a clinician needs to be in equipoise for each individual patient 
for it to be ethical for them to enrol that patient into a trial. When looking at recruitment to 
trials in general, this was identified as a barrier to recruitment in a number of studies. In the 
literature pertaining to primary care based trials, equipoise was discussed explicitly only 
once.85 This was in an RCT of structured problem solving and selective serotonin reuptake 
inhibitor (SSRI) medication for patients with depression. The authors conclude that, given the 
obvious differences between the trial arms, GPs decided which approach would suit 
individual patients early in the recruitment process, and this had a negative impact on accrual 
(20% of the potentially eligible patients were not considered suitable for one of the treatment 
arms by their GP).85 However, as this conclusion is based on speculation by the authors, it is 
not clear that this was actually the reason that GPs were reluctant to recruit to this trial. 
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Equipoise was mentioned indirectly in two further papers. Van der Windt et al, in a case study 
of an RCT for treatment of painful stiff shoulder, report that GPs cite the ‘conviction that a 
patient would benefit more from a specific intervention’ as a reason for non-referral. 
Unfortunately they do not quantify the problem, or investigate it further.109 Bell-Syer et al 
compared recruitment in two trials treating back pain. The intervention being tested in one 
study was acupuncture, in the other exercise classes. In both trials, uncertainty about the 
benefits of the intervention reduced the willingness of some GPs to refer their patients. 
However, this was only cited as a reason by 9% of the respondents across both studies. 33% 
of GPs actually preferred the intervention and were deterred from referring patients because 
they were not guaranteed that treatment (patients had a 50% chance of being offered exercise 
or 66% chance of receiving acupuncture). Conversely, 34% of GPs involved in the same 
studies and who had a belief in the potential benefits of the intervention were more willing to 
refer their patients for trial entry because it gave them potential access to treatments that may 
otherwise not be available.25 It is difficult to interpret these findings with respect to the impact 
of equipoise on recruitment: while 33% of GPs were deterred from referral because of a 
preference for exercise or acupuncture, 34% of GPs were encouraged to recruit to the same 
trial for the same reasons. It may be that differences in services available locally account for 
this finding, but it is not possible to elucidate further from the information given in the paper.  
3.3.3.3 Factors Influencing the Informed Consent Discussion 
Clinician concerns regarding the process of informed consent impact upon the recruitment 
process to RCTs in general, but they seem to be less of an issue for primary care based trials. 
One qualitative study interviewed 41 GPs who were recruiting to an RCT treating 
depression.89 This study found that GPs differ in their ability to introduce the concept 
depending upon their confidence in their knowledge of the trial. GPs describe the process as 
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their ‘sales pitch’ and develop stock phrases that they are comfortable with. Their ease with 
this was also dependent upon how research active their practices are: those in less active 
practices sometimes felt uncomfortable introducing research as their patients would not be 
expecting it. Some described research as being intrusive and disrupting to the normal flow of 
the consultation, and were concerned that if they did not introduce it confidently it may 
compromise the patient’s trust and confidence in them.89 This qualitative study indicates that 
some GPs may have concerns about discussing trials with their patients, while others are less 
worried. There is no discussion about how this translates into actual recruitment, whether GPs 
who express more concern are less likely to recruit their patients. Furthermore, this article 
examines recruitment to a trial of depression; consultations with depressed patients may differ 
from other consultations and could impact on a GPs willingness to discuss the trials in a way 
that is not evident in trials in other disease areas.  
3.3.3.4 Impact on the Doctor/Patient Relationship  
When looking at trials in general, concerns about the impact of recruitment to trials on the 
Doctor/ Patient relationship were often cited: this was also identified as a concern in primary 
care based trials. This section will examine how far the concerns already identified relate to a 
primary care setting. 
Discussion of Uncertainty 
As discussed in section 2.3.3.2.2, one of the drivers of the Doctor/Patient relationship is the 
physician expert knowledge. The need to discuss uncertainty about the best treatment was 
uncomfortable for clinicians and led to them selecting patients with whom to discuss the 
research. This was identified as a problem in two primary care based trials.85,89 In their article 
examining recruitment to a failed trial, Hunt et al did not identify worries about the discussion 
of uncertainty as a problem influencing recruitment, rather they felt that their GPs lacked the 
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confidence to deliver the intervention effectively.85 In contrast, a study that interviewed GPs 
recruiting patients to a trial treating depression did find that the acknowledgement of 
uncertainty was a barrier to recruitment.89 GPs felt that patients with depression preferred 
their GP to make treatment decisions for them, and were concerned that uncertainty would 
jeopardise the patient’s trust in them.89 However, within the same study, other GPs held 
contrasting views. They felt that the introduction of the topic of research in a consultation 
could actually strengthen the relationship as it indicates a greater interest in the patient’s 
welfare.89 
Dual role of GP and Researcher 
The difficulties faced by clinicians who are acting in the dual role of doctor and researcher, 
and the concern about the negative impact this may have on the doctor/patient relationship has 
been identified as a factor that impacts negatively on recruitment to trials in general. Three 
primary care based studies discussed this issue but in little detail. In one interview study, 
some GPs perceived a degree of divergence between their clinical goals and those of 
researchers, and as such, were sometimes reluctant to introduce the subject with their 
patients.89 Hunt et al had similar findings, concluding that the change from practitioner to 
researcher was too great to facilitate a shift in behaviour, and that this inherent contradiction 
is a basic problem for clinical research.85 However, this article was descriptive and is based 
only on author speculation, and so it is not possible to determine whether this contradiction 
actually did contribute to the trial’s failure. The issue was explored in more detail by Frayne 
et al. They conducted a focus group study with 7 GPs with the aim of assessing their attitudes 
towards recruitment of their patients to cancer prevention trials.76 They found that some GPs 
expressed considerable concern about this perceived conflict in roles. They felt that trying to 
act as the patient’s advocate within the health care system whilst also enrolling them in a trial 
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would ‘erode their relationship with the patient’. GPs used terms like ‘crossing the line’ or 
patients say’ Wait a minute. Who are you working for?..... Me? Or is it just that you want to 
sign me up for a research study’.76 However, they also found that where GPs have faith in the 
trialists or the PI, they were willing to ‘spend’ some of the trust that they had banked with 
their patients and recruit to the trial despite their concerns.76 As patients were found to be 
more likely to consent to participation if their personal physician, rather than an unfamiliar 
physician, is the investigator106,110 and patients are becoming more accustomed to shared 
decision making,89 it is possible that this paternalistic, protective attitude, whilst well 
meaning, is actually misplaced. Patients may like to be given the option of taking part in 
research, and would like the opportunity to make the decision for themselves.89  
There are relatively few articles discussing concerns about the impact on the doctor/patient 
relationship in primary care based trials and the evidence from these is conflicting. It may be 
that GPs have a different relationship with their patients than specialists do, and so the 
introduction of the subject of trials into the consultation holds fewer concerns for GPs. It is 
also possible that GPs who do hold these concerns choose not to participate at all, so the 
impact of worries about the effect on the relationship is minimal. However, given the small 
amount of research in this area and it is not possible to draw firm conclusions on the true 
impact of these concerns on GP recruitment of patients.  
3.3.3.5 Clinical Autonomy 
The concern about the loss of clinical autonomy when involving patients in trials was 
explored in two studies. In a focus group study, GPs described difficulties in the co-ordination 
of care within primary care, and described it as a ‘loss of control over clinical management’; 
they were concerned that, in the extreme, this might lead patients to abandon continuous care 
entirely.76 There is an argument that autonomy in medicine has been challenged in recent 
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years and that growing reliance on evidence based medicine further dis-empowers individual 
practitioners.113 In light of this, after interviewing 23 GPs, Salmon et al conclude that GPs feel 
the need to preserve their sense of individual professional autonomy by emphasising the 
individuality of their clinical work. GPs emphasised the importance of clinical experience 
over evidence, which in turn caused them to maintain their distance from anything associated 
with evidence based medicine. The authors conclude that loss of autonomy is a substantive 
barrier to GP involvement.104  
3.3.3.6 Structural Barriers 
A number of other barriers to recruitment were identified that are also relevant to primary 
care. These have the potential to impact on any point in the recruitment flow. 
Time constraints 
As previously discussed, time constraints play a role in whether or not a GP will take part in a 
trial. However, once they have made the decision to participate, the necessary time 
commitment may still make it difficult for them to actually recruit patients. Busy surgery 
hours were commonly cited by GPs as a reason for failing to recruit or refer patients.107,109 
This is especially true for trials that need to recruit patients during routine consultations:92,97 
the need to gain informed consent is seen as a ‘time-consuming disruption of the normal work 
flow’92(p 501) Other GPs say that the need to pick out patients in the middle of surgery puts 
them under pressure.97 Some trials use a practice nurses to share the workload. They help in a 
variety of areas, including: administration; obtaining informed consent; identification of 
patients or reminding GPs about the study. One study found that GPs who had the assistance 
of a nurse were significantly more likely to recruit than those who did not (56% of GPs with 
nurse help recruited versus 33% of those who did not, p = 0.02).57 Foy et al carried out an 
examination of existing literature to determine whether any of the recruitment strategies 
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commonly employed were evidence based. They concluded that use of a researcher to carry 
out recruitment is one of the few evidence based strategies that improves recruitment.74 These 
findings do imply that reduction of workload will increase the ability of practices to recruit. It 
is possible that the involvement of different types of staff could be equally beneficial, as could 
the use of researchers to carry out recruitment. However, as already discussed, this could 
merely remove one barrier only to replace it with another.  
Staff shortages 
Lack of staff, specifically support staff, was identified as a barrier to recruitment to trials in 
general, and may impact on the ability of GPs to recruit. When looking at the literature 
pertaining to primary care based trials this is not discussed directly in any papers, so it is not 
possible to ascertain how relevant this remains. 
Research experience and training 
Lack of experience or training was also shown to be an issue influencing recruitment to trials 
in general. However, in relation to primary care based trials, only one article discussed the 
relation between experience and recruitment. This survey found no association between prior 
research experience and the number of patients recruited, although confidence intervals are 
wide, so an association cannot necessarily be ruled out (OR 1.5; 95% CI 0.6-3.6).34  
Identification of eligible patients 
Another issue that seems to affect recruitment to primary care based trials is the identification 
of sufficient numbers of eligible patients. Despite efforts to estimate the number of potentially 
eligible patients, trials often suffer from a phenomenon referred to as Lasagna’s 
Law.37,109,114,115 Lasagna’s Law is attributed to Dr Louis Lasagna, who noted, in the 1970s, 
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that as soon as a study starts the theoretical pool of 100% of patients instantly drops to 20%, 
and goes back up to 100% at study conclusion.115,116 This could be attributable to a number of 
reasons: overestimation of disease prevalence; decrease in the prevalence of the disease in 
question;57 inability to identify all potentially eligible patients; the restrictiveness or otherwise 
of inclusion/exclusion criteria; or the time available to recruiters.109 If trialists have based 
their recruitment projections on disease prevalence alone, it is possible that they have set 
themselves an impossible recruitment target, as identification of potentially eligible patients 
has been reported to be problematic within primary care. Practices often lack the computer 
skills to run the necessary reports.117 When patients need to be recruited during normal 
consultations, GPs report that they often forget about the study, resulting in potential patients 
being missed.109 Furthermore, calculations often do not allow for exclusion of patients who 
are considered unsuitable by their GP.109  
3.3.4 Interventions to Improve Recruitment to Primary Care RCTs 
3.3.4.1 Identification of Eligible Patients 
A number of interventions have been tried with the aim of overcoming the problems posed by 
Lasagna’s Law. One approach is to improve the use of computers.81,92,102,108 One article 
discussed the development of a computerised reminder system that could be integrated with 
practice systems. It would remind GPs about the study when the record of a potentially 
eligible patient was opened, and would guide the GP through the recruitment procedure. 
Despite the reminder popping up on the computer screen, the approach was not entirely 
successful: 6.5% of GPs still forgot to enrol the patient, and others still found the requirement 
to obtain informed consent during routine consultations too time consuming.92 These findings 
are supported by those of Rollman et al. They compared a computerised prompt for 
recruitment based on specific criteria from electronic medical records (EMR) with a waiting 
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room based recruitment process, which involved a researcher being stationed in the surgery 
waiting room. The researcher would screen patients for eligibility through use of a 
questionnaire, and where appropriate, would carry out informed consent. This study found 
that fewer than 5% of referrals were made via the EMR.102 These findings should be 
interpreted with caution in the context of improving GP enrolment, as the EMR was not 
compared directly to the referral rates of GPs without the use of EMR. It is possible that the 
findings actually reflect that recruitment in the waiting room is simply a more successful 
approach.88,99  
Stuardi et al examine the recruitment rates of a number of studies that utilised the EMR 
system to perform database searches to identify potentially eligible patients in an attempt to 
maximise the number of potentially eligible patients who are identified. They compared the 
recruitment to four studies using this approach with that of two studies that asked GPs to 
approach patients during regular consultations. They found that all trials using EMR recruited 
on time and above target, whilst the studies using the GP approach either extended their 
recruitment period or failed to reach their required numbers.108 As already discussed, 
recruitment during regular consultations is problematic, so these findings may merely reflect 
those difficulties. However, there may be potential for use of computer systems to influence 
recruitment rates in a number of ways: further research would identify the most successful 
ways of doing this. 
Trialists often send recruiting GPs newsletters and reminders about the study, or carry out 
regular site visits in an attempt to keep the trial at the forefront of their minds.109 Clear, timely 
communication between sites and study teams is also thought to improve recruitment. 
However, an RCT looking at the effects of enhanced communication between central trial co-
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ordinators and clinical sites failed to show a significant difference in accrual rates between the 
additional contact and usual contact groups.91 Advice to trialists is to ensure that 
inclusion/exclusion criteria are as unrestrictive as possible, to maximise the numbers of 
potentially eligible patients, thus avoiding the need for protocol amendments that may require 
lengthy changes to trial approvals.17 Protocol amendments to relax these criteria are 
sometimes made, and study procedures are often streamlined or simplified in an attempt to 
improve a poor recruitment rate.2 These approaches are often based on logical assumptions 
rather than evidence: no trials testing these approaches have been identified. 
3.3.4.2 Different Approaches to Recruitment  
A number of articles were identified that had tried to improve recruitment to primary care 
based trials by using different techniques. Paine et al invited all patients who may be eligible 
for their trial to an education seminar prior to recruitment by their GP. They found that 
women who attended the seminar were twice as likely to consent to participation than those 
who did not, and that GP time spent screening their patients and discussing the trial with the 
seminar group was reduced.94 However, as patients self-screen, there is the potential to 
introduce selection bias, so the researchers advocate the use of an RCT to determine the role 
of seminars on patient recruitment.94 Another approach was to test the use of postal 
randomisation as opposed to the usual telephone randomisation technique.69 This involved 
patients completing and posting baseline material to the study centre, where randomisation 
took place when received. The intervention was not successful: it actually reduced the number 
of patients recruited, although this finding was not statistically significant.69 Two studies 
compared GP recruitment with use of the media to advertise the study.71,78 Both studies found 
the media to be a useful tool in improving recruitment: it was faster and more cost effective.71 
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This approach should be used with caution, as one of these studies did find differences in 
disease characteristics and preferences at baseline between media and GP recruited patients.78 
3.3.5 Comparison of Recruitment to Primary and Secondary Care Based 
RCTs 
The evidence pertaining to recruitment issues in primary care based trials is broadly similar to 
that relating to trials in other settings. Similar problems are cited, and no factors were 
identified that were unique to primary care based trials. However, the primary care based 
literature differs in its emphasis. In contrast to general trial settings, much of the primary care 
literature relates to the problems encountered when recruiting sites or investigators, and how 
to overcome them: in general trials, the focus is on factors that influence the process once the 
physician has agreed to participate. Recruitment of secondary care sites to trials seems to be 
less problematic than recruitment of primary care sites. This may reflect the different career 
structure for physicians in these settings: hospital doctors aiming to be consultants may find 
their career prospects enhanced by publication; GPs have no need to do so, and therefore may 
be less interested in research involvement.104 
When considering the recruitment of patients once a physician has agreed to participate, 
similar issues were raised, for example, concern about the doctor/patient relationship; issues 
encountered during the informed consent process; or practical barriers. However, in primary 
care based trials there seems to be fewer studies examining these issues than there are when 
looking at secondary care based trials. This could be for a number of reasons: maybe the focus 
of research in primary care has been on the recruitment of practitioners rather than patients, 
and these problems are actually more acute than is reflected in the literature. It is possible that 
these issues are genuinely less of a concern in primary care than they are in secondary care: 
GPs may be in a position to develop different relationships with their patients than those 
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experienced between specialists and their patients, as they can develop these relationships 
over a long period of time.118 Differences in the relationship may mean patients have different 
expectations from their GP than they do a specialist, and so makes it easier for a GP to 
introduce the possibility of research participation. This may account for the different focus in 
the literature.  It may also be that GPs are much more selective about participation than 
hospital clinicians. With less pressure to publish because of differing career structures,104 GPs 
who are concerned about any of the issues may simply decide not to take part at all; 
specialists, in contrast, may become involved and find that their concerns about discussing 
trials only come to the fore when faced with individual patients.  
3.3.6 Current Guidance on Recruiting to RCTs 
The Primary Care Research Network (PCRN) Recruitment Methods Group have published a 
Practical Guide to Primary Care Research Recruitment which is a resource for researchers 
involved with the practicalities of patient recruitment.17 It was developed through the use of 
focus groups with stake holders and aimed to bring together the experience and knowledge 
from a variety of research active professionals. The authors hope that it will inspire others to 
adopt procedures that they may otherwise not have thought about, thus achieving their targets. 
The document is comprehensive and offers practical tips on a range of issues, from 
governance and approvals to ‘selling’ the study to potential participants.  
The guide gives advice on developing a feasible recruitment plan, and advises those who wish 
to recruit patients through primary care to carefully consider whether alternative approaches, 
for example, direct targeting of specific patient groups, would be more appropriate. They give 
suggestions for addressing Lasagna’s Law, including: methods of identifying suitable 
patients; consideration of the content of the patient information sheet; examination of how the 
study is explained to participants; suggestions to overcome the barrier of investigators who 
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are too busy to enrol patients. There is a chapter devoted to the recruitment of primary care 
collaborators, giving advice on areas such as identification of collaborators, being explicit 
with practices about both direct and indirect benefits of participation, use of incentives and 
careful consideration of the anticipated roles of primary care staff. 
This practical guide is a very useful document. It addresses many of the common pitfalls 
encountered in primary care research, gives good advice on how to overcome the problems 
and tallies with the problems identified in the literature search. It is an effective way of 
tapping into the wealth of experience of researchers. However, it does not negate the need for 
further research into the subject: the combination of experience (around which this practical 
guide was largely based) and a sound evidence base may lead to improved recruitment to 
trials. 
3.3.7 Conclusions 
Factors that influence recruitment to trials in general are also applicable to trials carried out 
within the primary care setting, although in this setting the emphasis in the literature is placed 
more on the recruitment of sites than the recruitment of patients: in hospital based studies, the 
opposite is true. As with all research, it needs to be carried out in the appropriate setting: the 
underlying issues of recruitment in primary care differ enough from those encountered in 
hospital settings to render much of the current literature of limited applicability. While there 
were reasonable numbers of articles identified in the literature search, it is evident that there 
are still no solutions to the problem of recruitment. Although observational data or case 
studies of individual trials are useful starting points, even when taken as a whole there is no 
clear picture of exactly what the causes of the problems are, or what the effective solutions 
may be. The evidence is often contradictory or inconsistent, and may not necessarily paint the 
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full picture, as with the possibility that the barriers to recruitment attributed to time 
constraints are actually covering up the fact that there are more complex reasons why GPs 
choose not to participate.  
There is a complicated interplay of issues that influence recruitment to trials. In primary care, 
further research needs to be carried out in virtually all areas of recruitment in order to fully 
understand the problems and to identify and test potential solutions. Given the number of 
components that could contribute to the problem, studies should be carefully considered, and 
carried out with consideration of the MRC guidance on developing and evaluating complex 
interventions.119  
One approach is to consider a study that was initially failing to meet recruitment targets but 
which was ultimately successful: no papers were identified that have done this.2 It would be 
useful to examine the recruitment strategies undertaken in such a trial and to ascertain 
whether there were identifiable time points where there were significant changes to 
recruitment rates. Although studies of this type cannot provide evidence of cause and effect, 
any findings could provide a useful springboard for the design of future intervention trials.  
The Birmingham Atrial Fibrillation Treatment of the Aged Study provided such an 
opportunity.  
3.3.8 Limitations of the Literature Review 
The main limitation of this literature review is that bias may have been introduced, which can 
make it difficult to judge its quality and reliability. Bias may have been introduced in a 
number of ways. Firstly, only one person (myself) identified the papers and extracted the data. 
Good quality systematic reviews use more than one reviewer to identify and code the studies, 
and report the level of agreement between the individual reviewers. This ensures consistency 
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and reliability of identification and coding. Use of only one reviewer may therefore result in 
inappropriate inclusion or exclusion of studies, or in non-systematic data extraction. 
Secondly, bias may have been introduced through the lack of formal quality assessment of 
included studies. Quality assessment uses previously agreed indicators to determine whether 
individual studies were of sufficient standard to provide reliable results. The lack of formal 
assessment in this review may therefore have led to the inclusion of evidence provided by 
poorly designed studies that may themselves provide unreliable evidence.  Thirdly, a date 
limit was used to exclude a number of studies: articles prior to 1990 were not included. 
Systematic reviews aim to identify all evidence pertaining to the research question; date limits 
may result in the exclusion of important articles. Although it is acceptable to implement time 
frames where appropriate, it must be acknowledged that this may result in the loss of 
important evidence. Finally, ascertainment bias may have been introduced into this review 
due to the exclusion of studies that were not published in the English language, if those 
published in other languages were systematically different to those published in English. For 
example, English language journals tend to have a higher impact factor than foreign language 
journals, so it is possible that included studies show more ‘positive’ results than excluded 
ones. In this subject area, positive results may mean that publication is more likely for trials 
that do not reach their recruitment targets as lessons can be learned from these failed trials 
(See section 2.2). Therefore, ascertainment bias as a result of the exclusion of non-English 
language papers may have resulted in important missed information. 
Despite the limitations discussed in the previous paragraph, the impact of bias on this review 
is felt to be small. Although it is acknowledged that bias may have been introduced through 
the use of one reviewer and the lack of formal a priori criteria to assess quality, the simplicity 
of the inclusion criteria ensured that any bias would be kept to a minimum. All studies, 
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regardless of their design, were included if they discussed practitioner or practice factors 
influencing recruitment to an RCT: the subjectivity of a single reviewer was therefore 
minimised.  Informal quality assessment was carried out (i.e. the strengths and weaknesses of 
individual studies were discussed but no formal checklist to enable systematic quality 
assessment was followed) and the limitations of individual studies were included in the 
discussion. This ensured that the aim of including any issues that were identified was 
achieved. The date limit and exclusion of non-English language papers may mean that factors 
that influence recruitment were missed. However, it was decided to exclude articles prior to 
1990 because they often discussed the need for written informed consent. This consideration 
is not relevant to current trials because written consent is a requirement; the debate 
surrounding this issue is therefore no longer applicable and it was felt that exclusion of older 
papers would not, therefore, result in a significant omission. It is plausible that exclusion of 
foreign language papers may have omitted important factors. Unfortunately, resource 
limitations rendered translation impossible, and any bias that may have been introduced by 
this remains. 
 
3.4 The Birmingham Atrial Fibrillation Treatment of the Aged 
(BAFTA) Study 
This section will provide the background to the BAFTA study. It will summarise the original 
protocol and give details about the practical aspects of the trial, for example, how patients 
were identified and which staff carried out individual roles. As the thesis is focussing on the 
recruitment of patients, study follow up procedures and data analysis will not be discussed in 
any detail. However, this has been reported elsewhere.120 During the recruitment period, 
changes were made both to the protocol and the processes. These amendments will be 
relevant to the rest of the thesis, and will be detailed in the appropriate chapters. 
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3.4.1 Study Design 
The Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study was a primary 
care based pragmatic RCT of aspirin (75mg/day) versus adjusted dose warfarin (Target INR 
2.5, range 2-3) for stroke prevention in older people (aged > 74) with atrial fibrillation 
(AF).120,121  
3.4.2 Sample Size and Recruitment Estimates 
The study aimed to randomise 1240 patients (620 in each arm) and follow them up for an 
average of three years. Based on published data regarding the prevalence of AF in this 
population, it was estimated that a total practice population of 1,097,000 would be required, 
comprising 76,800 aged > 74. This equated to 157 practices with an average list size of 7,000, 
and recruitment of 8 patients per practice. (See Figure 3) Patient recruitment was expected to 
start in January 2001 and last for two years. 
3.4.3 Practice Recruitment 
Practices were located in the West Midlands, although it was anticipated that the trial would 
extend to other regions (Gloucester; Oxfordshire; Cheshire; Warwickshire; Worcestershire). It 
was intended to recruit larger practices in preference to smaller ones. All GPs within the 
practice were sent a letter inviting them to take part in the study, together with information 
about the study and the expected workload. Interested GPs returned a faxed reply slip, and 
were sent an invitation to attend a study training session. The agenda for the training session 
can be found in Appendix One. After the training, practices made the final decision about 
whether or not they would take part. 
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Figure 3: Expected Recruitment Rates  
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3.4.4 Study Aims 
The aim of the study was to provide evidence of the risks and benefits of warfarin and aspirin 
therapy in an elderly population in atrial fibrillation drawn from primary care. The primary 
aim was to: 
 Compare the incidence of fatal or non-fatal disabling stroke or significant systemic 
embolism in patients treated with adjusted dose warfarin or aspirin. 
3.4.5 Study Design 
The study was a randomised controlled trial of warfarin versus aspirin for prevention of stroke 
in elderly patients identified in general practice with atrial fibrillation confirmed by 
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electrocardiogram (ECG). In all participating practices, a computer search to identify all 
patients aged > 74 was carried out. Within this population, patients were identified in two 
ways: further computer searches and by opportunistic screening of the pulse by practice staff. 
The recruitment strategy is summarised in Figure 4. 
Figure 4: BAFTA Study Recruitment Strategy 
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3.4.6 Computer Searches 
These were tailored towards the information that was held on the computer in each practice. If 
practices held AF registers, or used READ diagnosis coding, then these were used. 
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Additionally, searches on prescriptions of digoxin, anti-arrhythmic agents, aspirin or warfarin 
were carried out. The case notes of patients identified in any of these searches were reviewed 
for a diagnosis of AF. If present, patients were invited to attend the practice for an ECG. 
Patients identified in this way were classed as the Case Note Review (CNR) group. 
3.4.7 Opportunistic Screening of Pulse 
A flag was placed in the case notes of all patients aged ≥ 75 who were not invited to an ECG 
clinic as a result of the computer searching described above. In paperless practices, electronic 
prompts were used instead of paper flags. These prompts were to remind any member of the 
primary health care team to check the pulse the next time they saw the patient. The result 
(regular or irregular) was recorded, and if irregular, then the patient was invited to attend the 
practice for an ECG. Patients identified in this manner were classed as the Opportunistic 
Screening (OS) group. 
3.4.8 Confirmation of AF by ECG 
Patients identified in either of the ways described above were invited to attend a dedicated 
nurse-run clinic at which a 12 lead ECG was performed. The ECG was sent to the central 
study office for verification of diagnosis by a cardiologist. ECG results were then returned to 
the practice. 
3.4.9 Patient Eligibility 
Once an ECG diagnosis was returned to the practice, patients were reviewed for eligibility: 
the Practice Nurse reviewed the patients’ medical records for evidence of absolute exclusion 
criteria. (See Table 8)  
3.4.10 Patient Information and Consent 
Case Note Review patients were sent an information sheet and an invitation to attend an ECG 
clinic. Opportunistically Screened patients were given the information sheet during the ECG 
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clinic unless they met any of the absolute exclusion criteria. Patients with ECG confirmed AF 
were then invited back to a randomisation clinic appointment. During this appointment, the 
ECG results were discussed, and eligibility for the trial assessed. The GP obtained written 
consent from those patients who would like to take part. (See Table 9, page 89)  
Table 8: Initial Study Inclusion and Exclusion Criteria 
Inclusion Criteria 
 Age ≥ 75 
 Atrial fibrillation or flutter confirmed by ECG 
Absolute Exclusion Criteria 
 Known rheumatic heart disease 
 On warfarin 
 History of major non-traumatic haemorrhage (e.g. gastro-intestinal) 
 History of intra-cranial haemorrhage 
 Endoscopically proven peptic ulcer disease in preceding year 
 Known allergic hypersensitivity to either of the study medications 
The Uncertainty Principle 
 If a GP was certain that a patient should not be entered into the trial, for whatever reason, 
then that patient was not eligible  
 If a GP was uncertain whether or not warfarin was indicated, then the patient was eligible 
 This decision was made on a case by case basis after consideration of all relevant factors, 
including: 
o Factors increasing the risk of haemorrhage set against high risk of stroke in these 
patients 
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3.4.11 Practice Staff Roles and Anticipated Workload 
Each practice nominated a GP and a practice nurse (PN) who would be responsible for 
identifying and recruiting patients within their practice. They would attend an initial full day 
study training session which would encompass study paperwork and procedures, and GCP 
training in relation to the study. The roles and responsibilities of each practice member were 
explained, together with a discussion about the anticipated workload and details of 
reimbursement to the practice.  It was anticipated that practices would complete their patient 
recruitment over a 12 month period, and follow up would continue for an average of three 
years. Full details about the roles and workload can be found in Table 9 (Page 89).  
The BAFTA study was initially failing to reach its recruitment targets. (See Figure 5, page 
88) The research team implemented a number of changes: protocol amendments; practical 
changes that influenced both the work flow and workload for practice staff; increased the 
number of participating practices; and extended the recruitment period. A new power 
calculation was carried out and a revised target of 930 patients was set (the original target was 
1240 patients). It was calculated that this target would enable the study question to be 
answered in the context of meta-analysis with the existing literature. The revised target was 
eventually exceeded (973 patients recruited). As such, BAFTA provides the ideal opportunity 
to investigate the recruitment process and the remainder of this thesis will focus on analyses 
of recruitment to this trial. 
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Figure 5: BAFTA Recruitment Targets 
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Table 9: Staff Roles and Workload 
Task Staff 
Type 
Info Collected Estimated time Total numbers expected 
per practice (7000 ave) 
Total estimated 
practice time** 
Computer 
search 
RA AF status on patients aged 75+. 
Drug information 
N/A 490 aged 75+  
245 AF + 
245 AF - 
N/A 
Patient notes 
tagged for OS 
Reception N/A One off task 470 notes 8 hours 
ECG Clinic Practice 
Nurse 
Patient reported medical history; 
current medications; carry out 
ECG; initial discussion about trial 
Average 20 mins per 
patient 
119 patients 40 hours 
Case note 
search for 
medical history  
Practice 
Nurse 
Case note reported medical 
history; current medications; AF 
evidence 
Average 10 minutes 
per patient 
36 patients 6 hours 
Decision about 
patient 
eligibility 
GP Using case report form (CRF) 
completed by PN during case note 
search of medical history 
Average 5 minutes 
per patient 
36 patients 3 hours 
Randomisation 
Clinic 
Appointment 
PN/GP PN 
Patient questionnaires (Rankin; 
EQ5D; SF12); memory test; 
baseline blood pressure;  
GP 
Double check eligibility; discuss 
trial and obtain informed consent; 
call randomisation telephone line 
PN 
Average 20 minutes 
per patient 
GP 
Average 20 minutes 
per patient 
31 patients PN 
10.5 hours 
GP 
10.5 hours 
Patient Follow 
up* 
GP Adverse events; endpoint and 
hospital admission information; 
change in medications; Rankin 
20-30 minutes per 
patient 
8 patients 23 hours (over 3 
year period) 
* follow up information enclosed to give an idea of the expected practice workload 
** total estimated practice time involvement 101 hours.  
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Chapter 4: Choice of Methodology  
As discussed in section 3.3.5, although there is a growing body of literature examining the 
issue of patient recruitment to trials, analysis of data from a trial that demonstrated 
identifiable change points in recruitment would be useful:2 the BAFTA Study provided the 
opportunity to do so. It was decided that a mixed methods approach would be the most 
appropriate way of addressing this study question, as recruitment to trials seems to be a 
complex area, and there is a dearth of good evidence available: mixed methodology can 
accommodate both of these issues. This chapter will outline the reasons for choosing this 
approach and will introduce each stage separately: Stage One, factors that predict patient 
consent to take part in an RCT (Chapter five); Stage Two, trends in the recruitment of patients 
to BAFTA (Chapter six); Stage Three, understanding the experience and attitudes of GPs who 
recruited patients to BAFTA (Chapters seven – nine).  
4.1 The Mixed Methods Approach 
Although mixed methods research has been controversial122 and is still developing, it is 
becoming increasingly common in health services research. 123 It is characterised by the use of 
both qualitative and quantitative approaches to data collection and analysis123,124,125 and aims 
to integrate the findings from both techniques in order to ‘offer insights that could not 
otherwise be gleaned’.126 It is a useful approach to use when the question is complex, or if 
there is little existing evidence in the area. Greene et al developed a conceptual framework for 
mixed methods research identifying five different purposes, any one of which would make it 
appropriate to adopt a mixed methods approach.124 Two apply to this study: development; and 
expansion. The first, development, ‘seeks to use the results from one method to help develop 
or inform the other method, where development is broadly construed to include sampling and 
implementation’.124 In this project, the results from the first two stages informed the design of 
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the third phase. Full explanation of individual methodologies are given in the relevant 
chapters, but essentially stage one and two results informed both the sampling and the topic 
guide used in the final phase. 
The other mixed methodology purpose appropriate to this study is elaboration. This was 
defined by Brannen as where ‘qualitative data analysis may exemplify how patterns based on 
quantitative data analysis apply ….the use of one type of data analysis adds to the 
understanding being gained by another’.123 In this thesis, the aim of the final stage of this 
project was in part to identify potential explanations for the existence of patterns found in 
parts one and two, therefore elaborating on the findings of the first phases. 
As is the case with other mixed methods studies, the questions addressed by this study cannot 
be comprehensively answered by one method alone. The use of both qualitative and 
quantitative methods allows for a more detailed understanding of this complex question, with 
each approach being suited to a different aspect of the project. The mix of techniques offers a 
more comprehensive way of investigating a GP’s view of enrolling patients into an RCT and 
how this may influence their ability to recruit successfully, than a single methodological 
approach would allow. 
Despite the strengths offered by a mixed methods strategy, there are potential pitfalls in using 
this approach. There are fundamental differences between both the approach and the 
theoretical underpinnings of quantitative and qualitative paradigms, and there is controversy 
surrounding their combination.122,125 Furthermore, additional skills are needed to combine 
such different methods, which pose additional challenges for the researcher. However, in 
order to fully address the questions of the study, it was felt that the benefits of using this 
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approach outweighed the disadvantages, and would provide more useful information for other 
researchers looking to address the issue of poor recruitment to their trials.  
4.2 Individual Methods 
This section will look at the individual study questions that this thesis aims to address and 
introduce the methods used to answer each question. This introduction gives a brief overview 
of the individual research question and the methods used: full details of the methods 
employed will be given in the relevant chapter. 
4.2.1 Stage One: Factors that Predict Patient Consent to take part in an 
RCT 
Stage one aims to determine whether there are any patient and/or practitioner factors that 
predict whether or not a patient will give their consent to participate in an RCT.  As discussed 
in section 2.3.3.1, simple involvement of clinicians as local investigators for multi-centred 
studies does not necessarily lead to good patient recruitment, and the discrepancies between 
the number of practitioners who agree to participate and the number of those who actually 
recruit is often cited in the literature.35 The reasons for this are not clear. Extensive literature 
exists that cites problems with the consent process as being a major barrier to recruitment,16 
but these often focus on patient understanding and acceptance of the issues under 
discussion:2,4,127 there is little research looking at whether there are practitioner or patient 
factors that influence the process. Better understanding of what makes some practitioners 
recruit well may enable trialists to identify practitioners who would be most likely to recruit 
successfully, thus enabling research teams to optimise resource use. Analysis of patients 
invited to take part in BAFTA would address this question. Therefore, a cross sectional study 
using logistic regression analysis was carried out to determine which patient and/or 
practitioner factors predicted consent. 
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4.2.2 Stage 2: Trends in the Recruitment of Patients to BAFTA 
Stage two aims to identify whether protocol or procedural changes in BAFTA were associated 
with changes in patient recruitment. As described in previous chapters, there is a growing 
body of literature surrounding the issues of recruitment of patients to trials, and the methods 
used to overcome these barriers. Although there are few trials testing recruitment 
interventions, the available evidence does indicate that how the trial is conducted can 
influence accrual rates.  In contrast to this assumption, there is an argument that it is not 
possible to make design changes that will improve recruitment to a trial that does not initially 
recruit well.128 (See Section 6.1) This stage will examine the impact of study design on patient 
recruitment and will address the question: was the increase in recruitment over time due to an 
increase in the size of the study population as a result of expansion of the number of active 
sites, or was it due to changes in study design and conduct? An observational time series 
analysis of patient recruitment to BAFTA was conducted to achieve this aim. 
4.2.3 Stage 3: Understanding Experience and Attitudes 
As discussed in Chapter 3, although the attitude of GPs towards research has been examined 
in a limited fashion, there has been little work done that looks at the experience of GPs 
recruiting their patients to trials. Analysis of recruitment data from BAFTA (discussed in 
chapters five and six) will allow identification of factors that may influence patient 
recruitment, but will not provide any understanding as to why any influences exist. Therefore, 
the aim of this stage of this project is to understand the GPs experience of participating in this 
study, from their decision to participate through to study close down and, where possible, to 
identify any patterns within the data that may provide theories as to the reasons for any 
influences. It is anticipated that development of these theories will provide a springboard for 
subsequent work that may help trialists overcome some of the barriers to recruitment. 
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There are no easy quantitative ways to measure an individual’s experience, as it comprises 
many personal and subjective issues. Qualitative methods are better suited to exploring this 
area as it is the most appropriate way to explore why individuals act in a particular manner; to 
explore new areas; or to address sensitive issues.129 Qualitative study can gain rich 
descriptions and explanations of processes in local contexts; Miles and Huberman describe 
how it can preserve chronological flow, thus indicating which events lead to which 
consequences.130 For example, they are referring to how rather than just finding out that a GP 
did not enrol as many patients as anticipated, they may say they did not enrol because they 
could not identify eligible patients, or they were not comfortable with the trial interventions. 
Here, qualitative investigation allows the researcher to gain more insight into causation by 
having the opportunity of probing the reasons for the effect. 
Initially it was decided that this study would use a grounded theory approach to data 
collection and analysis.131 It was considered an appropriate methodology as there is little 
existing knowledge in this area and grounded theory is a useful tool in ‘the investigations of 
relatively unchartered waters’132,133 It is also allows the development of theories that can then 
be tested in subsequent projects. There are a number of central aspects to grounded theory, 
including theoretical sampling and constant comparison analysis: these are described in more 
detail in Chapter 7. However, as described in section 7.7, a modified approach to grounded 
theory was eventually utilised, taking into account the researcher’s intimate involvement in 
the BAFTA Study. 
Having established that the most appropriate method to use for this phase of the project is a 
qualitative approach, it was decided that individual semi-structured interviews would be the 
best data collection method. Focus groups were considered as an alternate data collection 
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method. There would have been a number of advantages to using this approach: fewer focus 
groups than interviews would need to be conducted, especially useful where there are time 
limitations; discussion of some subjects may be stimulated by the group environment; and it 
may be possible to include the views of more people by carrying out a few focus groups than 
it would by choosing to use individual interviews. However, there are also a number of 
disadvantages: the logistics of organising groups can be problematic, especially when the 
population in question are geographically diverse or a particularly busy group of people; 
discussion of potentially sensitive topics can be difficult in a group setting as people may be 
less willing to talk about their experience or opinions; and the composition of the group needs 
to be carefully considered. For example, if a focus group consisted of employees and 
employers, the employees may find it more difficult to be involved in the discussions. For 
subject areas or populations where it would be difficult or inappropriate to carry out focus 
groups, individual interviews are often the most appropriate method to use; they minimise the 
potential logistic issues, making it easier to reach otherwise difficult to access populations, 
and they provide the respondent with an environment in which they have the confidence to 
discuss difficult or sensitive topics.134  
For three main reasons it was decided that individual, semi-structured interviews were the 
most appropriate data collection method for this stage of the study. Firstly, the population in 
question (GPs) are difficult to access for research135,136 because they are a particularly busy 
group of people. It was felt that they were more likely to participate if their involvement could 
be carried out at a time and location suitable for them; the logistics of organising focus groups 
would be difficult. Secondly, they were a very geographically diverse population, with GPs 
potentially being as far apart as Sheffield, London and Cornwall. Again, the logistics were 
considered to be impossible for a focus group approach. Thirdly, it was felt that the subject 
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under discussion could be potentially sensitive; GPs were likely to be discussing how they 
communicate with their patients, how they feel about involving their patients in trials, and 
how well, or otherwise, they recruited to the study. It was felt that interviews would 
potentially allow GPs to discuss these topics more freely. 
Having discussed the methods that were employed in this project, the thesis will now go on to 
discuss each stage in detail.  
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Chapter 5: Factors that Predict Patient Consent to 
take part in a Randomised Controlled Trial  
5.1 Background 
As discussed in Chapter 4, better understanding of the factors that influence consent is needed 
to enable trialists to plan their studies appropriately. The literature search (Chapter 2) 
identified three articles that examined the impact of clinician motivation for participation on 
patient recruitment rates.33,34,37 These have been described in detail in section 2.3.3.1, but 
essentially they looked for associations between the reasons given by physicians for 
participating and patient recruitment rates. Two of these studies were carried out in a primary 
care setting.34,37 They were postal surveys of recruiting GPs and included questions about 
GPs’ reasons for agreeing to take part in a trial. The authors found a positive association with 
recruitment rates for those ranking the involvement of an academic group highly (adjusted OR 
2.9, 95% CI 1.2-6.9)34 and for those expressing an interest in research per se (74.8% recruiters 
wanted to learn more about research versus 63.8% of non-recruiters p<0.023),37 and a 
negative association for those who ranked personal appeal by the research team as an 
important motivator (OR 0.4, 95% CI 0.2-0.9).34 All other factors showed no association with 
recruitment rates. These findings indicate that practitioner factors impact on whether or not a 
patient will give consent. However, they are restricted to why a clinician agreed to take part 
and do not take any other factors, for example, practice demographics or GP experience, into 
account.   
BAFTA provided an ideal opportunity to conduct analysis that may identify factors that 
influence consent, as it was a multi-centred trial carried out throughout England and Wales 
and involved large numbers of GPs. Although the recruitment target was achieved, patient 
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entry was slower than anticipated and required a re-structuring of the recruitment strategy to 
achieve study power within a reasonable timescale. Over the four year recruitment period, the 
number of participating practices was increased, and it was initially assumed that this 
expansion of the available patient pool was responsible for the study’s ultimate success. As it 
is possible that patient, practice and/or practitioner characteristics influenced recruitment to 
the study, a cross sectional study of patients invited to take part in the BAFTA study was 
carried out in order to assess whether any of these factors predicted whether an individual 
would consent to take part in the trial. This chapter will detail the methods and results of the 
cross sectional study. These findings have already been published in Family Practice, and a 
copy of the final publication can be found in Appendix Two. 
5.2 Methods 
The methods of the BAFTA trial are described in chapter 3 and have been published 
elsewhere.120 In brief, potentially eligible patients were identified through computer searches 
for atrial fibrillation supplemented by opportunistic screening of the pulse. An 
electrocardiograph (ECG) showing AF was required to confirm eligibility for the study. One 
doctor per practice acted as the local investigator for the study. The research team trained 
investigators in study procedures and GCP over the four year period (2001 to 2004) that 
patients were recruited. During this time changes were made both to study procedures and to 
investigator training. (See Table 10, page 99) These are described in detail in Chapter Six. 
Once trained, investigators screened their patients to determine eligibility. The medical 
records of patients aged over 74 who were found to have ECG confirmed AF were examined 
for presence of any study exclusion criteria and if the GP was in equipoise as to whether or 
not they should be treated with aspirin or warfarin after review of relevant risk factors for 
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stroke and haemorrhage, the patient was invited to attend a study clinic.  Eligible patients 
were sent a patient information sheet and a letter inviting them to see their primary care 
physician to discuss trial participation. During this appointment, the patient made the decision 
whether or not to take part in the study.  
Table 10: Summary of Changes to the Trial Procedures 
Criteria Date of 
Change 
Detail of Change 
Changes to 
trial 
procedures  
2002 
 
 
2003 
 
 
 
 
 
2004 
Broadening of inclusion criteria to allow people already on 
warfarin to be considered 
 
Assessment process of patients simplified to shorten time 
from investigator training to patient recruitment and to 
reduce investigator workload 
Payments to practices changed from payment in advance 
to payment for work carried out 
Computer searches for atrial fibrillation expanded to 
reduce need for opportunistic screening, and thus further 
reduce investigator workload 
 
Changes to 
training 
methods 
2003 
 
 
2004 
Training sessions reduced from 8 to 5 ½ hours 
New evidence to support study rationale included137 
 
Training sessions reduced to 4 hours 
Good Clinical Practice (GCP) reduced and made more 
study specific 
More detail on rationale for study 
Sessions made more interactive  
 
This analysis focuses on the 1763 patients from 262 practices in England and Wales who 
demonstrated that they were willing to consider study participation by attending the study 
clinic. Both patient and practitioner factors were taken into account. (See Table 11) Data were 
collected from a variety of sources: information on past medical history and medications were 
collected from the medical records; disability score (Rankin) was completed by the patients 
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during the study clinic appointment; practice and practitioner characteristics were collected in 
a questionnaire completed by each practice on recruitment to the study; data on the year that 
the practice and the patient were recruited to the study and the number of patients attending a 
study clinic appointment from each practice were available in the study database.   
Table 11: Factors Taken into Account 
Patient Characteristics 
 Demographic characteristics (Sex; age; ethnicity; Index of Multiple 
Deprivation (IMD) score) 
 Current medications 
 Past medical history (diabetes; TIA; stroke; epilepsy; previous myocardial 
infarction (MI); angina; heart failure; non-rheumatic valve disease; 
hypertension; AF) 
 Disability score (Rankin) 
 Year attended study clinic 
Practitioner Characteristics 
 Demographics (sex; year of full GMC registration) 
 Size of practice (number of GPs) 
 Year of practice recruitment to the study 
 Number of patients attending study clinic 
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5.2.1 Statistical Methods 
Descriptive statistics (patient characteristics and proportions of patients randomised) were 
carried out using SPSS version 17. The more complex analysis (logistic regression and multi-
level modelling) was carried out by the BAFTA study statistician. The effect of patient, 
practice and practitioner factors on patient consent was explored using logistic regression, 
univariable for factors considered one at a time and multivariable for factors considered in 
combination.  Further multivariable analysis was conducted using a multi-level mixed effects 
model. 
5.3 Results 
1763 people attended the study appointment. Of these, 23 (1.3%) had absolute exclusion 
criteria and should not have been invited to an appointment to discuss trial entry. These were 
excluded from this analysis, leaving 1740 patients. Characteristics of these patients can be 
found in table 12. The mean age of attendees was 81.9 years (range 74-96). 
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Table 12: Characteristics of included patients (n=1740) 
Patient Characteristics  No. (%)ǂ 
Randomised* Yes 973 (56) 
 No 767 (44) 
Age 75-79 654 (38) 
 80-84 676 (39) 
 85+ 391 (23) 
 Not known 19 (1) 
Sex Male 882 (51) 
 Female 765 (44) 
 Not known 93 (5) 
Ethnicity White 1637 (94) 
 Non-white 45 (3) 
 Not known 58 (3) 
Already on warfarin Yes 548 (32) 
 No 1080 (62) 
 Not known 112 (6) 
Already on aspirin Yes 773 (44) 
 No 831 (48) 
 Not known 136 (8) 
History of TIA** Yes 154 (9) 
 No 1489 (86) 
 Not known 97 (6) 
History of Stroke Yes 106 (6) 
 No 1533 (88) 
 Not known 101 (6) 
Newly identified AF Yes 524 (30) 
 No 1216 (70) 
ǂ Totals may not equal 100 due to rounding 
*randomised patients gave full consent to participate in the trial; non-randomised patients 
gave consent for researchers to have access to their medical records. 
**TIA = transient ischaemic attack; AF = atrial fibrillation 
 
 
973 (55.9%) patients consented to be randomised, although there was a wide variation 
between local investigators in the proportion of eligible patients who gave their consent (0-
100%). (See Figure 7, page 102)  
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Figure 6: Proportion of Eligible Patients Giving Consent Per Practice* 
 
*Practices who saw fewer than 10 patients at study clinic are not included in this figure 
 
5.3.1 Patient Factors 
On univariable analysis, people already on warfarin were more likely to give consent. Patients 
offered trial entry in 2004 were almost twice as likely to participate as those considered in 
2001. Patient socio-economic status also predicted whether or not a patient would consent, 
although there was not a simple linear association between the quartiles. Patients on aspirin 
and those with an increased risk of stroke (history of TIA, angina or non-rheumatic valve 
disease) were less likely to give their consent, as were people aged over 85. There was no 
significant difference, however, between the two younger age groups. (See Table 12) 
On multivariable analysis taking both patient and practice factors into account, patient 
deprivation and use of aspirin were no longer significant. All other factors that were 
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significant in univariable analysis remained so with the logistic regression model. (See Table 
12, page 105) Patient deprivation was eliminated as it was strongly associated with the 
number of practitioners in a practice, the number of patients attending a study clinic 
appointment and the date that the patient entered the study. Use of aspirin was no longer 
significant because there was a strong inverse association with use of warfarin. With the multi 
level model, the pattern of effects was very similar to that seen with the logistic regression, 
with the regression coefficients from the two analyses showing a correlation of 0.95. 
However, as expected, effects were generally less significant. Previous TIA was no longer 
significant and the significance of valve disease was marginal (p=0.06). Other factors 
remained significant. 
5.3.2 Practice Factors 
On univariable analysis all practice factors, with the exception of primary care physician sex, 
had a significant effect on a patient’s likelihood of giving consent. Patients registered with 
practices who attended study training during 2004 were almost twice as likely to consent as 
patients in practices who trained in 2001. Similarly, patients in smaller practices were most 
likely to consent. There was a clear linear association with practice size, with people being 
less likely to consent as the number of practitioners within their practice increased. Patients in 
practices where fewer people attended a study clinic were also more likely to consent. Patients 
of longer practising primary care physicians (those registered with the General Medical 
Council (GMC) prior to 1975) were also more likely to give their consent.  
On multivariable analysis, the year that the practice was recruited to the study was no longer 
significant, due to its strong association with the year of patient recruitment. All other factors 
that were significant in univariable analysis remained so. (See Table 12) With the multi level 
model, year of full GMC registration was no longer significant. 
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Table 13: Influence of Patient and Practice Characteristics on Patient Consent (n = 1740) 
Patient factors         
 No. (%) giving 
consent 
Odds ratio (95% CI) from logistic 
regression 
   Univariable ǂ Multivariable ǂ* 
Sex Female 443 (58) 1.00  
(No. missing = 93) Male 
 
530 (60) 1.09 (0.90-1.33)  
Ethnicity  White 913 (56) 1.00  
(No. missing = 58) Non-white 
 
29 (64) 1.44 (0.77-2.67)  
Age 75-79 385 (59) 1.00  
(No. missing = 19) 80-84 395 (58) 0.98 (0.79-1.22) 1.11 (0.87-1.42) 
 85+ 
 
193 (49) 0.68 (0.53-0.88) 0.75 (0.56-0.99) 
Index of Multiple 
Deprivation 
(quartile) 
1 (least deprived) 338 (54) 1.00  
2 224 (54) 0.99 (0.77-1.26)  
3 192 (52) 0.97 (0.71-1.19)  
(No. missing = 97) 4 
 
150 (65) 1.55 (1.14-2.12)  
Disability score 
(Rankin) 
0 (least disabled) 173 (54) 1.00  
1 265 (58) 1.19 (0.89-1.58)  
(No. missing = 60) 2 296 (60) 1.29 (0.97-1.71)  
 3 187 (53)  0.97 (0.72-1.31)  
 4-5 
 
26 (45) 0.70 (0.40-1.22)  
Already on warfarin No 592 (55) 1.00  
(No. missing = 112) Yes 
 
381 (70) 1.88 (1.51-2.34) 1.47 (1.13-1.91) 
Already on aspirin No 527 (63) 1.00  
(No. missing = 136) Yes 
 
407 (53) 0.64 (0.53-0.78)  
Polypharmacy (on 5 
or more drugs) 
No 559 (55) 1.00  
Yes 
 
414 (57) 1.07 (0.89-1.30)  
Diabetes No 844 (59) 1.00  
(No. missing - 95) Yes 
 
129 (60) 1.06 (0.79-1.42)  
Previous TIA** No 893 (60) 1.00  
(No. missing = 97) Yes 
 
80 (52) 0.72 (0.52-1.01) 0.65 (0.45-0.94) 
Previous Stroke No 914 (60) 1.00  
(No. missing = 101) Yes 
 
59 (56) 0.85 (0.57-1.26)  
Epilepsy No 951 (59) 1.00  
(No. missing = 118) Yes 
 
7 (39) 0.44 (0.17-1.13)  
Previous myocardial 
infarction 
(No. missing = 97) 
 
No 870 (60) 1.00  
Yes 
 
103 (56) 0.85 (0.62-1.16)  
Angina No 818 (61) 1.00  
(No. missing = 103) Yes 
 
155 (52) 0.67 (0.52-0.86) 0.64 (0.48-0.84) 
Heart failure No 783 (60) 1.00  
(No missing = 100) Yes 
 
190 (56) 0.83 (0.65-1.06)  
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Patient factors 
 No. (%) giving 
consent 
Odds ratio (95% CI) from logistic 
regression 
   univariable multivariable* 
Non-rheumatic valve 
disease 
(No. missing = 105) 
 
No 905 (60) 1.00  
Yes 
 
68 (52) 0.70 (0.49-1.00) 0.61 (0.41-0.90) 
Hypertension No 445 (59) 1.00  
(No. missing = 97) Yes 
 
528 (60) 1.03 (0.84-1.25)  
AF status** Already known 683 (56) 1.00  
 New case 
 
290 (55) 0.97 (0.79-1.19)  
Year patient attended 
study clinic 
2001 96 (3) 1.00  
2002 184 (44) 0.71 (0.50-1.00) 0.70 (0.48-1.02) 
 2003 252 (54) 1.06 (0.75-1.50) 1.00 (0.68-1.47) 
 2004 
 
441 (66) 1.75 (1.25-2.43) 1.76 (1.18-2.61) 
Practitioner & 
Practice factors 
    
 
Practitioner  sex 
 
Female 
 
246 (56) 
 
1.00 
 
 Male 
 
727 (56) 1.01 (0.81-1.25)  
Year of full GMC 
registration** 
-1975 195 (63) 1.00  
1976-80 206 (53) 0.67 (0.49-0.91) 0.63 (0.44-0.90) 
 1981-85 195 (54) 0.70 (0.51-0.95) 0.70 (0.48-1.02) 
 1986-90 238 (62) 0.96 (0.71-1.31) 1.08 (0.74-1.56) 
 1991 – 
  
139 (47) 0.53 (0.39-0.74) 0.61 (0.41-0.90) 
Size of practice (no. 
of GPs) 
1-2 98 (75) 1.00  
3-4 262 (62) 0.55 (0.36-0.86) 1.13 (0.68-1.89) 
 5-6 335 (54) 0.40 (0.26-0.61) 0.65 (0.39-1.07) 
 7-8 225 (51) 0.34 (0.22-0.53) 0.63 (0.38-1.07) 
 >8 53 (42) 0.25 (0.15-0.42) 0.40 (0.21-0.75) 
 
Year of recruitment 
to study 
 
2001 
 
310 (50) 
 
1.00 
 
2002 98 (47) 0.86 (0.63-1.18)  
 2003 262 (57) 1.31 (1.03-1.67)  
 2004 
 
303 (66) 1.95 (1.52-2.50)  
Number of patients 
attending 
1-5 249 (69) 1.00  
6-10 286 (49) 0.44 (0.33-0.57) 0.46 (0.33-0.64) 
 11-15 220 (53) 0.50 (0.37-0.67) 0.54 (0.38-0.78) 
 16-20 104 (57) 0.59 (0.41-0.86) 0.82 (0.51-1.30) 
 >20 114 (56) 0.58 (0.40-0.83) 0.77 (0.49-1.21) 
ǂ Statistically significant results are given in bold 
*Adjusted odds ratio only given if factor significantly associated with likelihood of consent 
** TIA = transient ischaemic attack; AF = atrial fibrillation; GMC = General Medical Council 
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5.4 Discussion 
This is the largest study to look at factors influencing patient consent to a multi-centre 
primary care based RCT. Both patient and practice factors independently predicted whether a 
patient would consent to take part. 
5.4.1 Patient Factors 
A number of the patient factors found to be associated with the likelihood of giving consent 
may reflect general attitudes towards trials, with understanding and acceptance of issues such 
as randomisation, uncertainty and acceptability of treatment arms playing a part in a patient’s 
decision on whether to participate.138,139,140 Patients with a history of valve disease, angina or 
transient ischaemic attack were less likely to give consent. This could be due to the impact of 
perceived illness severity on trial participation: patients with differing disease processes or 
illness severities were found to retain different levels of information about trials for different 
reasons.139 It is possible that this explains why some conditions predicted the likelihood of 
consent, while others did not. Alternatively, it is possible that these patients had a strong 
preference for warfarin as they felt that they had more to benefit from this therapy.44,141 
Many of the patient factors could also be specific to the interventions (warfarin and aspirin) 
being tested,4 with patients already on warfarin being more likely to give consent. This 
presumably reflects the inconvenience and unpopularity of the treatment.142 People already 
taking warfarin are perhaps less likely to be deterred from participation because of the need 
for ongoing monitoring, or because of the uncertainty surrounding the extra risk associated 
with the drug, than those who have never taken it. Given that how the study is described to a 
patient can influence participation43 it is also possible that the way in which warfarin was 
explained by GPs influenced patients’ decisions about whether or not to consent. 
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The reduced likelihood of older patients (in this case over the age of 85) giving consent has 
been reported in other studies.143 The reasons for this are not clear, but it may reflect an 
aversion to the extra time, expense or tests associated with involvement in a trial. Older 
people are often carers for their spouses144 and may feel unable to commit to any further 
demands on their time. It is possible that as people age they develop more co-morbidities and 
this means that they are reluctant to risk or complicate their health further. However, this does 
not seem to be borne out by the research: Petty et al found that patients on five or more drugs 
(the number of different medications taken by patients is often used as a proxy by researchers 
for co-morbidity: the higher the number of drugs, the more conditions the patient is expected 
to have) were more likely to consent than those on fewer medications (OR 1.3, 95% CI 1.1 - 
1.5)143 and the current analysis found that those on five or more drugs were no more or less 
likely to consent than those who take less (OR 1.07, 95% CI 0.88-1.29). It may be that some 
potentially ‘healthier’ people (those on fewer drugs) were actually the people who were 
reluctant to jeopardise their current health status, and that accounts for these findings. 
The year that the patient was invited to enter the study was the most significant patient factor, 
with a patient approached in 2004 being twice as likely to take part as one approached in 
2001. There are several possible explanations as to why there was such a strong association 
between when a patient was recruited and whether or not they gave consent. It is possible that 
changes to investigator training methods had an impact on the way in which investigators 
conducted the consent process (See Table 10, page 99). As discussed in the background 
chapter, many doctors encounter problems obtaining consent satisfactorily, and changes in 
training may have helped to alleviate some of these. An individual patient meta-analysis of 
oral anticoagulants versus aspirin in nonvalvular atrial fibrillation, published at the end of 
2002137 was incorporated into the training sessions in 2003. This helped underline the 
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uncertainty as to whether the benefits of warfarin outweighed potential harm as compared 
with aspirin in the study age group. Investigators trained after this date may, therefore, have 
been more confident that equipoise existed for individual patients,145 possibly resulting in an 
increased likelihood that a patient would consent to take part.  
There were several changes to trial procedures (See Table 10, page 99) throughout the 
recruitment period which might account for the increased likelihood of gaining consent over 
time, though most of these changes will have affected the trial ‘upstream’ of the consent 
process. These amendments potentially had a two-fold effect. Simplification of study 
procedures resulted in a reduced workload for investigators, minimizing the negative impact 
that a time consuming protocol has on a physician’s ability to engage with the research,4 thus 
making the project more attractive to them.146 Changes to both payment methods and study 
procedures reduced the time between investigator training and commencement of patient 
recruitment (from approximately four months to approximately two months). Haidich et al 
demonstrated in a secondary care setting that the longer the gap between study 
commencement and enrolment of the first patient, the less likely the site is to recruit well.147 
Reduction of the time delay could mean that investigators were more familiar with the trial 
rationale and protocol than they would be after a lengthy delay. It is also possible that they 
retained their initial enthusiasm for the study and this translated into improved recruitment. 
The broadening of the inclusion criteria to allow people on warfarin to be considered may be 
a partial explanation of the trend observed in patient consent, though it is not clear why there 
should have been a two year lag before it had an effect. It may be that there was a secular 
change in patient attitude, either to trial participation in general or the value of warfarin in 
particular over the study period. Warfarin use has become more common in older people over 
time,148 and this may have influenced willingness to participate.  
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5.4.2 Practice and Practitioner Factors 
In this study a higher proportion of patients from smaller practices gave consent than from 
larger practices.  As discussed in chapter two, practitioners can be uncomfortable describing 
personal equipoise and the randomisation process and will often emphasise aspects of the trial 
that they expect patients to understand more easily.149 These difficulties may be mitigated in 
smaller practices where continuity of care is more likely,150 and physicians can get to know 
their patients better, giving patients a feeling of security151 and the primary care physician a 
better understanding of152 and increased feeling of responsibility towards their patient.118 This 
enables them to be both more selective about which patients they invite, and more confident 
that the informed consent discussion will have no detrimental effect on the doctor/patient 
relationship.   
This study also found that older GPs were more likely to obtain consent than younger GPs, 
although there was not a simple linear relationship with age. The effect of age may reflect a 
number of factors, including variations in consulting style or differing attitudes to warfarin. It 
could be that older GPs have a longer term relationship with their older patients, and this 
builds the trust that facilitates the consent process.153 Older doctors are seen to be more 
willing to listen and more reassuring than younger doctors, and are viewed more positively by 
older patients:90 these perceptions may help to account for this finding. 
5.5 Strengths and Limitations  
The patients in this analysis were all considered eligible for the study by their primary care 
physician and all attended a clinic appointment, so were not averse to trial participation per se. 
Therefore, the factors considered here impact directly on the process of obtaining consent, 
rather than on other parts of the patient pathway leading to trial participation, such as 
willingness to attend, or physician decisions about eligibility. Another strength is the large 
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size, and the high degree of data completeness, with over 90% data completeness (worst data 
item was prior aspirin use, with 7.8% missing data).  
There are some weaknesses to this analysis. Although it demonstrates that a wide variety of 
factors influence recruitment, it does not allow us to understand how or why these 
characteristics have such a significant effect. It is based around a single trial, so may be 
difficult to generalise to other primary care trials. However, there are findings here that are of 
general interest.  The effect of practice size and the impact of year of recruitment are unlikely 
to have been primarily related to the nature of the trial interventions. Furthermore, as the way 
that study treatments are described to a patient influences whether or not they are willing to 
take part,43 it is possible that even study specific factors (i.e.acceptance of the trial drugs) 
were influenced by how the investigator conducted the consent process.  
5.6 Implications for Future Primary Care Based RCTs 
The two fold difference in the likelihood of whether or not a patient would give consent over 
the time course of the study, having adjusted for the influence of other patient and practice 
factors, suggests that the conduct of a trial can have a dramatic effect on patient recruitment. 
It is possible that changes made to investigator training, study procedures and payment 
methods account for this finding. As the analysis only considered patients who were eligible 
for the study and who went through the informed consent procedure, the changes must have 
affected either the type of patients attending this appointment, or what was said to them 
during the consent process.  The evidence base for how to train investigators and conduct 
trials in primary care is poor.74 This analysis suggests that research into this area could yield 
important benefits in terms of enhancing recruitment to future studies. 
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Given the strong association found between year of recruitment and consent, it was decided to 
analyse in greater detail the secular trends in recruitment to BAFTA, and observe to what 
extent these were associated with changes in the conduct of the trial. This analysis is 
described in the next chapter.  
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Chapter 6: Trends in the Recruitment of Patients to 
BAFTA  
As discussed in Section 4.2.2, it is not clear from the literature whether or not trial conduct 
can influence the recruitment outcome to a trial. This chapter will examine whether changes 
to BAFTA trial procedures and protocol amendments were associated with changes in patient 
recruitment. 
6.1 Background 
Although there is a growing body of evidence that indicates that trial conduct can influence 
the success or otherwise of patient recruitment (See Chapter 2), there is a contrasting 
argument put forward by Haidich et al that trials that initially fail to achieve recruitment 
targets cannot implement design changes that will improve patient recruitment. These authors 
undertook an analysis that examined recruitment patterns to 77 human immunodeficiency 
virus (HIV) efficacy trials. They found that the pace of accrual within the first two months of 
recruitment was associated with the likelihood of a trial ultimately reaching its targets (88% 
of very rapid early enrolling trials achieved targets versus 20% of slow early enrolling trials, p 
<0.001).  They also found that none of the included studies showed a marked acceleration of 
accrual over time, despite the fact that restrictive entry criteria were often relaxed in an 
attempt to boost recruitment. They concluded that, as even extensive protocol changes were 
unlikely to accelerate recruitment, the initial pace should be used to decide on the feasibility 
of completing an under performing trial and early termination due to futility should be 
seriously considered.128 
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One disadvantage of the analysis carried out by Haidich et al is the fact that the included trials 
were all looking at HIV. The authors acknowledge that this field has its own peculiarities, for 
example, rapidly expanding therapeutics or changes in the course of the epidemic affecting 
the pool of eligible patients, and that this may have influenced their findings. However, they 
posit that other diseases with steadier prevalent patient pools may have even more predictable 
enrolment patterns, therefore making early recruitment rates an even stronger indication of 
future trial success.128 Unfortunately, there were no articles that examined trials that were 
initially failing to achieve targets but were ultimately successful;2 a study of this nature would 
be useful for three main reasons: 
1. It may be possible to identify protocol or procedural changes that influenced 
recruitment  without having to consider complicating factors such as different disease 
types or differing patient populations; 
2. It could add information to the current body of literature about the most appropriate 
way to approach recruitment from trial set up, therefore reducing the need for 
potentially costly or time consuming changes throughout the life of the trial; 
3. It would provide useful evidence to counter the assertion of Haidich et al that the 
initial recruitment rate should be used to glean the eventual fate of a trial. 
The BAFTA study is an example of an ultimately successful trial where initial recruitment did 
not predict the overall recruitment rate (see Figure 8, page 113). Analysis of BAFTA 
recruitment as described in the previous chapter demonstrated that patients in the final year of 
recruitment were almost twice as likely to participate as those in the first year, suggesting that 
changes introduced during the course of the trial influenced recruitment.  
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Figure 7: BAFTA Recruitment Targets 
 
In order to address the question of whether the increase in recruitment over time was due to an 
increase in the size of the study population as a result of expansion of the number of active 
sites, or due to changes in study design and conduct, this chapter will describe the actions 
taken to improve accrual to the BAFTA trial and will examine recruitment patterns to try to 
identify which of the changes made to the design and conduct of the study were most closely 
associated with recruitment rates. Although this is an observational study and cannot therefore 
determine cause and effect, it is hoped that the findings will: provide a useful addition to the 
existing body of literature; air a note of caution to funders and Trial Steering Committees who 
may consider the findings of Haidich et al when deciding the fate of under-performing trials; 
and provide a springboard for future research into trial conduct. The findings from this 
chapter have been published in the Family Practice journal: the full published article can be 
seen in Appendix Three. 
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6.2 Methods 
6.2.1 Recruitment Processes 
As detailed in section 3.4.11, each participating practice nominated one GP to act as local 
investigator, and one practice nurse (PN) to assist the GP with the identification and 
recruitment of patients. In summary, the research team trained all nominated practice staff in 
study procedures and GCP: after attending training, practices were responsible for the 
identification and recruitment of potentially eligible patients. Practice nurses carried out an 
electrocardiogram (ECG) on all patients with an AF diagnosis in their medical records, or 
who were found to have an irregular pulse during opportunistic screening. When AF was 
shown on the study ECG, GPs examined patients’ medical records to establish the presence of 
study exclusion criteria. If the GP was in equipoise over whether to treat a patient with aspirin 
or warfarin then the patient was invited to an appointment to discuss trial participation. (See 
Figure 4, page 84) Patient recruitment was carried out over a four year period (2001-2004), 
but it became apparent within the first six months that the study was failing to recruit enough 
patients: accrual rates were poor.  
6.2.2 Actions Taken to Improve Recruitment 
Over the recruitment period a variety of changes were made in an attempt to improve accrual. 
These included: revision of inclusion/exclusion criteria; procedural changes to reduce primary 
care workload and time to recruitment; expansion of the number of active sites; and a 
different approach to the recruitment and retention of practices. (See Table 13, page 115) 
Further details about the amendments are given below. 
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Table 14: Changes to Trial Procedures and Protocol amendments 
Protocol changes 
Change 
number 
Date 
introduced  
Problem Change Procedure prior to 
change 
Procedure post change Expected Impact 
1 2002 Lower than 
expected 
prevalence of AF 
on study ECG 
Amendment to 
inclusion criteria 1 
 
Allows patients to be 
potentially eligible if 
have ECG diagnosis 
of AF in records but 
sinus rhythm (SR) 
on study ECG 
 
All patients ECG’d prior 
to determining eligibility 
and ineligible if SR on 
study ECG 
 
Patients with ECG in 
records (within 2 years) 
showing AF now 
potentially eligible. Only 
patients consenting to 
participation have study 
ECG, allowing 
categorisation into AF or 
paroxysmal AF 
 
Reduction in 
investigator 
workload  
 
Increased number of 
potentially eligible 
patients 
 
 
2 2002 Higher rate of 
patients already 
taking warfarin 
than expected from 
the literature 
Amendment to 
inclusion criteria 2 
 
Broadening of 
inclusion criteria to 
allow people on 
warfarin to be 
considered 
Patients on warfarin were 
ineligible.  
No change to procedure.  Increase in numbers 
eligible.  
Procedural changes     
3 2002 Intensive practice 
workload 
Reduced workload 1 
 
ECGs only carried 
out on potentially 
eligible patients 
ECGs carried out on all 
patients with AF on 
computer searches and 
patients with an irregular 
pulse 
ECGs now only carried 
out on potentially eligible 
patients 
Decreased workload 
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Change 
number 
Date 
introduced  
Problem Change Procedure prior to 
change 
Procedure post change Expected Impact 
4 2003 Intensive practice 
workload 
Reduced workload 2 
 
Data on past medical 
history and 
medications only 
collected on 
potentially eligible 
patients  
Data collected on all 
patients with AF 
Practices no longer search 
medical records for 
detailed data for patients 
who are ineligible for the 
trial 
Decreased workload 
5 2004 Intensive practice 
workload 
Reduced workload 3  
 
Evidence of AF in 
patient records used 
to determine 
eligibility, patients 
only have ECG once 
they have consented 
to participation 
All potentially eligible 
patients received a study 
ECG prior to 
randomisation 
Practices look for evidence 
of AF in the records when 
determining eligibility for 
the study. Patients then 
invited to participate and 
receive an ECG if they 
consent to randomisation 
Decreased workload 
6 2004 Intensive practice 
workload/ 
recruitment 
timeframe 
(recruitment closed 
September 2004) 
Reduced workload 4 
 
Practices no longer 
carried out 
opportunistic pulse 
screening 
All patients without AF on 
computer searches would 
have their pulse screened 
to identify potential new 
cases of AF 
Opportunistic screening no 
longer carried out. Incident 
cases of AF could still be 
considered 
Decreased workload 
and shortened time 
to complete 
recruitment process 
7 2004 New trial team 
approach to site 
retention 
 Once trained, the study 
team would endeavour to 
keep each site as 
participants, offering help 
and support where 
appropriate 
Under performing 
practices or sites who were 
unsure about their ability 
to carry out the work 
within the required time 
were simply allowed to 
withdraw 
Enthusiastic 
successful practices 
to remain active, 
ensure optimal 
recruitment and 
optimal allocation of 
study team resources 
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6.2.2.1 Revision of Inclusion/Exclusion Criteria 
Protocol Amendment One  
One of the issues identified as contributing to poor recruitment was the higher number of 
ineligible patients than was anticipated. As shown in table eight, one of the exclusion criteria 
at the start of the recruitment period was if a patient was already taking warfarin.  It was 
estimated from the literature that 17% of the prevalent AF population over the age of 74 
would be taking warfarin, and it was assumed that it was appropriate for these to be on a 
potentially dangerous treatment despite the lack of evidence to support this, because they 
were usually patients who had co-morbidities that further increased their risk of stroke. In 
reality, 34% of patients in the target population were on warfarin prior to the study. This 
situation effectively doubled the number of ineligible patients from the prevalent AF 
population, so some analysis of data collected from participating practices was carried out. 
This analysis demonstrated that many people were taking warfarin who were not at extra risk 
of stroke, and so the balance of risk and benefit for them was still unknown. Therefore, it was 
appropriate that they were also eligible for study inclusion and in 2002 the protocol was 
amended accordingly. 
In addition to increasing the pool of eligible patients, this protocol amendment had two 
further potential advantages:  
1. It reduced the level of complexity for the practice staff carrying out the trial; 
2. It reduced the time from practice involvement to patient recruitment. 
Although people on warfarin were originally ineligible, practice nurses were still asked to 
invite them to the initial clinic where an ECG was carried out and pre-baseline data was 
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collected: this would allow generalisability of trial results to be examined. Informal 
discussions with PNs revealed that they often found this confusing, and so they had a 
tendency to invite all their warfarin patients to the ECG clinic before they considered any who 
were potentially eligible. While this approach reduced the complexity of the study for practice 
staff (which may contribute to improved recruitment, as discussed in the background chapter), 
it also meant that there was a long time lag between the commencement of practice 
involvement and the recruitment of their first patient, resulting in slower than anticipated 
accrual. It was hoped, therefore, that this amendment would improve recruitment from a 
number of angles. 
Protocol Amendment Two 
Another issue that was felt to be contributing to poor recruitment was that of Lasagna’s Law. 
115,116 Estimates for the number of people expected to have AF were taken from the literature; 
as is often reported in articles looking at recruitment problems, the disease prevalence seemed 
to be far lower in reality than was expected. In the case of BAFTA, patients were only eligible 
if their study ECG showed AF: it was found that many study ECGs showed sinus rhythm 
(SR), despite the fact that they had a diagnosis of AF in their medical records. It was felt that 
this anomaly was caused by a higher than expected prevalence of paroxysmal AF (where 
patients switch between AF and SR): patients were only eligible if they happened to be in AF 
at the time of their ECG. The protocol was amended to allow inclusion of paroxysmal AF 
patients. Post amendment, patients with an ECG in their medical records (within two years) 
showing AF were potentially eligible and only those who consented to study participation 
were given a study ECG. This allowed categorisation of patients into constant AF and 
paroxysmal AF groups.  
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6.2.2.2 Procedural Changes 
A number of procedural changes were made that were intended to reduce the workload to 
practice staff.  
Change One (changes to the number of patients requiring a study ECG) 
PNs were initially asked to carry out ECGs on all patients who had AF on computer searches, 
as well as on all patients who were found to have an irregular pulse as part of the 
opportunistic screening programme (Section 3.4.7), regardless of whether or not they were 
potentially eligible. Again, this was intended to allow generalisability of the trial to be 
examined. However, this represented a massive time investment on the part of the PNs. It was 
felt that they were spending time on the collection of data on ineligible patients that would be 
better spent on actual recruitment. Therefore, in 2002, nurses were asked to only carry out 
ECGs on people who did not have any of the study exclusion criteria. 
Change Two (changes to the data collected on ineligible patients) 
Initially, data on medical history and medications were collected on all patients with AF. This 
necessitated detailed searching of the medical records and the completion of study Case 
Report Forms (CRFs) for large numbers of patients. Again, this was done to allow the 
discussion of study generalisability, and again, it was decided that nurse time would be better 
spent focussing on eligible patients. Therefore, in 2003 nurses were asked to collect this 
information on potentially eligible patients only. 
Change Three (further changes to the number of patients requiring a study ECG) 
Despite the changes already implemented, all potentially eligible patients received an ECG 
prior to study inclusion and this still represented a heavy workload for practices. In 2004, 
further changes were made to address this. Instead of carrying out an ECG on all eligible 
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patients, nurses were instead asked to search medical records for sufficient evidence of a 
diagnosis of AF. This evidence could either be an ECG that had been carried out within the 
preceding two years, or a hospital consultant letter that referred to an ECG showing AF, also 
within the preceding two years. ECGs were then only carried out on patients after they had 
consented to study participation. This change represented not only a significant reduction in 
workload, but also had the added benefit of minimising the delay between a practice 
becoming active and recruiting their first patient.  
Change Four (changes to the opportunistic screening programme) 
All patients aged 74+, without a diagnosis of AF in their records were part of the 
opportunistic screening programme for the study. Each patient had a flag attached to their 
records (either electronic or paper as appropriate to individual practices) reminding all clinical 
staff to take their pulse during a routine consultation. As this needed to be done only once for 
each patient, once the pulse had been taken the request was removed from the notes. All 
patients having an irregular pulse on this examination then received an ECG to determine 
eligibility for the trial. This was another time consuming process for practices. Practice staff 
had to add reminders to patient medical records in all practices where paper notes were 
routinely used during consultations, and they were also responsible for ensuring that 
processes for following up patients with an irregular pulse were in place. Although patient 
recruitment was due to close in September 2004, practices were still being trained and 
becoming active in April. In order to enable them to complete recruitment within these tight 
time frames, these practices no longer carried out the opportunistic screening programme, 
although incident cases of AF were still eligible for inclusion. 
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6.2.2.3 New Research Team Approach to Site Retention 
Recruitment and training of sites is a time consuming and costly part of the trial process, and 
as discussed in section 3.3.1, is potentially one of the most problematic areas of recruitment 
for primary care based trials.65 Initially, the BAFTA team put significant resources into 
ensuring that all trained sites would remain active participants. Support to resolve queries or 
concerns was given, and where appropriate and possible, practical assistance in the form of 
administrative help or nurse time was offered. The research team worked closely with under-
performing sites, or those expressing reservations about their ability to commit to the level of 
work involved, in an effort to enable them to recruit. However, as the number of sites 
increased and became more geographically diverse, and the time frames for completion of 
recruitment became increasingly short, a decision was taken that these practices would simply 
be allowed to withdraw. This allowed enthusiastic and successful practices to remain active, 
ensuring optimal recruitment and the most appropriate allocation of study team resources. 
6.2.2.4 Changes to the Training Sessions 
Changes were made to the timing and content of the training sessions over the four year 
recruitment period. Initially, a GP and PN from each site were required to attend a full day 
training session. The morning was spent discussing generic trial issues, for example, GCP, 
trial rationale, ethics: in the afternoon, GPs and PNs were divided into small groups and 
specific trial procedures appropriate to their role were discussed. Each year, changes were 
made to the sessions and they became increasingly streamlined. For example, GCP sessions, 
although covering the crucial elements, were much more study specific; less time was spent 
describing the study manual and study Standard Operating Procedures (SOPs) as these areas 
were incorporated into the more practical afternoon sessions. By 2004, the training sessions 
were condensed to a half day session which still incorporated important generic issues such as 
GCP and trial rationale, but were more focussed on the practicalities of carrying out the 
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research. This made it easier for practice staff to attend the sessions: releasing two members 
of staff from the practice for half a day is much easier for sites to achieve than releasing them 
for a full day. Full details of the topics covered during training can be found in the example 
training session agendas in Appendix One. 
6.2.3 Statistical Analysis  
This analysis was performed to address the question: was the increase in recruitment over 
time simply due to an increase in the size of the study population (i.e more practices were 
taking part), or due to the changes in the design and conduct of the study? To explore this, 
analysis was undertaken to look at whether the recruitment rate per population available 
varied over time in line with the observed increase in recruitment. If the increase in 
recruitment was potentially due to changes in how patients were recruited, this would be 
associated with an increase in recruitment rate per 1,000 population.  
The recruitment phase of the study was divided into 3 month periods. For each quarter, only 
data from active practices (those who had reviewed their patients for eligibility or had invited 
two or more patients to attend a study clinic during the period) were included. For each 
quarter, the number of patients enrolled into the study was calculated. The recruitment rate 
per 1000 patient population was also calculated; the denominator was the population of 
patients aged 75+ in active practices. In order to identify whether there was a seasonal effect 
on recruitment, the effect of quarter on recruitment was also examined. 95% confidence 
intervals were calculated to identify whether there were any significant increases/decreases in 
recruitment rates. The analysis was carried out using SPSS version 17. 
6.2.3.1 Further Analysis for Publication 
In order to determine whether there was a significant change in recruitment rate, a conducted 
change point analysis with the Moving F statistic using the first seven quarters as the baseline 
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sample and a moving average of three quarters was carried out.154 This was done at the 
request of peer reviewers to enable publication and was carried out by one of the BAFTA 
study statisticians. 
6.3 Results 
A total of 535 practices attended study training sessions, with 330 (62%) continuing through 
to active participation. Of those, 257 (78%) sites saw at least one patient at a randomisation 
clinic appointment and 234 recruited one or more patients. The revised target of 930 patients 
was exceeded, with 973 people recruited into the trial. An average of 65 patients were 
recruited per quarter (range 4-219). The overall recruitment rate per 1000 study population 
was 4.7 patients. The average rate per practice was 5.5 patient per 1000 (range 0-66.7). This is 
higher than the overall average as it reflects the number of smaller practices that recruited a 
high proportion of their patients. Protocol amendments accounted for 44% of patients 
recruited. (See Figure 9) 
Figure 8: Proportions of Recruited Patients as per their Status at Baseline 
 
 
56% 
39% 
5% 
Not on warfarin On warfarin Paroxysmal AF
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Recruitment fluctuated during the recruitment period with a number of changes to the 
numbers recruited. (See Figure 10) The last half of 2003 saw a large increase in recruitment, 
but this was dwarfed by a bigger rise in the last six months of the study, which followed the 
introduction of a number of procedural changes (See Table 10, page 99).  In general, the 
pattern of changes in numbers recruited per quarter was closely matched by changes in 
recruitment rate per 1000 population. (See Figure 10) Broadly speaking fluctuations in the 
size of the total study population  also reflected these recruitment patterns, with higher 
recruitment attained in quarters with a larger total study population and vice versa. However, 
the large increase in both recruitment numbers and rates in the last six months of the study 
was not mirrored by a similarly large increase in the total population available.  
Figure 9: BAFTA Patient Recruitment Patterns* 
 
 
*see table 14 for full details about protocol changes and procedural amendments 
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95% Confidence Intervals demonstrated a number of statistically significant increases in 
recruitment, in quarter 3 2001, quarter 4 2002, quarter 3 2003, and most noticeably in quarter 
3 2004. (See Figure 11, page 125)  
Figure 10: Confidence Intervals around Recruitment rates* 
 
*see table 14 for full details about protocol changes and procedural amendments 
 
6.3.1 Further Analysis for Publication 
When published, peer reviewers requested that some further analysis was carried out. BAFTA 
study statisticians calculated the Moving F statistic. The Moving F is calculated as the moving 
average of squared deviations about the series model in ratio to the baseline residual mean 
square. A change is identified when the Moving F crosses the critical F.  
Analysis using the Moving F statistic demonstrated that there was a significant increase in 
recruitment rate (p<0.05) in the last six months of the study. (See Figure 12, page 126)  
  
 
O point estimate 
 
I 95% confidence limits 
 
 130 
 
Figure 11: Moving F Statistic* 
 
 
  *The horizontal reference line indicates the critical F(2,6,0.95)=5.14. 
6.4 Discussion 
This study found that the increase in recruitment in the last 6 months of the study was 
associated with a significant rise in recruitment rate per 1000 population, rather than merely 
with an increase in the overall size of the study population. Inclusion of more sites to increase 
the total study population is an obvious way of improving recruitment. As discussed in the 
background chapter, it is an approach that is often advised in the literature, and is something 
that trialists often utilise.3,18,29 However, this analysis indicates that recruitment to BAFTA 
was affected more by factors influencing the proportion of eligible patients participating than 
it was by the expansion of the number of  recruiting sites.  
 131 
 
The protocol modifications in BAFTA had mixed success. Broadening of inclusion criteria 
had no immediate impact on recruitment; both amendments to eligibility criteria were carried 
out early in the recruitment process and were not associated with a noticeable increase in 
recruitment. However, when considered overall, these changes did make a significant 
contribution to the number of patients included in the study, as 44% of patients would have 
been ineligible prior to the modifications (See Figure 9, page 123). These findings 
demonstrate the importance of careful consideration about inclusion/exclusion criteria during 
the protocol design phase: it would be better to set these parameters optimally from the outset. 
This can be difficult to achieve, as prevalence estimates are usually gleaned from the literature 
and often do not reflect reality. Pilot trials may allow recruitment estimates for the main trial 
to be based on real prevalence figures and therefore reduce the number of trials failing to 
reach expected accrual targets.  
This finding also has implications for bodies who are considering the fate of failing trials. 
Haidich et al suggested that even extensive protocol amendments fail to achieve impressive 
acceleration in recruitment rates; BAFTA recruitment demonstrates that, while the protocol 
changes may not result in immediate large increases in accrual, overall they have the potential 
to contribute a significant proportion of study patients. Funding bodies or Trial Steering 
Committees need to allow sufficient time for the amendments to filter through before deciding 
on the feasibility of a study. 
As discussed in section 6.2.2.2 a number of procedural changes to reduce investigator 
workload were introduced (See Table 10, page 99). Figure 12 (page 126) demonstrates that 
early changes did not seem to impact on recruitment although changes introduced in 2003 
were followed by a noticeable but not statistically significant increase. The 2004 amendments, 
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however, were associated with a significant increase (See Figure 12, page 126). Unfortunately 
it is not possible to determine from this analysis whether this increase was a direct result of 
the procedural changes that were implemented that year: it could have been a result of the 
cumulative effect of the alterations that took place over the whole recruitment period. 
There may also be other explanations for the observed increase in recruitment. In 2004 a new 
approach to site retention was adopted by the research team, with underperforming or 
overstretched practices simply withdrawing from participation (See Table 10, page 99). 
Remaining practices were likely to have been more interested in the study question or more 
able to incorporate the extra workload into practice, and it is possible that this translated into 
more successful recruitment. Furthermore, these practices had tight timeframes within which 
to complete recruitment, so they may have given the study a higher priority.  
It is possible that factors extrinsic to the trial might have been responsible for the observed 
increases. In 2002 an individual patient data meta-analysis was published which helped 
underline the uncertainty surrounding the benefits and harms of aspirin versus warfarin in the 
over 75 age group.137 This new evidence was incorporated into investigator training in 2003. 
This may have made GPs more confident about the treatment uncertainties and therefore more 
comfortable with explaining equipoise to individual patients. How a study is explained to a 
patient has been shown to impact on their willingness to participate,43 so better acceptance of 
the study question by investigators may lead to more patients giving consent. 
The increased recruitment rates could also be a result of changes in patient attitudes, either to 
warfarin or to participation in trials in general. Warfarin use in older people has increased 
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outside of trial settings;148 increased general acceptance of one of the study drugs may 
account for their increased willingness to participate. 
6.5 Strengths and Limitations 
One strength of this analysis is that it demonstrates identifiable time points in the recruitment 
period which can be related to both protocol and procedural changes. Unfortunately it is not 
possible to determine what aspects of the steps taken to improve recruitment were actually 
responsible for the changes in recruitment. The large jump in recruitment seen in 2004 may 
have been caused by any one of the interventions described, or by a combination of all of 
them. Nevertheless, this analysis does provide evidence that it is possible to significantly 
improve recruitment rates without simply recruiting more centres, and gives an insight into 
ways in which this may be achieved. It is difficult to generalise from the particular (i.e. 
recruitment of older people to a trial of atrial fibrillation) to the general (i.e. recruitment to 
primary care trials across different diseases and ages). Despite this, the lessons learnt, for 
example with regard to workload minimisation and simplification of study protocol, add 
weight to the existing body of literature and could be considered by investigators designing 
other trials.90,155 
6.6 Implications 
The findings suggest that the conduct of a trial is a vital consideration if accrual targets are to 
be reached. Minimisation of investigator workload seems to be important and care should be 
taken to ensure that only relevant data are collected. For example, data collection on non-
eligible patients to consider generalisability issues diverts resources from patient recruitment. 
Whilst generalisability is important to the external validity of a trial, it is vital to ensure that 
the focus of effort is on patient accrual; data collected to ensure generalisability must be 
secondary to this aim. Expanding the number of active sites, while logical, is not necessarily 
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the most effective way of improving recruitment. It may be more useful for trials to consider 
whether other approaches would be more appropriate before investing time and money in 
expansion.  
Care should also be taken when using early recruitment data to predict overall recruitment or 
to determine the continued feasibility of a study128 since initial patterns may not account for 
the potential success of protocol changes. Therefore, one very important implication of these 
data is how funders of research interpret initial recruitment data. If the funder had not shown 
flexibility in extending the trial, BAFTA could have failed. Given the major clinical impact of 
the study, this would have been unfortunate. Reasonable time for protocol amendments to 
take effect is needed and funders need to balance reasonable desire to stop a trial where 
recruitment targets seem futile with the cost to society of never answering the research 
question. Prospective studies to test the impact of interventions on recruitment rates would 
benefit future RCTs. 
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Chapter 7: Interview Study Methods 
This chapter introduces the interview methodology, describes participant selection and 
recruitment, then details the development of the topic guide and conduct of the interviews. It 
continues with description of how the analysis was carried out, and concludes with an 
explanation of how the results are presented.  
Ethical Approval 
Ethical approval was obtained for this study as an amendment to the main BAFTA study 
approval, from the West Midlands Multi-centre Research Ethics Committee (Ethics 
Reference: MREC/99/7/57a). Approval was also gained from all relevant Primary Care 
Trusts. 
7.1. Semi-structured Interviews 
While designing the project, the use of focus groups instead of individual interviews was 
considered. The decision to use semi-structured interviews was discussed in detail in Chapter 
four. During the interviews, a topic guide was used to guide the interview, but the main aim 
was to use the prompts to gain a detailed understanding of the interviewee’s perspective. An 
audio recording was made of the interview, which was later transcribed verbatim by the 
interviewer or an administrator. The first four interviews were transcribed by the researcher. 
Repeated listening and verbatim transcription of these interviews enabled the interviewer to 
become immersed in the data and identify tentative explanations and note unexpected topics 
for exploration in further interviews. 
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7.2. Recruitment of Interview Participants 
This section will look at the sampling strategy used in this project, and will describe how the 
participants were recruited. 
7.2.1. Sampling Strategy 
The intention initially was to use purposive sampling to identify participants. Purposive 
sampling is defined by Pope and Mays as a deliberate choice of respondents representing 
theoretically important groups of subjects.156 This approach is used to gain a wide range of 
perspectives, as opposed to a statistically significant sample that is representative of the 
population. It allows selection of specific participants based upon the findings of previous 
research. The aim was to include GPs representing a range of characteristics previously 
shown to be associated with recruitment to BAFTA (See Table 14, page 134). However, this 
approach can be time consuming: GPs have to be selected and invited, non-responders need to 
be chased and those declining the offer have to be replaced by GPs with similar 
characteristics, thus starting the whole process again. It was considered vital that GPs were 
interviewed before the BAFTA results were published because some of the questions related 
to their thoughts about the study question or interventions. It was felt that knowledge of the 
trial results could change the responses to these questions. The BAFTA results were fast 
tracked and were due to be published in May 2007. Therefore, there was only a two month 
window in which to carry out all the interviews; it became apparent that this approach to GP 
recruitment would not allow enough time for them to be completed. Therefore, a more 
pragmatic approach to recruitment was taken.  
The actual process of selecting and inviting GPs is described in more detail in section 7.2.2. 
This section will focus on the aims of the sampling, while the extent to which the aims were 
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achieved will be discussed in section 8.3. The sample was taken from GPs who carried out 
randomisation clinic appointments with patients who were eligible for the BAFTA study. As 
informed consent was carried out during the randomisation clinic appointment and one of the 
aims of this study is to examine the GP experience of taking consent, GPs who had not carried 
out one of these clinics were excluded from the sample. Practices where it was known that the 
recruiting GP was no longer working there were also excluded. It was considered important to 
include GPs with varying levels of recruitment success in the sample, as the aim was to 
identify whether different attitudes or experiences between those who were more or less 
successful at gaining consent existed. Therefore, proportions of the eligible patients (i.e. those 
who attended a randomisation clinic appointment) who gave consent were calculated and split 
into four recruitment groups (See Table 14, page 134); GPs were sampled from each group. 
Most of the sampling criteria were those previously found to be statistically associated with 
gaining consent (See Table 14, page 134). Year of GMC registration was used as a proxy for 
GP age, as age was not available in the study database. Year of registration was taken from 
the CVs provided by the GPs on study entry; where this was missing the information was 
collected from the GMC website.157 Practice size was calculated using the number of GPs 
working in the practice; this was available in the BAFTA database. In order to ensure that the 
very small and very large practices, as well as a range of sizes in between these extremes were 
represented, practices were divided into three groups (See Table 14, page 134). Year of study 
training was also included in the sampling framework. Although this was not significant in 
previous analysis, it was closely associated with the year that a patient was recruited to the 
study, which was a highly significant patient level factor. Year of practice recruitment would 
therefore allow exploration of whether there were any time dependent effects on GP attitudes 
or experiences. Practice recruitment and training for BAFTA was carried out over a four year 
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period (2001-2004); practices were selected to ensure that each recruitment year was 
represented. Practices trained in 2001 and 2002 were grouped together for sampling, as there 
were relatively few practices trained throughout 2002. 
One further characteristic was included in the sample: practice location. Although this was not 
included in the previous analysis (See Chapter 5), it was felt that this had the potential to 
impact on experience and so a range was desirable. For example, there may be regional 
differences that impact on a GP’s attitude towards research participation: Birmingham GPs, 
for example, may have different experience of research than their counterparts in Cornwall.  
Table 15: Sampling criteria 
Sampling Criteria 
Recruitment group 
 High (>60% eligible patients recruited) 
 Low (<40% eligible patients recruited) 
 Medium (40-60% eligible patients recruited) 
 Small (<5 patients deemed eligible) 
 
Year of GMC Registration 
 -1975 
 1976-90 
 1991- 
 
Practice Size (Number of GPs) 
 1-2  
 3-8 
 > 8 
 
Year of Study Training 
 2001-2002 
 2003 
 2004 
 
Practice Location 
 Hertfordshire 
 Midlands 
 Cheshire 
 Gloucestershire 
 Devon and Cornwall 
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7.2.2. Practice Selection and Invitation 
All practices taking part in BAFTA were given a unique identity number and this number was 
used during practice selection to ensure that known practice names were not favoured.  
Practices were split into the four recruitment groups (See Table 14) and for each group, the 
identity numbers of all eligible practices were printed out, together with details of their 
characteristics per the sampling criteria. Practices were chosen from these lists in a manner 
that ensured that a range of criteria were represented. In order to make sure that GPs at the 
extreme end of each recruitment group were represented, GPs were invited in order of 
proportion of their eligible patients recruited, starting from the extreme of each group and 
moving inwards until the desired sample was achieved. (For example, GPs in the <40% group 
who recruited 0% of their eligible patients and GPs in the >60% group who recruited 100% of 
their eligible patients were invited for interview first). Due to the fact that the practice identity 
numbers were known to the interviewer, they were selected by one of the supervisors 
(Jonathan Mant); this ensured that well known GPs were not selected in preference to other 
less known practices.  
Once selected, recruiting GPs within each practice were sent a letter describing the study; GPs 
were asked to return a reply by fax indicating whether or not they would be willing to 
participate in an interview. A secretary from BAFTA contacted the non-responders by 
telephone to determine whether they were willing to participate. When GPs refused, another 
practice with characteristics close to those who refused was chosen and approached. 
Although this approach to practice selection was working successfully, it was a very time 
consuming process. It was considered vital that all interviews were carried out before the 
BAFTA results were published (See Section 7.2.1), so a more pragmatic approach to 
 140 
 
recruitment was taken. All potentially eligible GPs were written to and the sampling was 
carried out from those GPs who had agreed to participate. Where specific characteristics were 
still required, GPs who had not responded were contacted by telephone to see if they would 
agree to be interviewed. 
GP recruitment was planned to continue until theme saturation occurred. At the planning 
stage this number was unknown, so it was proposed that 20 interviews would be carried out. 
This number was selected in order to limit the chance of missing any important issues158,159 
GPs are a busy group of people, and can be difficult to engage in research135,136 so it was 
anticipated that approximately 60 GPs would need to be approached in order to achieve this 
number. As there were 83 BAFTA GPs potentially eligible for interview, there was sufficient 
scope to be confident that this number could be reasonably achieved.  
Based on a grounded theory approach, the original study design aimed to carry out data 
collection and analysis concurrently, so that data collection could continue until theme 
saturation had been achieved.131 However, the time constraints imposed by the fast tracking of 
the BAFTA publication meant that this was not able to happen. A decision was taken to carry 
out as many interviews as possible within the time available, without the benefit of concurrent 
analysis; the risk with this approach is the possibility that saturation would not be achieved 
and that questions would remain about whether all possible opinions or experiences had been 
identified. However, within the time limits, it was possible to carry out the number of 
interviews that were initially estimated to be necessary, so it was hoped that saturation would 
still be achieved. It is acknowledged, however, that this was a risky approach that may have 
resulted in questions remaining about the experience of recruiting patients to BAFTA, and 
that this was potentially a shortcoming in this project.  
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7.3. Development of Interview Schedule 
The development of the interview topic guide was based upon information gained from the 
existing literature, as discussed in chapter three, and on the findings of the earlier BAFTA 
analysis, as discussed in chapters five and six. The questions were worded to include the 
general topics thought to be important, but to allow the participants to express what was 
particularly important to them. It began with a general background, both to the GP and the 
practice, proceeded to explore issues specific to BAFTA, and concluded with an exploration 
of broader trial issues. GPs were given the opportunity to suggest whether any aspects of the 
trial could have been improved upon, and how this could have been achieved. Prompts were 
used, where appropriate, to delve more deeply into GPs’ experiences. Although the topic 
guide was detailed, this was to ensure that all important subjects were covered, and served 
mainly as a reminder to the interviewer, rather than a rigid format for the interviewer to 
follow. The topic guide can be found in Appendix four. 
7.4. Conducting the Semi-Structured Interviews 
GPs who agreed to be interviewed were contacted by telephone to arrange a convenient time 
and location. They were offered the option of coming to the University where the researcher 
was based, or they could choose to have the interviewer visit them either at their practice, 
their home or an alternative location suitable for them. Although interviewing people in their 
homes can sometimes be difficult as there is the potential for distractions and interruptions, it 
was felt that offering total flexibility on time and location would minimise the number of GPs 
who would not take part due to logistic reasons.  
At the start of each interview an explanation of the study was given, together with 
reassurances about confidentiality and anonymity. As it was likely that the GPs would be 
aware that the interviewer was also the BAFTA trial manager, emphasis was placed on the 
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fact that discussion of both positive and negative aspects of the trial would be welcomed. The 
GP and the researcher completed the consent form together. One copy was retained by the GP 
and one copy was retained for the research file. Provided consent had been obtained, the 
interview was tape recorded and then transcribed, either by the researcher or by an 
administrator as soon as possible after the interview. The first interview was transcribed 
immediately to allow assessment of how well the topic guide worked. The GPs name was not 
recorded with the transcript, and any other potential identifiers, such as the name of the 
practice or particular nurses, were concealed during transcription to preserve anonymity. The 
tapes and transcripts were stored in locked cupboards at the University; electronic copies were 
saved in password protected folders. 
The interviews followed the previously mentioned topic guide, which can be found in 
Appendix Four. The topic guide began with background questions about both the GP and the 
practice and then asked for a description of the BAFTA study. Attitudes towards the trial 
question and drugs were discussed, followed by more detailed descriptions of their experience 
of taking part. GPs were given the opportunity to suggest whether any aspects of the trial 
could have been improved upon, and how this could have been achieved. The interview 
continued with questions about broader issues to do with trials and concluded with the 
opportunity for them to make any further comments. Respondents were asked about the trial 
in a general way, allowing them to focus on the areas that they considered important. 
Although the topic guide was used to ensure that all topics were covered during the interview, 
the interviewer allowed the GPs to talk about the issues important to them, in the order that 
they chose themselves, and used the topic guide as a memory aid rather than a strict order of 
questioning. 
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7.5 Interviewer Characteristics 
The characteristics and orientation of the researcher are important and are considered part of 
the process of doing qualitative research: the behaviour and interactions of the researcher with 
the participants have the potential to lead to bias in the work.160 For example, the professional 
background of the researcher has been shown to influence the interactions during interviews 
carried out as part of two qualitative studies looking at heart disease.161 One interviewer was a 
GP, the other was a sociologist. The GP was open about her medical qualifications, whereas 
the sociologist introduced herself as a researcher and stressed that she was not medically 
qualified. Although there were some common interactions, many respondents spontaneously 
gave their often unfavourable views about medical professionals: this was not evident in in 
the interviews carried out by the GP.161 In order to allow assessment of these potential biases, 
any relevant limitations or advantages of the researcher’s ethinicity, gender, socioeconomic 
status or other relevant factors should be openly discussed.162 There are two schools of 
thought with regard to how involved researchers should be with their subjects. One opinion 
states that if a researcher develops a close relationship with those being researched, the 
researcher may be blind to unpleasant facts, therefore introducing bias.160 Alternatively it may 
be argued that if researchers develop close ties with their subjects, their ability to experience 
empathy will allow them to communicate at a more intimate level, thereby enhancing their 
ability to gain information that would otherwise not be obtained.160 
In this study, the characteristics and orientation of the researcher may be particularly relevant, 
so it is important to consider the potential impact. One researcher conducted all interviews. 
She is female, aged 39 years and of white European appearance. The researcher is not 
medically trained but was very familiar with the BAFTA study, having worked on the study 
from the design phase, and having been the trial manager from 2003 until study conclusion. 
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The role that the interviewer had in BAFTA was not made explicit, either in the initial 
invitation or during interview. Despite this, it is likely that the majority of responders knew 
the interviewer and were aware of her role in the BAFTA study. It is possible that this 
relationship may have deterred GPs from giving honest opinions about negative aspects of the 
trial. In order to minimise this risk, care was taken during the interview to emphasise that 
there were no right or wrong answers to questions, and that their genuine opinion was sought. 
Negative comments were actively sought during analysis. However, a minority of GPs 
spontaneously raised the subject during interview, and explicitly stated that they would 
definitely be honest about negative opinions despite the fact that they were aware of the 
interviewer’s association with the trial. It is therefore hoped that this prior professional 
relationship did not influence the content of the interviews. 
It was also not explicitly stated to respondents that the interviewer was not medically 
qualified. It is not clear whether GPs were aware of this fact; they discussed medical facts in 
relation to BAFTA in some detail, and obviously assumed a prior knowledge on behalf of the 
researcher, so it is unlikely that this background influenced the discussions. However, the GPs 
were aware of the research experience of the interviewer, and a minority of GPs were explicit 
in their opinion that the interviewer had more knowledge about the research process than they 
themselves had. This may have had some influence on discussions about their understanding 
of technical terms associated with RCTs, as some GPs stated that they felt the interviewer 
would know the answer better than they would. However, they all went on to describe their 
understanding of the terms; again it is hoped that this knowledge had minimal impact on the 
content of the interview.  
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7.6. Respondent Validation 
Respondent validation is a method of external validation which compares the investigator 
account with that of the inverviewees in order to establish ‘the level of correspondence’ 
between them156 and is considered by some as the strongest check on the credibility of the 
research.163 There are, however, limitations to their use as a validation test. For example, 
researcher accounts are likely to differ from individual accounts as the researcher account is 
designed for a wide audience. Therefore, it may be better to view respondent validation as a 
process of error reduction rather than a check on validity.156 
Respondent validation was carried out in this project. This aimed to ensure that interviewee 
opinions were represented as they were intended and the researcher was not inadvertedly 
imposing her views on the data.134 Each GP was sent a short one page summary of their 
interview transcript, together with a response sheet. They were asked to confirm whether or 
not the summary was a correct interpretation of their thoughts and to return the response sheet 
to the researcher by fax. 
7.7 Data Analysis 
There are a number of approaches that can be taken when carrying out analysis of qualitative 
data: one of the main considerations is whether the coding of the data is carried out 
inductively or deductively. A grounded theory approach is an example of inductive analysis: 
theories are allowed to ‘emerge’ from the data, through the process of analysis. This is a 
particularly useful technique to use when little is known about a subject, and it is not possible 
to predict what the findings are likely to be. The emphasis is placed on the development of 
theories as the final outcome of the analysis:164 theory is defined as ‘plausible (likely or 
probable) relationships between sets of categories which have emerged from data 
analysed….a statement about possible relationships among categories about a 
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phenomenon’.165 An important feature of the grounded theory approach to analysis is the 
constant comparison technique: categories that emerge at one stage of the analysis are 
compared with those that emerged at a previous stage; this process continues until no new 
categories emerge and ‘theoretical saturation’ is achieved.  
A different way to carry out qualitative data analysis is to utilise a deductive approach: when 
using deductive analysis, theories or categories have been decided in advance. This is an 
approach often used when conducting policy research, and The Framework Method of 
analysis, as devised by the National Centre for Social Research166 is a good example. This 
approach allows the researcher to set categories at the start of the process; the data are then 
searched for examples that will correspond with them. However, the framework approach can 
share the same broad principles as the grounded theory approach, as it also enables inclusion 
of themes that may emerge from the data: the constant comparison technique can be utilised 
and the framework amended accordingly. Once the data has been categorised it is presented in 
the form of thematic charts and analysis of the data both within-case and between-cases can 
be carried out. With the framework approach, data analysis can stop at the level of 
description, or can continue in a similar vein to grounded theory approach until theories have 
been built and saturation achieved.165 
For this particular project, a grounded theory approach would have been appropriate, as little 
was known about the subject area. Generation of theories about practitioner factors that 
impact on patient recruitment to trials that can be tested in further research would be useful. 
However, it was not possible to use grounded theory as the interviewer had substantial prior 
knowledge about BAFTA and had carried out an extensive review of the literature in this 
area.  Therefore, Framework was used. However, the coding structure was developed 
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inductively from the data, as described in the previous paragraph. Coding and analysis were 
then carried out using Framework Software.166 The remainder of this chapter will describe in 
more detail how the analysis was carried out, and will conclude with an explanation of how 
the results will be presented. 
7.7.1 Development of the Coding Framework 
Due to the time constraints described earlier (Section 7.2.2) all interviews had been completed 
prior to the start of analysis and it was therefore not possible to carry out concurrent analysis. 
Concurrent analysis would have been preferable, as it would have allowed adjustment of the 
interview schedule to explore themes in subsequent interviews that may have been emerging 
from the data during the early ones. In order to determine whether theoretical saturation had 
been achieved, transcripts from the first eight interviews were used to identify themes and 
provide the basis of the coding framework; constant comparison was then used for the 
remaining transcripts and the framework was adjusted where new categories or themes were 
continuing to emerge.  
To identify themes in the data, one researcher read the first eight transcripts and noted all the 
subjects or keywords raised by the GPs on separate post-it notes. Generally, researchers note 
the points in the margins of the transcripts or on the analytical software being used at this 
phase of the process,165 but it was decided that it would be easier to categorise topics if they 
were noted on individual sheets of paper; it did not matter, at this point, which interview the 
comments were taken from. This approach aided the thought processes of the researcher. Each 
point was then placed into groups and duplicate comments removed. Each group was given a 
category title, and these categories discussed with one of the supervisors (JM). The categories 
were then collated into three main themes and a basic coding framework was developed. To 
test the applicability and validity of the proposed thematic framework, one interview that had 
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not been used for the framework development was chosen at random and coded; following 
this, a number of changes were made to the coding structure and version two was produced. 
Two further researchers then coded this transcript. Following discussion and comparison of 
this coded interview, the themes were refined and version three of the coding framework was 
produced. All interviews were then coded using this final version of the framework. A table 
depicting the coding structure can be found in Appendix Five.  
7.7.2 Carrying out the Analysis 
Once the framework had been developed, all transcripts were imported into the software and 
coded. Inter-rater reliability was carried out to ensure rigorous data analysis:134 the first eight 
interview transcripts were coded by two researchers and their coding was then compared to 
look for consistency and variation. Any disagreement was discussed and agreement reached. 
The remaining interviews were coded by one researcher. Following the coding, thematic 
charts were produced.  
Following production of the charts, the next stage in the analysis involved between-case 
comparison: this aimed to identify the variety of experience between interviewees, for each 
theme. Between-case comparison also aimed to explore whether typologies exists, looking for 
common explanations or experiences between GPs. Typologies, as described by Ritchie and 
Lewis are: 
Specific forms of classification that help to describe and explain the 
segmentation of the social world or the way that phenomena can be 
characterised or differentiated. They may apply to groups of people 
within the population or to sets of phenomena, like beliefs, 
circumstances or behaviours134(p 214) 
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Essentially they are patterns within the data, for example, GPs who recruited successfully may 
have a similar experience of research, but this experience may differ from the experiences of 
GPs who recruited less well. Therefore, for this study, typologies attempted to identify any 
groups within the sample who had similarities in their attitudes towards or experience of 
research, and to determine whether there were different typologies in one recruitment group 
than there were in others.  
To identify typologies, the data was grouped together by different interviewee characteristics, 
and frequencies of different experiences were sought. Patterns within the data were then 
examined to illuminate any factors that might predict outcomes, such as demographic 
characteristics that may predict the way participation in research is experienced. Once these 
factors had been examined, within-case analysis was carried out to consider patterns within 
the data by investigating links between themes. For example, within-case analysis may 
demonstrate that GPs who describe a negative experience of participation also have a low 
tolerance for the risk posed to their patients by exposure to trial drugs. Utilising these 
techniques applied a structured approach to data extraction, grouping and analysis. 
7.8 Presentation of Results 
There are two schools of thought in presentation of qualitative results: to include numbers (of 
individuals who raise each point under discussion), or to exclude numbers. The results are 
presented, in this thesis, to represent frequency of views in a general way rather than 
presenting numbers of interviewees for each theme or concept. This choice was made for two 
reasons: firstly it is suggested that inclusion of numbers can detract from the reading style and 
secondly, there is no indication as to how these numbers should be interpreted:134 because the 
sampling strategy does not aim to identify a statistically representative population it may be 
misleading to express relative frequencies of responses.167 Use of more general terms can 
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indicate dominance of views in a way that would be more difficult to interpret if using 
numbers,134 and is a style that is represented in a variety of journals.168 
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Chapter 8: Interview Results 
This chapter reports the results of the final stage of this project, the semi-structured 
interviews. It will begin by giving details of uptake rates and an overview of the interviews. 
Details about the demographic characteristics of respondents are given, explaining to what 
extent the aims of the purposive sampling were met. The chapter will then put forward the 
themes that emerged from the interviews, presenting quotations to illustrate these themes.  
8.1 Overview of the Interviews 
Interviews were conducted up to 18 months post BAFTA patient recruitment and 
approximately six months post patient follow up. All were conducted before the trial results 
were available. The interviews varied in length (between 30 and 90 minutes) depending upon 
how much time was available to the GP for the interview.  Fifteen of the interviews were 
carried out at the GPs’ surgeries; three within their homes; and one was carried out at the 
University. The three carried out within the GP’s home were longer (approximately 90 
minutes); two contained interruptions where the interview had to be paused for a time (one 
was interrupted by children entering the room, the other by a telephone call). The shortest 
interview (approximately 30 minutes) was where the GP was late because they had been 
delayed while carrying out home visits and were unable to extend the end time as they were 
due to start afternoon surgery. In two interviews carried out at surgeries, there were also 
interruptions that caused the interview to be paused (in one, the GP had to interrupt the 
interview to attend a short meeting; in the second, the interview had to be moved to a different 
room). The topic guide was used throughout (See Appendix Four). 
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8.2 Uptake Rates 
As described in section 7.2.2, two approaches to inviting GPs were taken: both produced very 
different results in terms of the numbers responding to the invitation and agreeing to 
interview. Figure 13 gives the overall uptake rates for the study. 
Whilst inviting GPs to participate during phase two of recruitment, care was taken to ensure 
that the sampling requirements were being fulfilled (discussed in detail below). Nineteen GPs 
were interviewed, but only 17 were included in the analysis (two interviews failed to record). 
One GP did not consent to the interview being recorded so notes were taken during the 
interview; the notes were subsequently included in the analysis, although no direct quotes 
were taken from this interview. 
Figure 12:  Recruitment Overview of Interviewees 
 
8.3 Participant Characteristics 
As described in section 7.2.1, purposive sampling was attempted to gain variation in 
interviewees (in age, proportion of eligible patients recruited, practice size, year of training), 
and therefore variation in experience.  Table 15 shows the characteristics of the participants. 
83 
GPs invited to participate in interviews 
20 (24%) 
Agreed to interview 
56 (67%) 
Did not respond 
7(8%) 
Declined interview 
19 (23%) 
Interviewed 
1 (1%) 
Unable to arrange 
interview 
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Table 16: Characteristics of the Participants 
Interview 
No. 
Gender Year of 
GMC 
Registration 
Practice 
Size 
Practice 
List 
Size 
Region Recruitment 
group 
Year of 
Training 
1 F 1970 5 8053 Herts >60% 2003 
2 F 1977 6 12600 Midland 40-60% 2001 
3 F 1980 4 7696 Cheshire 40-60% 2001 
4 M 1985 4 6500 Glos <40% 2003 
5 M 1979 3 4439 Glos 40-60% 2003 
6 M 1981 4 4237 Midland <40% 2002 
7 M 1996 6 12133 Devon <5 2004 
8 M 1969 7 8269 Devon >60% 2004 
9 M 1979 6 4744 Midland >60% 2001 
10 M 1993 16 14028 Herts 40-60% 2003 
11 M 1984 5 8880 Herts >60% 2003 
12 F 1982 5 9400 Herts 40-60% 2003 
13 M 1989 5 8900 Cornwall >60% 2004 
14 F 1988 10 18000 Herts <5 2003 
15 M 1985 3 4571 Midland 40-60% 2001 
16 F 1996 4 6878 Glos <5 2003 
17 M 1991 5 5850 Midland <5 2001 
Having looked at the individual characteristics of participants, it is important to establish 
whether the sampling aims have been fulfilled, especially given the challenges faced during 
sampling. Table 16 (page 150) contains a summary of the characteristics of participants. As 
can be seen from the first four sections, all of the sampling aims were fulfilled, with the 
exception of inclusion of a GP from a practice with one-two partners. Although one GP from 
this category was interviewed, this was unfortunately one of the failed interviews.  The 
remaining sections of the table demonstrate that there was representation from all of the other 
potentially important factors. 
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Table 17: Summary of Participants’ Characteristics 
Recruitment Group  
High (>60%)  √√√√√√ 
Low (<40%) √√ 
Medium (40-60%) √√√√√ 
Small (<5 patients deemed eligible) √√√ 
Year of GMC Registration  
-1975 √√ 
1976-80 √√√√ 
1981-85 √√√√√ 
1986-90 √√ 
1991+ √√√ 
Practice size (No GPs)  
1-2  
3-4 √√√√√√ 
5-6 √√√√√√√ 
7-8 √ 
>8 √√ 
Year of Training  
2001 √√√√ 
2002 √ 
2003 √√√√√√√√ 
2004 √√√ 
IMD Quartile  
1 (Least) √√√√√ 
2 √√√√√ 
3 √√√ 
4 √√√ 
Gender  
Male √√√√√√√√√√ 
Female √√√√√√ 
Region  
Hertfordshire √√√√√ 
Gloucestershire √√√ 
Midlands √√√√ 
Devon/Cornwall √√√ 
Cheshire √ 
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The lack of very small practices is a significant omission from the sample, especially when 
considering the significance of practice size in earlier analysis (See Chapter Five). The 
potential impact of this will be discussed in section 9.1. 
8.4 Responder Validation 
Of the sixteen GPs who were sent a summary of their interview transcripts, nine GPs returned 
a response. All nine indicated that they agreed with the summary and none expressed any 
concerns or objections to this initial interpretation of their comments.  
8.5 Interview Themes 
The interviews aimed to understand the GPs’ experiences of recruiting their patients to an 
RCT, uncovering their reasons for deciding to take part, identifying how they carried it out 
and understanding how they felt about the process. Suggestions for improvements were also 
sought. The order in which topics emerged was influenced by the topic guide, but not 
exclusively driven by it; some GPs, for example, would discuss the responsibility they feel for 
their patients with regard to involving them in trials when talking about their reasons for 
deciding to take part. 
Three main themes emerged from the interviews: risk and responsibility; doctor/patient 
interaction; and GP motivation, experience and understanding (See Table 17, page 152). Each 
theme will be presented individually, broken down into sub-themes and supported by 
verbatim quotes from the interviews. Sub-themes as presented will not necessarily be identical 
to those found in the coding framework (See Appendix Five): some sub-themes are 
intrinsically linked and will be presented together for ease of explanation and understanding. 
The quotations were selected on the grounds of representativeness.  
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Table 18: Emergent Themes 
Theme 
Description 
Risk and Responsibility 
 Risks of BAFTA 
 Risks of enrolling patients into trials 
 Ethics of trials 
 GP Responsibility 
 Changes in attitudes to BAFTA 
   
How GPs felt about the risk associated with 
trials, and the uncertainty around the study 
treatments, to include reasons for 
participation, the ethics of RCTs and the 
responsibility they feel towards their 
patients.  
Doctor/Patient Interaction 
 Explanation of the trial 
 Doctor/Patient relationship 
 Patient experience & understanding  
 Clinical autonomy 
How the GP explains the trial to patients, to 
include discussion of trial drugs, 
randomisation and uncertainty, how GPs 
think their patients feel about trial 
participation and their need for 
information, and thoughts about clinical 
autonomy. 
GP Motivation, Experience & 
Understanding 
 Motivations for taking part 
 Overall experience 
 Interaction with the BAFTA study team 
 BAFTA Training 
 Practicalities 
 Understanding 
 Suggestions for improvement 
To include understanding of BAFTA and 
trial principles in general, issues affecting 
recruitment (including practical 
considerations), relationship with the study 
team, benefits for the practice and 
suggestions for future improvements. 
8.5.1 Risk 
The concept of risk runs through many of the decisions that GPs took about recruiting patients 
to BAFTA, from the initial decision to participate to the choice of patients they considered 
appropriate for inclusion.  This section will start by presenting GPs’ discussions of the risks 
associated with involvement both in BAFTA and with trials in general, and will continue with 
their perception about the ethics of trials and the responsibility they feel for their patients.  
The section will conclude with changes in GP attitudes over the course of the trial.  
8.5.1.1 The Risks of BAFTA  
When asked to describe the study, a significant majority gave a correct description of the 
study as being a trial of aspirin versus warfarin for stroke prevention in older people with AF.  
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“the purpose of the trial I understood was to, to decide whether 
aspirin or warfarin was the best treatment for people in atrial 
fibrillation to prevent er strokes and other complications, and to 
minimise the erm side effects of those drugs themselves in causing 
problems” 
Interview 5 (Male; medium recruitment group) 
All interviewed GPs discussed their views about the risks associated with the drugs in 
question. Aspirin and warfarin were regularly used in practice to manage the stroke risk of 
patients with AF, so they were both drugs that GPs were very familiar with. Most GPs 
acknowledged that warfarin was the superior treatment for younger patients, but some 
described it as a potentially dangerous drug for older people, and they were often concerned 
about prescribing it for them.  
“at the time when we were thinking of going into the trial, you know, 
certainly some of the GPs were very unkeen on prescribing warfarin 
and very keen to look for excuses not to” 
Interview 3 (Female; medium recruitment group) 
“obviously we were all worried about polishing people off with 
warfarin” 
Interview 5 (Male; medium recruitment group) 
One GP described the risks to their patients posed by the study drugs in a slightly different 
way. Although this GP acknowledged the risks associated with warfarin, he felt that it had 
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been shown to be the most effective treatment and he described how he considered the risk of 
exposing his patients to aspirin. 
“the gut feeling was they hadn’t had a, a very much inferior treatment 
for it now so we felt quite safe to expose them to the aspirin” 
Interview 13 (Male; high recruitment group) 
Although the dangers posed by warfarin were often discussed, it did not seem to deter GPs 
from participating in the trial; the majority seemed to balance their concerns with a variety of 
factors that offset the perceived risks associated with these drugs, and thus justified the 
potential exposure of their patients to the trial. For example, most GPs considered the trial 
question important, describing how AF is an increasingly common problem that is often seen 
in general practice. Its importance was felt to be increasing because responsibility for the 
ongoing care of people with AF was now falling more on general practice than it had 
previously. 
“atrial fibrillation and warfarinisation, it’s quite an important issue 
because we have to make these sort of decisions quite regularly” 
Interview 2 (Female; medium recruitment group) 
“I think atrial fibrillation is becoming much more the domain of 
primary care now as opposed to secondary care, there has been a real 
shift in that” 
Interview 16 (Female; small recruitment group) 
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BAFTA was further described by many GPs as being important because of its clinical 
relevance, partly because of the increasing number of patients diagnosed with AF and the shift 
to primary care of its management, but also because of the ongoing uncertainty surrounding 
the best way to manage a patient’s stroke risk. Most were aware that they were regularly 
making decisions about use of warfarin without an adequate evidence base to support it. 
“there wasn’t sort of definite evidence as to what we should be doing” 
Interview 14 (Female; small recruitment group) 
“you never really do know what you should be putting people on”  
Interview 16 (Female; small recruitment group) 
 
The clinical relevance was further highlighted by the implications for people, especially older 
people, of taking warfarin. Warfarin involves regular monitoring, care needs to be taken that it 
is taken correctly and ongoing consideration of changing risk factors needs to be taken into 
account. GPs face these dilemmas each time they encounter an older patient with AF and they 
were keen to ensure that they were making decisions that were in the best interest of their 
patients. 
“there is no doubt that putting 80 year olds on warfarin has a lot of 
implications, if only because it’s a hassle, they have to go and have 
their bloods checked, erm, and I don’t think I would want to do it 
without being fairly sure that I wasn’t doing them any harm” 
Interview 12 (Female; medium recruitment group) 
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“always posed a dilemma when you see an elderly patient with atrial 
fibrillation whether to warfarinise them……you’re never quite sure 
about the risk/benefit ratio really” 
Interview 10 (Male; medium recruitment group) 
A minority of other GPs described the risks to patients of sub-optimal management of the 
risks associated with their AF, and felt that BAFTA was an important study because of the 
‘major’ nature of having a stroke.  
“the proportion of those [older people with AF] are having strokes 
which is a devastating thing” 
Interview 5 (Male; medium recruitment group) 
The relevance and importance of the trial question convinced over half of the GPs that 
practice participation in BAFTA would be of benefit to their patients, both existing patients 
with AF and  those who develop it in the future, and so felt that justified the potential risks of 
taking part. 
“we thought it would really be serving our patients’ needs if we could 
come up with clear cut answers… it would make a difference to 
patient care” 
Interview 2 (Female; medium recruitment group) 
Having talked about the risks associated with warfarin, nearly all GPs went on to describe 
how they felt that BAFTA was a relatively safe study. Although warfarin was considered 
potentially dangerous, it was felt that enough was known about the drug to be able to assess 
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that risk. However, almost all GPs would not like to take part in drug company led research as 
this is often testing experimental drugs. 
“After that recent hmm drug problem in Oxford everyone worries…as 
a practice we wouldn’t be involved in any drug company led research. 
We were quite happy with academic led” 
Interview 2 (Female; medium recruitment group) 
The majority of GPs felt confident that BAFTA was well controlled, with independent bodies 
who monitor progress and would stop the trial if something was going wrong. 
“Built into the trial that is something is beginning to go wrong, 
someone is looking into it and picking it up on a relatively early 
basis” 
Interview 6 (Male; low recruitment group) 
A few also felt confident in the trial because it was being run by an academic department 
within a University. A small minority of GPs described how they felt supported by the 
University and this contributed to a feeling of safety.  
“with your study I felt very supported every time I needed to ask a 
question” 
Interview 16 (Female; small recruitment group) 
“erm, you know, we felt safe” 
Interview 11 (Male; high recruitment group) 
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8.5.1.2 The Risks of Enrolling Patients into Trials 
Even when GPs felt comfortable with the level of risk posed by a particular trial, about half 
still had concerns about the potential impact of enrolling their patients. A few GPs were 
worried about randomising their patients to different treatments; if anything should happen to 
one of their patients during a trial they would find that difficult to live with.  
“if something dire happens to a patient while they’re in the trial, that 
is a bit difficult to square” 
Interview 6 (Male; low recruitment group) 
One GP explained that, while he understood that trials would be stopped if they were doing 
too much harm, people still need to be hurt before it gets to that point, and if it was his 
patients that were hurt then he would be upset about it. 
“but you have to hurt a few people on the way to get that data and if 
it’s my patients then I would feel upset about it” 
Interview 11 (Male; high recruitment group) 
Other GPs had a more pragmatic approach to their concerns around the risks to their patients 
of trial participation. They felt that if they were happy with the trial concept, then their role is 
to portray the risks to their patients appropriately, and ultimately it is the patient’s decision 
whether or not to take part. 
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“I think it’s having a clear understanding…really satisfying yourself 
that you’ve explained that sufficiently to patients, erm, for them to be 
able to make the decision, erm, so no I don’t have an issue with that” 
Interview 10 (Male; medium recruitment group) 
One GP, however, spoke about his concerns about recruiting his patients to trials in a more 
general way. Although acknowledging that there are differing levels of risk associated with 
different studies, when asked how he felt generally about involving patients in trials, he stated 
that “I am very frightened about it” (Interview 4). On the other end of the spectrum, another 
GP described how he felt that although patients look at risk differently from doctors, the 
information provided by trials is necessary, so it is important to enrol patients into studies. 
“we know the patients look at the risks differently from the risks that 
doctors do, but we badly need more information in the older 
population” 
Interview 9 (Male; high recruitment group) 
A minority of GPs discussed how the acceptable level of risk depends on the ability of 
patients to understand and accept the risks involved; for studies like BAFTA, involving 
known drugs, it would still be acceptable to include patients who would have difficulty 
understanding the concepts of unquantifiable risks associated with testing newer drugs. 
“these were a fairly standard treatment, so you weren’t exactly 
exposing them to a great deal of risk, hmm, and an unquantifiable risk 
either… if you are using a really cutting edge new treatment…. Then 
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that’s different. I think people have got to know and understand a lot 
more then” 
Interview 8 (Male; high recruitment group) 
One GP explained how he hoped not to do harm by involving patients in trials, but felt that if 
you worried about it too much it would influence the selection of patients to be included, and 
this would influence the findings.  
“if everybody quite cautious only submits the best five patients… then 
you have to possibly question the results of that particular study” 
Interview 13 (Male; high recruitment group) 
8.5.1.3 The Ethics of Trials 
During interviews GPs were asked about their thoughts on the general ethics of trials, 
including their views on randomisation. Some GPs also discussed the role of ethics 
committees as part of this subject area. These will be presented in this section in turn. 
Ethics of Trials 
During interview GPs were asked to talk about how they felt about the randomisation of 
patients. All GPs discussed it in the context of the ethics of a trial, and said that they 
understood the need for randomisation and had no problems with it as a concept.   
“I don’t have a problem with that because I think if you want to find 
out things you have got to do this” 
Interview 15 (Male; medium recruitment group) 
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Having agreed with the concept, all GPs went on to qualify their belief and discussed a variety 
of conditions that need to be met if randomisation is to be ethical. Almost all GPs said that it 
depends very much on what patients are being randomised to. There needs to be no clear 
disadvantage to patients in one of the treatment arms, and this makes trials with a placebo arm 
more difficult. 
“there’s no other comparison with other treatment options you know 
with placebo and a treatment, I think that is quite difficult” 
Interview 2 (Female; medium recruitment group) 
A significant majority of GPs said that it was ethical only if there was no clear cut evidence 
for one of the treatments under investigation. This was also true at the individual patient level. 
Most GPs felt that they needed to not only be generally unsure as to the best treatment for a 
condition, but for each individual patient they also needed to be unsure as to the best 
treatment option. 
“if you genuinely don’t know the answer to the question and you 
genuinely don’t know what is best for the patient, then I’ve no ethical 
issues with the randomisation” 
Interview 3 (Female; medium recruitment group) 
Most GPs also said that patients need to be fully informed about the trial, aware of the 
randomisation element, and be happy to be involved for randomisation to be ethical. A 
minority also said that they felt it was important for the ethics of a trial that patients were 
aware that they could withdraw at any time. 
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“Patients have to know whether there is a likelihood they’ll get a 
placebo or that they are taking part in a trial. And I think it is equally 
important to let patients know that they can drop out” 
Interview 16 (Female; small recruitment group) 
A minority of GPs felt that to randomise was actually more ethical than to not randomise. 
Non randomised trials would allow recruiters to select patients they liked to go on the drug 
they liked and this would call the trial results into question. One GP felt that it was more 
ethical to randomise than to continue using the wrong treatment. Furthermore, another GP felt 
that clinicians are often too influenced by drugs representatives, and that this practice is more 
ethically questionable than the randomisation of patients. 
“otherwise you have like an unethical way… if you’re trying to push 
everyone onto that arm and don’t randomise it and all the people you 
don’t like you give the other stuff, then, that’s when I think you have 
problems” 
Interview 13 (Male; high recruitment group) 
“it seems ethically much better to try and find out the best treatment 
rather than just carry on randomly using the wrong treatment” 
Interview 8 (Male; high recruitment group) 
“we as doctors are historically notorious for taking too much notice 
of… drug reps and that to me seems much more ethically debatable 
than putting people into trials” 
Interview 12 (Female; medium recruitment group) 
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When asked about how they felt generally about involving patients in trials, almost all GPs 
raised concerns about the ethics of involving patients in drug company funded trials, as they 
felt that these are ethically more questionable than NHS funded or academic type trials. Many 
questioned the motivation, feeling that the aim of these trials was to prove that their drug was 
superior, rather than to genuinely discover the most effective treatment.  They felt that the 
question was often couched in such a way as to provide an inherent bias towards their drug of 
choice.  
“drug sponsored trials, they want to prove their drug is best. And they 
will compare it with ones that they know are not as good erm, and 
they will selectively erm look at things, they may use sub-groups or 
different forms of statistical analysis or whatever to prove their drug 
is right” 
Interview 3 (Female; medium recruitment group) 
About half of the GPs felt that drug companies often failed to publish the results of trials that 
were not favourable to their drug, and that pressure was put on them to use their drug at the 
end of trials. Some of these GPs were put off participating for those reasons, while others felt 
that they may still get involved if there was an independent clinician involved in the trial 
management. 
“we are pretty anti drug company erm, I have a lot of qualms… all the 
drug company research that hasn’t been published for instance… you 
probably know why, and erm often there’s a lot of pressure to use 
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their drug afterwards and I don’t like that at all… I think you’d want 
it done by somebody impartial really” 
Interview 5 (Male; medium recruitment group) 
A minority of GPs felt that a direct link between payment and recruitment made a trial 
unethical. Putting pressure on practices to recruit a specified number of patients may 
encourage them to enrol unsuitable people, and direct payment for recruited patients was felt 
to encourage this. 
“that a minimum number and a certain payment is triggered, well I 
think that would then get to the unethical side… that aspect I would be 
very uncomfortable with then” 
Interview 13 (Male; high recruitment group) 
Ethics committees 
Many GPs felt that ethics committees played a central role in their judgement about the ethics 
of an individual trial, contributed to their decision to participate, and felt that ethical 
committee approval would ensure that patients were not asked to do anything that involved 
too much risk to themselves. 
“to get a trial approved now it has to go through fairly extensive 
review from medical ethics or what not. So it’s very unlikely that 
anything particularly risky is going to be asked of a patient” 
Interview 15 (Male; medium recruitment group) 
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However, one GP pointed out that delays caused by the ethics approvals process can cause 
problems for practices wishing to participate, and urged researchers to act to minimise this 
delay. 
“it was held up at the ethics committee wasn’t it? And that’s very 
unfortunate, that really really is unfortunate… it is a major problem 
because… people would very rapidly lose interest in something like 
that” 
Interview 1 (Female; high recruitment group) 
8.5.1.4 GP Responsibility  
GPs were asked about how responsible they would feel if harm was done to one of their 
patients as part of a trial that they had enrolled them onto, and it transpired that the patient had 
been taking the inferior treatment. Almost all GPs said that they hope not to do harm to the 
patient, but they would not feel responsible for the inferior treatment because they did not 
know that was the case when the patient was enrolled. One GP felt that despite this, patients 
would hold him responsible. 
“You did it with the best information that you had at the time, no I’m 
completely definite about that, that’s not my responsibility” 
Interview 9 (Male; high recruitment group) 
“I know in my heart of hearts that I am not responsible but I’m sure 
the patients might blame” 
Interview 4 (Male; low recruitment group) 
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The majority of GPs felt that the trial would not change the responsibility they feel for 
patients, because it is the prescribing or changing of drugs that they feel responsible for, rather 
than inclusion in the trial.  
“I don’t think the difference is the trial, I think the difference between 
if someone suffers you know, as a consequence of their illness, then 
that’s not so bad, but when it’s a consequence of your intervention 
then that’s when it feels uncomfortable” 
Interview 7 (Male; small recruitment group) 
A few GPs felt that inclusion in the trial actually took some of that responsibility away from 
them, and felt that was why it was so important to be happy with the trial concept from the 
outset. 
“I felt that this other responsibility had been lifted really, for putting 
people on warfarin, that it  wasn’t really so much my responsibility, 
whereas I was sticking my neck out by putting them on warfarin 
without any hard and fast evidence” 
Interview 5 (Male; medium recruitment group) 
“I would feel equally bad, er probably feel worse because it’s truly my 
choice without any prompting from a well designed trial, so I would 
probably feel less responsible… I would dread it more making some 
mistake in other aspects which is genuine” 
Interview 13 (Male; high recruitment group) 
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Responsibility was also mitigated by the fact that patients are also involved in the decision to 
participate. A minority of GPs said that they also bear some of the responsibility, so long as 
the risks had been explained to them adequately. 
“you do feel a certain responsibility …. Because if it wasn’t for you 
they wouldn’t be in the trial… but equally they are an adult, they can 
make their own decisions” 
Interview 16 (Female; small recruitment group) 
A small number of GPs also discussed the responsibility they have towards carrying out 
research. One GP felt that taking part in a trial meant that you have responsibility, not only to 
the patient, but to the trial too, and this dual responsibility needed to be balanced. 
“if you’re involved in a trial you’ve got a duty of care to the patient, 
but you’ve also got a second obligation which is to the trial, and its 
balancing the erm, that out” 
Interview 10 (Male; medium recruitment group) 
Others described how they felt that GPs should be responsible for carrying out research, 
because general practice was a speciality in itself and so should be responsible for providing 
its own evidence base. Furthermore, the large numbers of patients available in primary care 
ensured that it is the optimum place for carrying out large studies. 
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“we have to be prepared to prove in primary care and do the 
research… research should be inherent in medical training and 
people shouldn’t be allowed to stop” 
Interview 12 (Female; medium recruitment group) 
“you have the numbers…. General practice should be used for this 
large numbers type studies” 
Interview 2 (Female; medium recruitment group) 
8.5.1.5 Changes in Attitudes towards BAFTA  
BAFTA recruitment was carried out over a four year period. It is possible that changes in GP 
attitudes towards the study question or the drugs involved took place over this time; maybe 
new guidelines, or an increased awareness of existing guidelines would change clinicians’ 
perspectives and this may impact on their level of patient recruitment.  
The majority of GPs said that they had changed their opinion over the course of the trial. 
Almost all of them described a different attitude towards prescribing warfarin for this patient 
population. Many talked about a general increase in the acceptability of warfarin for use in 
older people over the course of the trial, even pressure on GPs to prescribe it. At the start of 
the trial, many were nervous about prescribing warfarin: 
“at the time we started doing it I think the jury was sort of really 
rather out on whether warfarin should be prescribed. I think things 
have shifted….when we were thinking of going into the trial… some of 
the GPs were very unkeen on prescribing warfarin and very keen to 
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look for excuses not to, where as now, you’re sort of negligent almost 
if you don’t” 
Interview 3 (Female; medium recruitment group) 
“I do know that the sort of, the pressure upon us to give warfarin in 
anybody in AF is across the age range, seems to be definite” 
Interview 12 (Female; medium recruitment group) 
When asked why they thought that there had been this shift in attitude, a few GPs alluded to 
trials that had been published during the BAFTA recruitment period that suggested this was a 
good thing, or mentioned guidelines that advocated warfarin use. However, they were not sure 
that this attitude shift was evidence based. 
“my impression is that clinically it’s not evidence based, since the 
start of BAFTA we’ve moved that way and now we use warfarin 
clinically much more widely, but I don’t know if that’s right” 
Interview 6 (Male; low recruitment group) 
A minority of GPs felt that their attitude towards prescribing warfarin for older people had 
changed as a direct result of their participation in BAFTA. They realised that giving warfarin 
to the over 75s was not necessarily too different than giving it to younger people. 
“I realised probably by giving it to the elderly population are not too 
dis-similar to giving it to the under 75s….I think my opinion changed 
because the people who were randomised to warfarin seemed to cope 
with it really very well…. I was pleasantly, you know, surprised really 
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at the ease with which people did adapt to these sorts of regimes so it 
did change some of my view points about it” 
Interview 16 (Female; small recruitment group) 
“I sort of noticed, it’s not the age really, that matters its hmmm, … but 
how the person is functioning … the chronological age really that 
seems to be that important”  
Interview 2 (Female; medium recruitment group) 
About half of the GPs felt that the trial had given them a better understanding of the issues 
around older patients with AF and managing their stroke risk. Additionally, having more 
patients on warfarin as a consequence of the trial improved their experience of dealing with it, 
thus giving them a different perspective on the risks. 
“I kind of feel I have changed and I would be a lot more adventurous 
about the slightly older age group because I feel my understanding 
has improved” 
Interview 2 (Female; medium recruitment group) 
8.5.2 Doctor/Patient Interaction 
The second theme to be addressed is doctor/patient interaction. Discussions that GPs have 
with patients about research may be different in content than standard consultations, and GP 
concerns about raising the subject may impact on these discussions.  This section will present 
GPs thoughts about this, and will start with a description of how GPs explained the trial to 
patients, including any concerns that were raised about discussion of trial concepts. It will 
continue with the impact involvement in trials may have on the doctor-patient relationship, 
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including GP thoughts about clinical autonomy when participating in trials, and will conclude 
with GP thoughts about how patients felt about trials. 
 8.5.2.1 Explanation of Trials to Patients 
GPs used different ways to explain the trial to patients, although most used the patient 
information sheet as a starting point. Some GPs tried to keep it as close to a usual consultation 
as possible by establishing what patients already understood and tailor the subsequent 
conversation accordingly. 
“you quickly then establish what they understand and you can tailor 
to it” 
Interview 9 (Male; high recruitment group) 
Most GPs explained AF to their patients, and the risks associated with it. They continued, 
discussing the treatment options and explaining the pros and cons of each option. Some GPs 
kept this explanation very simple, explaining that aspirin thins the blood, and warfarin is a 
stronger version of it, while others explained in more detail. 
“aspirin most people know thins the blood… warfarin is a stronger 
version of that… it would have been quite simple” 
Interview 4 (Male; low recruitment group) 
“we know aspirin reduces that risk by about a third, we know that 
warfarin decreases it by about two thirds” 
Interview 9 (Male; high recruitment group) 
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At this point in the discussion, GPs would discuss the uncertainty around the treatment 
options to patients. All GPs explained the risks and benefits, but a minority felt that it was 
difficult to explain the comparison, and were not sure how well this had been done. 
“it’s difficult because it is a slightly technical comparison and to put it 
in terms that people can understand and I wonder if retrospectively it 
was… the concept or if it was the way I described it” 
Interview 14 (Female; small recruitment group) 
Most GPs described treatment uncertainty with a mix of general scientific uncertainty, and 
personal uncertainty. Most used the phrase ‘we don’t know’ (i.e. the scientific community) 
but were happy to admit to their patients that they did not know the answer either. One GP 
described how he did not like to leave patients with uncertainty and so would focus on the 
facts that are known and minimise the impact of what is not known. 
“I’d say to patients we know an awful lot…we don’t know enough 
about this… I don’t use the word uncertainty because I think it sends 
them away with a feeling of unease… it’s different words but I hope it 
sends them away without the burden of uncertainty” 
Interview 9 (Male; high recruitment group) 
For patients happy with the concept so far GPs would continue, describing randomisation. 
Most would use a simple analogy, for example, like the flip of a coin. A minority said that a 
computer decided, but other GPs felt that patients would not like that and so used alternative 
explanations. Others ‘passed the buck (and said that) the lady in Birmingham decides’ 
(Interview 7). 
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“the best way to do that really, on the toss of a coin and then compare 
the people on one drug with the people who are on the other drug” 
Interview 10 (Male; medium recruitment group) 
“I wouldn’t put a computer in charge of a basic clinical decision for a 
patient, they wouldn’t like that” 
Interview 1 (Female; high recruitment group) 
Almost all GPs did not explain the need for randomisation, as they did not see a reason to do 
so: no patients asked them for further explanation. Those that did describe the need aimed to 
keep it as straightforward as possible. 
“the reason for that is we need to make sure that we don’t, you know, 
select certain patients… but I didn’t go into the nitty gritty of the 
randomisation and why. Nobody asked” 
Interview 10 (Male; medium recruitment group) 
About half of the GPs described difficulties they encountered when explaining BAFTA to 
patients. As mentioned earlier, some found it difficult to explain the comparison between the 
two treatments. Others felt that uncertainty was much more difficult to explain to patients 
already taking one of the treatments because they may need to change. 
“Some of them you see were already on treatment anyway, so they 
have to be told that there is a possibility you might be randomised to 
the alternative” 
Interview 11 (Male; high recruitment group) 
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8.5.2.2 Doctor/Patient Relationship 
The majority of GPs felt that involvement in trials did impact on the doctor/patient 
relationship. Two GPs said that the relationship did not change, and felt that if you had faith 
in the trial it should not influence it in any way. 
“it would only do it if you didn’t believe in the trial surely… you’re 
not co-ercing them to do anything, you should have a belief in what 
you are doing is worthwhile and therefore no, I don’t think it does” 
Interview 14 (Female; small recruitment group) 
GPs described different influences that involvement in a trial has on the doctor/patient 
relationship. Most felt that the changes were positive, and helped strengthen the relationship. 
“they might be a little bit more familiar with you, which is alright” 
Interview 9 (Male; high recruitment group) 
“the few that erm went on to warfarin got a lot more attention, and I 
got to know them a lot better…I would have thought that was 
advantageous rather than disadvantageous to the patient” 
Interview 5 (Male; medium recruitment group) 
A minority of GPs had mixed feelings about whether the impact was positive or negative, and 
felt that depending on the situation, it could go either way. One GP felt that if patients started 
to expect more from you as a result of participation in a trial, then that could be a problem, but 
did not encounter that problem when taking part in BAFTA. 
 179 
 
“I don’t know if it is a good thing or a bad thing, but you kind of 
develop a relationship with people you spend a bit longer with…. The 
downside thing is because they very much feel that they are doing you 
a favour” 
Interview 16 (Female; small recruitment group) 
Another GP felt that it would be a good thing if it enabled patients to discuss issues with you 
that they would otherwise not bring up. 
“It would be a bad thing if it started to influence the way they fed back 
to you if they were unhappy… equally you could argue it, if you had a 
better relationship maybe they could say things so it’s really difficult” 
Interview 11 (Male; high recruitment group)  
8.5.2.3 Patient Experience and Understanding 
GPs were asked their opinion about what they thought about how the patient experienced the 
trial. Most felt that the patients enjoyed the experience of participating, were pleased about 
the extra attention they got as part of the trial, and enjoyed the almost social aspect of the 
follow up appointments. A minority of GPs felt that their patients were altruistic and enjoyed 
giving something back. 
“It became quite a social event” 
Interview 6 (Male; low recruitment group) 
“some people just enjoyed having some medical attention every few 
months which they didn’t think they qualified for” 
Interview 5 (Male; medium recruitment group) 
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Overall, most patients were felt to understand the trial and what they had agreed to participate 
in. A small minority of GPs questioned how far the patients understood the process or the 
reasons for randomisation, though most felt that patients understood that neither they nor the 
GP would choose the treatment they were assigned to. 
“he wouldn’t have understood the principal of randomisation 
presumably, I don’t know. But he understood he was given a choice to 
be in the trial or not in the trial, and if he was in the trial he had to 
agree to what the Birmingham lady said” 
Interview 5 (Male; medium recruitment group) 
“probably thought to some extent that you’d decided this was the best 
treatment for them”  
Interview 3 (Female; medium recruitment group) 
There were mixed opinions on the extent to which patients understood the risks that had been 
explained to them. About half of the GPs felt that patients had a good understanding of the 
risks of the trial drugs, and of stroke, while others were not sure how well this was 
understood. 
“they appreciated that warfarin overall would reduce their risk of 
stroke” 
Interview 7 (Male; small recruitment group) 
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“you can explain it but even when you have explained it the patient 
may not appreciate the full implications” 
Interview 15 (Male; medium recruitment group) 
When asked what information patients wanted to be given before they made the decision 
whether or not to enrol, the majority said that they felt it was important that patients 
understand that they can change their mind and opt out at any point. 
“as long as there’s exit criteria that the patient can decide, I think that 
is important actually” 
Interview 2 (Female; medium recruitment group) 
8.5.2.4 Clinical Autonomy 
GPs were asked about clinical autonomy and whether they had any thoughts about how trial 
involvement may impact on that. Most said that they had no concerns about the impact of 
BAFTA on autonomy as they retained the right to change or stop treatment, or to withdraw 
patients from the trial.  
“I didn’t have a problem at all.....it wasn’t an instruction I was 
following regardless” 
Interview 7 (Male; small recruitment group) 
Over half of the GPs felt that autonomy was not an issue because uncertainty was not a good 
place to be autonomous from. 
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“If you don’t know the erm, what’s right thing to do genuinely, then I, 
I can’t see that’s a very good place to be autonomous from” 
Interview 5 (Male; medium recruitment group) 
“It’s not a problem for me with that ‘cause we don’t know what the 
best thing to do is” 
Interview 11 (Male; high recruitment group) 
One GP felt that autonomy was not affected by trial involvement unless the trial specified 
what drug the patient was to remain on after trial completion; they would not choose to be 
involved in research that did not allow them that freedom of choice. 
“They would put them on a specific treatment and then we would have 
to continue afterwards, and we said no we are not going to take part 
in that” 
Interview 2 (Female; medium recruitment group) 
A minority of GPs said that autonomy was an outdated concept as consultations should be a 
negotiation with patients; decisions should be taken in conjunction with patients, rather than 
for patient. Many outside influences affect this negotiation, and a trial is just one of those 
potential influences. One GP felt that autonomy had no place in modern medicine as it was 
often used as an excuse to ignore evidence based medicine. 
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“Clinical autonomy is a pretty old fashioned concept... there are so 
many kind of outside influences.. its really a negotiation... a clinical 
trial is just another of the outside influences really. Not a problem” 
Interview 8 (Male; high recruitment group) 
“clinical autonomy means nothing, patient autonomy is what 
matters…. Doctors have to be their patient’s advocate but too often 
clinical autonomy is an argument for not following evidence based 
medicine… nothing to do with being the patient’s representative, 
that’s some funny idea that as a doctor you are entitled to your 
opinions whatever” 
Interview 12 (Female; medium recruitment group) 
8.5.3 GP Motivation, Experience and Understanding 
This theme looks at GP understanding and experience of BAFTA. It covers their reasons for 
taking part, experience of participating, their understanding of trial processes, and their 
comments on the very practical aspects of the study, including suggestions for improvement.  
8.5.3.1 Motivations for Taking Part 
 Having discussed their feelings towards the study question, GPs were then asked why they 
decided to take part in BAFTA. Most GPs alluded to the reasons already discussed, 
importance of the study, relevance to the practice, and the shift in practice to management of 
AF in primary care. However, a variety of other reasons also contributed to the decision. A 
minority of GPs wanted to take part because they had a personal interest in the topic area, or 
an interest in taking part in research as part of their career development. 
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“I thought it was an interesting topic, erm, I think that’s probably sort 
of the attraction” 
Interview 3 (Female; medium recruitment group) 
“I was quite excited cause I had always been keen on medicine for the 
elderly …. my appraisal was saying oh ever thought of doing any 
research…. Yeh, when the right thing comes along” 
Interview 11 (Male; high recruitment group) 
One GP felt that it was an interesting question that was relevant to his practice, but said he did 
not have a specific interest in the question and felt that he knew the answer anyway,  
“it wasn’t a burning question that was interesting to know the answer 
to, mmm, I must admit… I thought, well, I would probably know the 
answer anyway” 
Interview 4 (Male; low recruitment group) 
Many GPs decided to take part in BAFTA because they felt that it was a study that would be 
beneficial either to their patients or to their practice, or both. A few GPs said that it would 
give them an opportunity for better identification and monitoring of their AF patients, or 
would force them to make a considered opinion about warfarinisation for all of their AF 
patients. 
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“it gives us an opportunity to improve the care for our patients with 
AF as well, because we’ll, we’ll see them and monitor them and 
actually identify maybe new patients as well because of screening” 
Interview 10 (Male; medium recruitment group)  
“the trial pushed us into putting more people onto warfarin who we 
wouldn’t have done otherwise…. We were waiting to be pushed…. we 
were quite glad to get pushed” 
Interview 5 (Male; medium recruitment group) 
A substantial minority of the GPs discussed the timing of the study as contributing to its 
relevance. For some, this was the relevance of the topic, as practices were beginning to work 
on their disease registers at the time, and management of AF was one element of this. For 
others, it was the timing for more personal reasons, for example, a practice decision to 
participate in more research, or a personal desire to do something new. 
“at the time we were just starting to get our disease registers in 
order….. it was just all sort of relevant at the time” 
Interview 3 (Female; medium recruitment group) 
“I needed something to get my teeth into” 
Interview 6 (Male; low recruitment group) 
“we had a clinician and a key nurse ready to embrace something 
which slightly challenging” 
Interview 13 (Male; high recruitment group) 
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Altruism was cited by a minority of GPs as a factor contributing to their decision to 
participate. One GP linked this feeling of altruism to the low level of reimbursement on offer 
to practices for carrying out the study. Another GP described how none of the GPs in the 
practice were academics, so involvement in an academic study was something that was liked. 
“a bit of altruism I guess, it wasn’t the money, that’s for sure.” 
Interview 7 (Male; small recruitment group) 
“none of us are academics….so I think that was that feeling about it, 
this has got a feel for it that’s quite good” 
Interview 6 (Male; low recruitment group) 
Although not directly mentioning altruistic motivations, two GPs said that the tone of the 
initial invitation letter influenced their decision to participate. For one GP, the initial letter 
was given as his only reason for agreeing to participate. 
“you had a very pleading letter (laugh) so you were desperate…. 
Pleading letters work, yes” 
Interview 8 (Male; high recruitment group) 
“We had a nice invitation, a nice letter, yeh oh ok, we will do that… 
you write to people nicely they do it, demand you don’t get…. (KF so 
it was purely a nice letter?) yeh, nice letter” 
Interview 4 (Male; low recruitment group) 
The level of reimbursement available to the practice for taking part was also a subject raised 
by GPs when asked about their reasons for participation. Although the majority of GPs were 
not interested or involved with finance, as it was the domain of the Practice Managers, most 
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described reimbursement as being a facilitator that enabled them to take part. The level of 
payment available in BAFTA was designed to enable practices to free up staff time to carry 
out the required work, but was not sufficiently high for practices to make a profit. Without 
reimbursement, studies would rely solely on enthusiastic GPs who were willing to carry out 
the trial in their spare time. One GP said that while the money may not influence the decision 
to participate, trialists need to be clear at the outset what is available, because that may 
influence the practice’s ability to become involved. 
“if there had not been reimbursement then the practice would have 
said if you want to do it then you do it in your own time basically” 
Interview 8 (Male; high recruitment group) 
“I think that is going to be quite important really …. We have an 
agreement so anything done out of GMS1 time they (the practice 
nurses) will get that. So it needs to be quite clearly identified” 
Interview 2 (Female; medium recruitment group) 
Study training also contributed to the decision about whether or not to participate. A small 
number of GPs said that they were impressed by the initial presentations, and that this fed into 
their decision. However, the standard of training did not influence one GP who felt that the 
study was something they had decided to be involved in anyway. 
“I must have been quite impressed cos I came back and said well I 
think we ought to do that” 
Interview 6 (Male; low recruitment group) 
                                                 
1 GMS is the General Medical Services contract. It describes the services GP surgeries provide to their patients 
under contract with the National Health Service and determines the level of funding each practice receives from 
the NHS 
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“I think that was quite well presented… but again we were quite keen 
so I think you could probably have had a really bad trial I say we 
would have continued on with it” 
Interview 13 (Male; high recruitment group) 
If local training had not been available, then some GPs would not have considered 
participating. Additionally, the face-to-face nature of the session was an important factor for a 
significant majority; training via DVD or the internet would have put many off taking part. 
“for us to sign up to it, it kind of helps that the training sessions were 
local, if it had been a lot further afield one would have thought twice 
about it” 
Interview 11 (Male; high recruitment group) 
The final area discussed by GPs that influenced their decision to participate was practicalities. 
Just under half of the GPs felt it would be straightforward to carry out in their practice, partly 
because they see this particular age group regularly anyway. 
“it seemed you know, quite easy to do because those particular age 
people we tend to see… so it didn’t seem difficult to set up a system 
whereby we could take their pulses” 
Interview 1 (Female; high recruitment group) 
It was perceived by the majority as an easy study to do, with support and back up readily 
available, and one GP said that it would not be too time consuming. 
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“there seemed to be a lot of back up and support with it” 
Interview 15 (Male; medium recruitment group) 
“it interested me cos it looked like quite an easy study” 
Interview 16 (Female; small recruitment group) 
“it didn’t seem to be too time onerous” 
Interview 8 (Male; high recruitment group) 
8.5.3.2 Overall Experience 
Most GPs enjoyed participating in BAFTA, and commented that they thought it was well 
organised and well thought through, which made it easier for them to carry out the required 
work. Many felt that the workload overall was not a problem, though two commented that it 
was front loaded and it would have been impossible to maintain that pace for the duration. 
“it seemed quite hectic in the early stages, you know it calmed down 
quite a lot. I don’t think we could have continued at that pace” 
Interview 2 (Female; medium recruitment group) 
Most GPs expressed disappointment in the number of patients they actually recruited, and felt 
that there was a large workload for the number of patients they enrolled. One GP commented 
that he felt guilty about the number of patients he recruited in relation to the amount of money 
the practice was paid. 
“we did put a lot of work in, we did, and then it was a bit 
disappointing to only have a few actually” 
Interview 14 (Female; small recruitment group) 
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“it did seem like quite a bit of money for what was one patient…. I do 
feel guilty about it all… sorry we didn’t get any more” 
Interview 4 (Male; low recruitment group) 
A minority of GPs commented about how it was different to the usual work done in general 
practice, more structured. Some said this was a welcome change, while others described the 
process as tedious. 
“this formalised repetitive way of doing things is sort of the antithesis 
of what you do in normal general practice… and that is quite 
refreshing and it stays refreshing” 
Interview 8 (Male; high recruitment group) 
“the actual recruitment part was a little bit tedious just really, just 
getting, identifying the patient, and sending quite a lot of paperwork 
to fax machines” 
Interview 13 (Male; high recruitment group) 
Many commented on some unexpected benefits for the practice of participating. Over half of 
the GPs commented on the ways in which BAFTA improved patient care. Some practices, for 
example, developed protocols for dealing with AF patients, others introduced in-practice 
warfarin monitoring clinics in part as a result of taking part in BAFTA. Two GPs found that 
asking repetitive questions over time allowed them to keep track of changes in patients in a 
way that would not normally be possible. 
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“in a way it helped us…look at peoples atrial fibrillation…and create 
a protocol of what we were going to do” 
Interview 8 (Male; high recruitment group) 
“it’s because of it (BAFTA) from that came our sort of, probably 
setting up the warfarin clinic to a certain extent” 
Interview 14 (Female; small recruitment group) 
“It did help us which hasn’t been done before, looking at how a 
patient may have been on warfarin and over time just get gradually 
more muddled and may well be at risk of taking medication wrongly” 
Interview 13 (Male; high recruitment group) 
8.5.3.3 The BAFTA Study Team 
Overall, most GPs felt that the study team provided a good level of support throughout the 
trial. Many commented that the team was easily accessible, always available to answer 
queries and ran the study to a very high standard. 
“they run quite all of them to very high standards as we came to 
expect from the beginning” 
Interview 13 (Male; high recruitment group) 
“people were accessible and able to give you an answer” 
Interview 6 (Male; low recruitment group) 
A small minority of GPs commented that they would like more feedback about trial progress, 
as they felt a little out of touch over time. However, the most appropriate way to keep in touch 
was unclear. The team sent regular update newsletters to GPs, but a few GPs could not 
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remember them. Others were unsure as to their benefit, and a few felt that they were 
beneficial so long as they were kept brief. 
“you do kind of feel in limbo, you are doing all this stuff and then you 
wonder what is happening the other end, but I suppose until the trial 
is complete there is no feedback on anything useful really” 
Interview 8 (Male; high recruitment group) 
Many GPs commented that the confidence they had in the research team helped engender a 
feeling of security while participating. However, one patient was mis-diagnosed with AF and 
therefore incorrectly randomised into the trial. This GP said that this was a bad experience for 
both her and the patient, and that the incident dented her confidence in the team. This did not 
detract from her experience of participating, but did ensure that she took more responsibility 
for study processes. 
“where this mistake was made and it would have been better if that 
hadn’t been made…. If I took part in another one would be erm, I 
suppose it just bear that case in mind and think where the weak spots 
may be” 
Interview 3 (Female; medium recruitment group) 
8.5.3.4 BAFTA Training 
The influence of training on decisions to participate has been discussed in section 8.5.3.1. 
This section will address the impact of the training session on trial participation. Overall, 
training was perceived as a useful and enjoyable exercise. Most GPs felt that it provided a 
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good case for the need of the trial and demonstrated that the workload and timescales had 
been well thought through.  
“a well put together case as to why the trial is being done and a clear 
erm, you know that every stage of it had been clearly thought 
through…. I think it was well done” 
Interview 3 (Female; medium recruitment group) 
The majority of GPs felt that they came away from the training session well prepared to carry 
out the trial, and filled with enthusiasm. However, although stating she felt prepared, one GP 
did comment that it is possible that she did not come away with the right skills to recruit 
patients. 
“I enjoyed it…its going to be brilliant, there’ll be hundreds (of 
patients) ... but maybe the other thing, in retrospect is maybe you 
know, that it wasn’t enough to give me the skills to get them on to it” 
Interview 14 (Female; small recruitment group)  
8.5.3.5 Practicalities 
Identification of New Cases of AF 
Practices were asked to identify new cases of AF by taking a patient’s pulse when they 
attended the surgery; reminders (either paper or electronic) in patient records were used to 
ensure this was done. The majority of practices regularly highlighted the pulse screening at 
staff meetings to ensure it did not get forgotten. All GPs said that the system worked well, 
although one GP commented that it may have been more difficult if the practice had been 
larger. Another GP talked about the importance of the order in which computer prompts are 
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activated to minimise the risk of people ignoring them. For GPs entering the study towards 
the end of the recruitment period this area was not discussed, as identification of new patients 
was not carried out systematically; only existing AF patients were considered. 
“those [pulse reminders] got managed well in consultation … being 
just a small practice, if we’d had more people it would have been 
more intrustive” 
Interview 6 (Male; low recruitment group) 
“the sequencing of where things are in the computer record is terribly 
important if you want people to do things” 
Interview 1 (Female; high recruitment group) 
Patient Selection 
When describing how they decided on which patients to invite to participate, the majority of 
GPs said that they made the decision for all potentially eligible patients in the practice, but 
would discuss patients they were unsure about with the patient’s regular GP. All GPs 
followed the exclusion criteria, but some excluded patients for other reasons, for example, 
frailty or those in nursing homes. A few GPs said that they may have taken how they felt the 
patient would react to the invite into consideration. 
“if you felt that as their GP they were really not up to participating in 
the study then that was ok to do, and we had a few of those. Either in 
terms of physical infirmity or mental infirmity, yeah, or cussedness.” 
Interview 8 (Male; high recruitment group) 
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“I don’t think I sort of thought oh well, they’re a stroppy so and so, so 
I won’t invite them… you can never answer for subconsciously” 
Interview 9 (Male; high recruitment group) 
Consent Process 
Consent was carried out during a clinic appointment with both the GP and the nurse; the GP 
was responsible for gaining informed consent. Some GPs described the stepwise nature of the 
process, with consent starting at the point where the patient’s pulse was taken, culminating in 
the full consent for participation, and felt that this was a good approach for the patients. A few 
practices telephoned the patient after they had been sent the information sheet to discuss the 
study with them, and to organise a clinic appointment; one GP talked about how they 
explained to patients that they needed to discuss the study with them during this telephone 
conversation. 
“a telephone call to say look I’m involved in a clinical trial, we think 
this is very important and erm, we’d like to talk to you about it” 
Interview 1 (Female; high recruitment group) 
“I didn’t go through the original consenting, it was the practice nurse 
who did that when she did their ECG… I then got consent I think when 
they came back in having been diagnosed with AF” 
Interview 3 (Female; medium recruitment group) 
Patient Follow-ups 
Patient follow up forms were provided in the form of a booklet which some GPs said was a 
useful format, allowing referral to the paperwork from the previous appointment. Keeping 
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track of follow up due dates was difficult, and most GPs relied upon reminders sent by the 
study team. Keeping them timely, especially during the holiday season was difficult, and one 
GP said that they did not know what to do with a patient who was late or who had missed a 
follow up. 
“difficulty getting it timely… they might not ring for 2 or 3 weeks… 
and then I might be on holiday or whatever… I started to go by your 
letters that used to come reminding us….. I became a bit confused….. 
you kind of lose track of it a little bit so I think the letters were really 
helpful” 
Interview 10 (Male; medium recruitment group) 
8.5.3.6 Understanding 
Generally there was good understanding both of general trial principles and BAFTA specific 
procedures. Most GPs understood the important basics of BAFTA (for example, eligibility) 
although patient withdrawal was often poorly understood. Patients were not withdrawn from 
the trial because they were no longer taking their allocated medication, but GPs would often 
confuse this with withdrawal. 
“One lady we took out the trial because…. The nurse became 
increasingly concerned that she was sufficiently forgetful that she 
wasn’t sure she should be taking her warfarin” 
Interview 1 (Female; high recruitment group) 
There was a mixed level of understanding about the uncertainty principle in relation to trial 
eligibility; although the majority understood that they needed to be unsure about the best 
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treatment for an individual patient, many did not seem to understand that patients also needed 
to be uncertain as to which treatment they wanted. Patients with a strong preference should 
not have been entered, but this was not always the case. 
“There was one person who was happy to go into the trial but did not 
want warfarin, so he went in and got aspirin” 
Interview 9 (Male; high recruitment group) 
Almost all GPs had a good understanding of the need for randomisation, often discussing the 
need to prevent the results being confounded by other factors. A minority talked about the 
need to avoid selection bias. One GP seemed to confuse randomisation with blinding and used 
the two terms interchangeably when talking about how randomisation was explained to 
patients. 
“you randomise a trial which means that nobody knows, erm people 
doing the trial don’t know what you’re taking, and that I would use 
yes like the toss of a coin…. And sometimes I’d use the word blind if 
they obviously, if I felt they werent understanding” 
Interview 1 (Female; high recruitment group) 
8.5.3.7 Suggestions for Improvement 
GPs made a number of suggestions that would help to ensure that practices could carry out the 
research as effectively as possible. Most re-iterated the need to keep workload to a mimimum 
and keep the data collection forms as succinct as possible; flexibility in who can carry out the 
work was also considered essential by one GP. 
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“it would be a barrier you would insist on a doctor doing it. You want 
as many people as possible to do it because otherwise it starts to limit 
it” 
Interview 1 (Female; high recruitment group) 
Over half felt that it was important to keep the practice enthusiastic; communication was 
considered central to this. Effective feedback from the study team was cited as one way this 
could be achieved; newsletters were felt to be useful, so long as they were not too long or too 
often. A minority of GPs would have appreciated practice specific feedback, for example, 
giving them information on how many patients they had screened or ECG’d.  
“you do feel a little bit sort of out on a limb… so its [newsletters] 
quite good in that sense…. Keep it short though cause I havent got 
time to go through lots of stuff” 
Interview 2 (Female; medium recruitment group) 
“you will know.. how many we looked at and ECGs we did and 
actually that would be quite interesting” 
Interview 12 (Female; medium recruitment group) 
There were a number of suggestions to maximise recruitment and retention. One GP 
mentioned the mobility of patient populations, and felt that consideration of effective ways of 
ensuring newly registered patients were included would help; improved use of IT systems to 
provide reminders was one potential way to achieve this.  
“increasing mobility of patients... patients coming in and patients 
leave so I think that’s what we got to look at really.....IT things, I think 
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“that worked well because as soon as that clinical indication came up 
it just popped up... I think that’s good” 
Interview 2 (Female; medium recruitment group) 
One GP highlighted the need to inform local consultants about the study, because some gave 
patients conflicting advice, making it harder for patients to continue their involvement in the 
trial. 
“We did have a few incidents that people came back and say you 
know they [consultants] had a go at me again because I’m in 
fibrillation and I’m on aspirin...I wonder whether maybe the local 
consultants almost had to be got together in the beginning and told 
face to face... it did cause some anxiety that they were being told 
conflicting things” 
Interview 11 (Male; high recruitment group) 
Final suggestions to improve recruitment including the potential to allow patients to see their 
own GP, and consideration of the region you recruit in depending on the population of 
interest. 
“I might have done it that they see their doctor they normally saw... in 
hindsight perhaps if we had done that we might have got better 
enrolment” 
Interview 6 (Male; low recruitment group) 
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“some of the guys had come from Torbay and Torquay, which is 
retirement-ville, so if they wanted elderly people, then well you know, 
coming down here would be a good place to start” 
Interview 7 (Male; small recruitment group) 
8.6 Patterns of Experience 
The data were examined to identify whether any differences in opinions or experiences 
existed between different groups of GPs. The value of this process could be potentially 
limited by the fact that only 17 interviews were carried out. However, previous research has 
successfully identified important patterns in the data despite a small number of interviews.169 
It was decided to examine the data for patterns as it may prove useful to determine whether 
any exist that could provide any explanation as to why some GPs recruited more successfully 
than others.  
Differences were found between the recruitment groups across all three main themes, and 
these will be presented in this section. No patterns between demographic factors were 
identified: this may be due to the small sample size, although data saturation was achieved so 
it is hoped that this is not the case. It may also be due to the lack of very small practices in the 
sample. It is possible that patterns may have been identified if these practices had been 
represented.  
8.6.1 Patterns Between the Different Recruitment Groups 
As described in Section 7.2.1 GPs were grouped according to the proportion of their eligible 
patients that consented to participate in BAFTA (See Table 14, page 134). To reiterate, GPs 
recruiting more than 60% of eligible patients were classed as high recruiters; those recruiting 
40-60% of eligible patients as medium, less than 40% were considered low recruiters, and 
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GPs who deemed less than five patients to be eligible were classed as small recruiters. 
Differences in attitudes and experiences between these groups were found in a number of 
different areas. 
8.6.1.1 Risk and Responsibility 
Differences in attitudes towards the study question were found. GPs in the high recruitment 
group seemed to have a more clear-cut attitude towards the importance and relevance of the 
study than those in the other groups; all high recruiting GPs placed emphasis on these aspects. 
Those in the middle and small groups also discussed the importance of the study, but were 
more ambiguous. For example, some said that although it was important, they felt that they 
already knew the answer anyway. The low recruiters discussed the clinical appropriateness of 
the study, but were less vocal about its importance; these GPs either did not mention 
importance, or were unclear as to whether they thought it was important or not.  
Differences in attitudes towards the study drugs were also found. When asked how they felt 
about the study question, the high group described the benefits and weaknesses of both study 
drugs. The other recruitment groups also discussed the trial drugs, but placed more emphasis 
on the dangers of warfarin and less on the balance of risks and benefits of both. All these 
groups discussed the trial drugs spontaneously. The low recruitment group did not discuss the 
drugs at this point. When asked directly how they felt about the drugs, all GPs in the low 
group stated that they had no problem with either drug, but would also discuss how they felt 
safer with aspirin rather than warfarin. 
There were also differences in attitudes towards entering patients into trials. In the high, 
medium and small recruitment groups, most GPs were happy with the concept of including 
patients in trials. One GP said he did not like it because it “put upon” patients, but recruited 
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anyway because the evidence was needed, while others felt it was good for their patients 
because patients enjoy participating in trials. Most GPs qualified their statements; they were 
less comfortable with new drug trials, as they felt these pose more risk to their patients, they 
wanted the trial to be important and to benefit their patients. The low recruitment group, 
however, were more concerned. They too differentiated between the risks of new drug trials 
and trials of more established treatments, but were generally more concerned about the risks 
associated with involving their patients in trials. 
When asked about the ethics of randomisation, all recruitment groups discussed their concerns 
with drugs company trials, and how it depends upon what the patient is being randomised to. 
All groups discussed the perceived link between finance and recruitment in drugs company 
trials, and questioned the scientific basis for some of these studies. However, for the low 
recruitment group, this was all that was said about the ethics of randomisation. The other 
groups went into much more detail. All other groups discussed the importance of treatment 
uncertainty in relation to the ethics of randomisation; there must be no evidence in favour of 
one treatment over the other. All other groups also related ethical randomisation to patient 
consent. It was considered ethical if patients were fully informed and were aware of their right 
to withdraw. GPs in the high recruitment group alone felt that it would be more unethical to 
carry out trials without randomisation due to the risk of bias, or to continue to use existing 
treatments without knowing which one was most appropriate, than it would be to randomise 
patients. 
Again, there were differences in attitudes between the recruitment groups when discussing 
responsibilities towards patients. GPs in the high, medium and small recruitment groups said 
that they would feel responsible for events happening to patients as part of a trial, in a similar 
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way to how they would feel responsible outside of trial conditions. Some GPs in these groups 
felt that the trial actually took some of that responsibility away from them as long as they 
were happy with the trial parameters at the outset. In contrast, the GPs in the low recruitment 
group talked about how it would be difficult to ‘square’ if something happened to a patient in 
a trial. One GP said he would not feel responsible, but felt that patients would blame him 
anyway.  In the high, medium and small groups many GPs felt that the responsibility lay more 
with giving or changing medications than with involving patients in trials; events happening 
to patients because of their disease were seen to absolve the GPs of any responsibility. In the 
low group, this aspect of responsibility was not raised. 
8.6.1.2 Doctor/Patient Interaction 
When asked about how they discussed the study with patients, GPs in the high recruitment 
group described how they felt that patients often knew what they wanted to do with regard to 
the trial before they came to the appointment. They usually established what the patient 
understood and wanted to do, and tailored their explanation based on this. The patient 
information sheet was used as a starting point and the discussion was tailored to individual 
patient requirements. They often used simple analogies to describe randomisation, for 
example, like the toss of a coin, or the ‘computer decides’. The low recruitment group 
appeared to be more prescriptive and would read through the information sheet with the 
patient; the simple analogies for trial concepts like randomisation did not appear to be used. 
There were different feelings about the impact of trial involvement on the doctor/patient 
relationship between the recruitment groups. All GPs in the high recruitment group felt that 
involving their patients in trials did alter this relationship, though they all felt that it was a 
positive change: they felt that it helped them to get to know their patients better. Of those who 
recruited 40-60% of their eligible patients, most felt that it either did not influence the 
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relationship, or if it did, it was, again, a positive change. There was a different attitude 
amongst the low recruiting GPs however, as they expressed more concern about whether 
patients were wondering about the GP’s motivation for involving them in trials and felt that 
this would have a negative influence on their future relationship. 
8.6.1.3 GP Motivation, Experience and Understanding 
GPs were asked about their motivation for participating in BAFTA. Some of these centred 
around the study question and its relevance and importance: these have already been 
discussed in section 8.6.1.1. However, GPs often cited other reasons for taking part and there 
were, again, differences between the groups. GPs in all groups except for the low recruiters 
gave multiple reasons for taking part. The reasons given were discussed in more detail in 
section 8.5.3.1, but included benefits for their patients or the practice; the appropriate timing 
of the trial, altruism or personal interest. Their decision to participate was often multi-faceted 
with a variety of factors contributing. In contrast, the low recruitment group gave fewer 
reasons. One GP was interested because he was looking for something new to do, therefore 
the timing was right; he considered it mainstream research, not something that was novel or 
especially high risk. Another participated as a result of a nice invitation letter and stated that 
no other factors influenced the decision. 
Some GPs spontaneously discussed the unanticipated benefits of participating in BAFTA and 
again, there were differences between the groups in the way this was discussed. GPs in all 
groups except the low recruiters discussed it in terms of improved care for their patients. They 
felt that involvement in the trial enabled and encouraged the practice to introduce protocols 
and systems for the better identification and management of patients with AF. Improved GP 
understanding of the condition and how to manage it was also cited as a benefit of 
participation; the increased exposure to AF and warfarin management allowed them to 
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automatically know what factors to consider when they identified new AF cases. In contrast, 
the low recruitment group stated only that BAFTA allowed them to identify additional 
patients with AF. 
The final pattern that emerged from the data with regard to differences between the 
recruitment groups were their opinions about issues affecting the recruitment of patients. 
Again, there were distinctions between the low group and the others. Most GPs talked about 
how they found it difficult to identify eligible patients, how it was harder to include patients 
already receiving treatment for their AF than it was to enrol new AF patients, and how GP 
discretion in deciding eligibility allowed them to exclude patients that they felt would not 
want to participate. Low recruiting GPs, however, highlighted different concerns. They felt 
that the need for randomisation impacted negatively on recruitment, felt that their patients 
prefer to be left alone and discussed how difficult it is for practices to engage with research.  
8.6.2 Demographic Patterns 
There was only one pattern of opinions that emerged from the data when looking at 
demographic factors (for example, GP age; practice size; gender) or the year of practice 
involvement in the study, and this related to GP age and their thoughts about the study 
question. Older GPs (those who qualified before 1981) placed more emphasis on the 
importance of the study to their patients than their younger counterparts. Older GPs all placed 
emphasis on the importance of the question; they felt that it was important to find out the 
most appropriate way to treat older patients with AF. They were concerned about the risks to 
their patients of AF and of warfarin. Younger GPs tended to describe the trial in terms of its 
clinical appropriateness and relevance to practice; the discussion was less directly related to 
the benefits for patients. It did not appear that younger GPs were less concerned about their 
patients than older GPs, but they did seem to phrase their attitude to the study question 
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differently, and this may have communicated itself to patients. This will be discussed in more 
detail in Chapter Nine.  
8.6.3 Within-case Analysis 
When looking at the views of individual responders, only one trend was found. GPs that had 
cited benefits to the practice or their patients as a factor influencing their decision to 
participate tended to have similar views on various aspects of the trial. For example, they all 
felt that BAFTA was a low risk trial, and none had any concerns about the ethics of 
randomising patients to different treatments, providing that they were happy with the trial at 
the outset. None were worried about the doctor/patient relationship, and felt that trial 
involvement either had no impact on this relationship, or else there was a positive effect. Most 
felt equally responsible for patients outside trial conditions as they did for patients that they 
had entered into a trial; they felt more responsible for changes to medication than for trial 
enrolment. Furthermore, all cited two or more benefits to the practice of taking part in 
BAFTA. 
In contrast, GPs that did not include the benefits to their patients of participation in their 
reasons for participation had more mixed opinions on these other aspects of trial participation. 
A few considered BAFTA low risk, but most had more concerns about the risk associated 
with putting their patients into trials. About half of them felt that trial involvement would 
impact negatively on the doctor/patient relationship, and some were concerned about the 
potential for restriction on their clinical autonomy. Additionally, only a few of these GPs 
discussed any benefit to the practice of participation: those that did cited fewer reasons than 
those GPs who had identified the potential benefits at the outset. 
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Although there are a number of limitations to this study (discussed in detail in Section 9.4), 
many of these findings are supported by previous research. Concerns about the risks posed to 
patients of involvement in trials, the potential impact of participation on the doctor/patient 
relationship and the feelings of responsibility that doctors have for their patients have been 
raised by clinicians in the past. However, previous research looking at these areas has all been 
carried out in a secondary care setting, mainly with regard to cancer treatment trials. Until 
now it was not clear whether these concerns related to primary care based RCTs: these 
findings demonstrate that the concerns remain applicable. Interestingly, some of the attitudes 
demonstrated by GPs differ to those reported to be held by specialists, especially with regard 
to concerns about the impact that the trial discussion could have on the patient relationship. 
What remains unclear is why these concerns differ and whether they can be mitigated, 
therefore improving both practitioner and patient recruitment.  
This study also found that factors that motivate GPs to take part in research seem to influence 
patient recruitment. This is not a new finding. As discussed in section 2.3.3.1, three survey 
studies also found that motivations were associated with recruitment. Interestingly, the factors 
previously found to be influential were often different from those found in this study, so it 
remains unclear what motivators impact on a clinician’s ability to recruit patients for research. 
It is also not clear how or why these factors should impact in this way. However, if 
considered in the context of theoretical concepts of motivation, specifically Self-
determination Theory (SDT), these findings may begin to make sense: the relevance of SDT 
will be discussed in section 9.3. Understanding of how these complicated and often 
interlinked perceptions impact on patient recruitment may allow researchers to identify ways 
in which to overcome these potential barriers.  
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Another interesting area identified during the interviews was the idea that the act of 
participating in BAFTA improved patient care. Many GPs felt that their understanding of the 
condition and its management improved as a consequence of participation, and that this 
resulted in better care for their AF patients. This is not a finding that has been discussed in 
previous literature with regard to research, although there is evidence that Stroke Units 
provide better care for patients with acute stroke than they receive in general wards. 
Participation in research is a central tenet of Stroke Units, and it is possible that this 
contributes to their expertise.170 This finding could be potentially useful for researchers 
looking to recruit GPs to participate in their trials and will be discussed further in section 9.4.  
A number of interesting and potentially useful points have been identified during the 
interview phase of this PhD. These will be discussed in more detail in the next chapter. 
Interview results will be discussed in relation to recruitment to RCTs, and placed in the 
context of both existing literature and, where appropriate, to existing theoretical concepts. 
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Chapter 9: Discussion of Interview Results 
As previously stated, this chapter will discuss the findings of the interviews in more detail. 
Strengths and limitations of the qualitative study will also be discussed. 
9.1 Demographic Factors 
Only one demographic factor previously reported as being associated with patient recruitment 
(Chapter 5) was found to have any bearing on difference in GP attitudes: GP age. Older GPs 
demonstrated a slightly different attitude towards the trial than their younger counterparts and 
it may be that this impacted on their ability to recruit. For example, older GPs talked about the 
important, worthwhile nature of the study question and its importance to their patients, 
whereas younger GPs placed more emphasis on the clinical appropriateness and relevance to 
practice of the question. It may be that these perceptions transferred to the patients during the 
consent discussions, and as a result, patients of older GPs also considered the study to be 
important and were therefore more willing to participate. It was not possible, however, to 
identify any differences from the interview data in the way that the trial was explained to 
patients; more specific detail about how the consent process was conducted would be needed. 
Older GPs may have been more likely to recruit because older patients view older GPs more 
positively than they do younger ones.171 It may be down to the attitude of older GPs towards 
older patients: research has shown that GPs feel more responsible for their older patients than 
they do younger ones.118 It may be that older GPs feel that responsibility differently to 
younger GPs, and this was reflected in their ability to recruit. It is unclear how much practical 
use this finding may be to trialists, as a GP’s age cannot be changed. Site recruitment could be 
targeted towards older GPs, but care would need to be taken to ensure that this did not 
introduce any bias into the study population.  
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9.2 Risk and Responsibility 
Almost all GPs talked about their concerns about the risks associated with involving their 
patients in trials and concerns they have about the medications under examination. Risk is 
linked to motivation in that some GPs stated that one of the reasons they agreed to participate 
is they felt that BAFTA was a safe, well monitored trial that was not looking at potentially 
risky new drugs. However, risk was also a central theme running through many of the 
decisions GPs took with regard to the trial. This section will examine the potential impact of 
perceived risk on both GP involvement and patient recruitment. 
The findings from the interviews imply that the perceived risks of a trial play a large part in a 
clinician’s decision as to whether or not to participate. A significant majority of GPs 
described how they felt that BAFTA was a low risk trial, using established drugs with known 
risks and this factored into their decision to take part. Most also highlighted concerns about 
drug company funded trials, feeling that they posed more risk to patients as they tend to 
involve novel treatments with unknown or unquantifiable risks. It is likely that these opinions 
would not apply to all GPs: the sample included in this study would have been self-selecting, 
in that they all chose to take part in non drug company funded research. Many GPs are happy 
to take part in research testing newer drugs. The literature review did not identify any 
publications that directly linked the perceived risk of the trial with a clinician’s decision to 
participate. It may be that this has not previously been identified because the majority of prior 
research has been limited to survey studies or retrospective analyses of individual trial 
recruitment processes; the questions relating to risk and the decision to become involved may 
not have been asked. It could also be possible that concerns about risks have been masked by 
other concerns. For example, Salmon et al explain that non-participation due to lack of time 
actually masks deeper concerns, such as giving researchers access to their patient records.104 It 
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may be that when GPs describe the relevance of a trial, they have actually factored in the risks 
that they feel their patients may be exposed to and decided the potential risks make it not 
relevant enough to take part.  
The findings of this study imply that a clinician’s perception of the level of risk posed by a 
trial has an impact on their ability to recruit once they have decided to take part. Previous 
recruitment research has not identified this as a factor directly influencing recruitment. 
However, research about risk communication may shed some light on why this may be the 
case. It is known that there is often a discrepancy between individually perceived risk and 
medical understanding of risk as communicated by GPs: personal experience, interpretation 
and cultural context impacts on an individual’s evaluation of risk.172 Furthermore, how a 
person is informed about risk allows for different personal interpretations of the same facts.173 
The Royal Statistical Sociey recommends that greater use is made of numerical as opposed to 
verbal descriptions of risk, although this was aimed specifically at first-in-man trials.174 Risk 
communication research indicates that a GP’s personal perception of the risk of an activity, 
together with the way that is communicated to patients, will impact on an individual patient’s 
perception.172 It is possible, therefore that both the GP and the method of communication will 
influence a patient’s willingness to participate in research. However, one study examining risk 
communication to a hypothetical trial of pain relief medication in patients with cancer or 
arthritis found that this was not actually the case: although patients demonstrated a clear 
preference for being given risk information numerically, the format of presentation was not 
found to impact on their willingness to participate in a trial.175 
These mixed findings may be explained by the complexity of a trial situation. Clinicians in 
this scenario need to explain a variety of risks and benefits: the risks posed by the disease in 
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question; the risks and benefits of the treatments in question; and the risks and benefits of trial 
involvement. It is possible, therefore, that alterations to the format of risk presentation from 
verbal to numerical is too simplistic to be the complete solution. The difficulties are 
exacerbated further; for a trial, GPs need to explain the balance of risks and benefits across 
two different treatments. A minority of GPs in BAFTA said that they felt it was difficult to 
achieve balance in this respect.  
The need to cover prescribed requirements38 during the informed consent discussion adds a 
further level of complexity to the recruitment process. While it is obviously vital that patients 
understand research they are being asked to get involved in, and are satisfied with the risks 
and requirements associated with the trial, it is important that they are given the information 
in an unbiased manner, and that they receive the information in a manner that they are 
comfortable with. A law review of informed consent states that current guidelines, ‘Instead of 
providing a channel of communication between physician and subject… is a lifeless entity 
responsible for a large portion of the misunderstanding existing between these two parties’.176 
Ziker concludes that an understanding of how the patient perceives and reacts to risk can help 
to revise the existing consent process, allowing it to better achieve its objectives of protecting 
volunteers while encouraging participation.176 To understand how individuals interpret risk, 
GPs must first identify ‘where the patient is coming from’.177 It is not enough that researchers 
believe that the justification for a trial is good, as people also react to risk in a subjective 
manner.  
The risk perception concept has a number of principles that may help overcome some of the 
difficulties encountered during the trial consent process. The theory as put forward by Ropeik 
et al, states that people are more comfortable with risk if they have chosen to be exposed to it, 
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so clinicians should emphasise the voluntary nature of participation. They also recommend 
that clinicians emphasise the control that patients retain over their participation, underlining 
the fact that they can withdraw at any time.178 This concurs with the feelings of many 
interviewed GPs, who felt that it was important that they emphasise to patients their ability to 
change their mind at any point. Highlighting the benefits to patients of participation is not 
only a requirement of GCP, but also encourages people to enrol. Clinicians should explain the 
benefits both to the individual and to society of their participation. Although personal benefit 
is the prime motivation of participants, altruism, or the benefit to society, also encourages 
people to enrol.178 Trust also helps potential participants to be less fearful of the risks posed 
by trials.178 This can be advantageous to clinicians who have developed a relationship with 
their patients, as a bond of trust has already been formed. It may also account for why GPs 
seem to cite fewer concerns about the impact on the doctor/patient relationship than their 
colleagues in secondary care. GPs can get to know their patients over a long period of time or 
a large number of consultations, and this enhances both GP feelings of responsibility towards 
their patients118 and patient trust in their GP.153 It may be that specialists develop a different 
relationship with their patients, thus making it more difficult for them to broach the subject of 
research participation.  
The findings of the BAFTA interviews, combined with the literature surrounding risk 
perception, indicate that participation could be improved while still respecting ethical 
principles, if peoples’ reactions to risk and how the method of communication influences this 
were better understood. GPs taking part in research all receive GCP training prior to taking 
consent. However, this focuses on the ethical requirements of consent and does not touch on 
the practical aspects of the process. As stated by one GP who recruited fewer patients than 
expected, the study training was very useful, but with hindsight may not have furnished her 
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with the necessary skills to recruit patients. It is possible, therefore, that clinicians, patients 
and trialists could benefit from the development of a training course that would enable them 
to carry out the consent process in the optimum manner. 
9.3 Motivation 
Having discussed the impact of risk perception on trial recruitment, it must be acknowledged 
that improvements in the consent process are not likely to solve all recruitment problems. 
Clinicians have many different reasons for taking part in research, and in this thesis, 
differences in motivations between low and high recruiting GPs were found (See section 
8.6.1.3). As discussed, low recruiting GPs cited few motivations for taking part, whereas all 
other GPs gave multiple reasons. Low recruiting GPs participated because they either wanted 
to do something new and this was felt to be low risk to their patients, or because they were 
asked “nicely” to get involved. Others discussed perceptions about the study question, 
potential benefits to the practice or patients, timing, personal interest and altruism. Although 
little work has been done to determine the impact of clinician motivation on recruitment, these 
findings do support the findings of studies that have been carried out in this area (See section 
2.3.3.1).  The impact of motivation will be discussed further in section 9.3.2.   
9.3.1 Self-Determination Theory and Work Motivation 
The impact of motivation on recruitment also fits with theoretical concepts about motivation, 
particularly the Self –determination theory and work motivation.179 Self-determination theory 
(SDT) is based on Cognitive Evaluation theory (CET) which was amended to be relevant to 
motivation in the workplace.179 CET defines different types of motivation: intrinsic and 
extrinsic. Intrinsic motivation is that which comes from within, so people engage in an 
activity because they find it interesting and derive satisfaction from the activity itself, for 
example, ‘I work because I enjoy my job’. Extrinsic motivation is that which comes from 
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outside and involves tangible or verbal rewards; satisfaction comes from the reward rather 
than from the activity itself, for example, ‘I work because I get paid’. Intrinsic motivation is 
the most important type in terms of positive work outcomes because it enhances performance; 
interesting tasks that people choose to do often get carried out better than other tasks. CET 
suggests that it is possible to manipulate extrinsic motivations so that they become intrinsic, 
for example, by giving people increased autonomy over how they carry out tasks. Implicit in 
the model is the idea that the intrinsic and extrinsic motivations add together and result in 
total job satisfaction. The problem with this is that subsequent research demonstrated that 
different motivations do not add up, rather they are both positively and negatively 
interactive.179 A further concern when relating the theory to the workplace is that not all work 
tasks can be intrinsically interesting, so strategies to enhance intrinsic motivations are often 
not feasible. In response to these concerns, SDT was developed.179 
SDT distinguishes between autonomous and controlled motivation. Truly intrinsic motivation 
is completely autonomous as it is driven from within. Extrinsic motivation can vary in the 
degree to which it is autonomous versus controlled. Activities that are not intrinsically 
motivating need a link between doing the task and a desired reward, or avoidance of an un-
desired consequence, for example, ‘I work because the boss is watching’. However, SDT 
argues that controlled motivation can be internalised, therefore becoming autonomous, or 
intrinsic. For example, values are accepted and no longer require external controls, so ‘I work 
even though the boss is not watching’.  
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Internalisation is an overarching term for three different processes: introjection; identification; 
and integration. Introjection is a relatively controlled form of motivation: a process is carried 
out, but not accepted as an individual’s own regulation. The control comes from outside, for 
example, people feel pressured to behave in a specific way to feel worthy. Identification is 
classified as a partly autonomous extrinsic motivation, and arises when a behaviour is more 
linked to personal goals or identities. For example, a nurse may carry out uninteresting tasks, 
such as bathing a patient, because they understand it is for the good of the patient, and they 
strongly value patient comfort. Integrated regulation is a truly autonomous extrinsic 
motivation and is when a behaviour is an integral part of a person’s personality. For example, 
a fully integrated nurse would see the importance of maintaining their patient’s health and 
would carry out uninteresting tasks to achieve this, but would also demonstrate their caring 
tendencies in areas of their life outside work, caring for elderly relatives for example. Despite 
being autonomous, this type of motivation would remain extrinsic because interest in the task 
in question is not the primary motive. These distinctions are demonstrated visually in figure 
14 (page 213). 
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Figure 13: The Self-Determination Continuum*179 (P 336) 
 
*The self-determination continuum showing amotivation, which is wholly lacking in self-
determination; the types of extrinsic motivation, which vary in their degree of self-
determination; and intrinsic motivation, which is invariantly self-determined. Also shown are 
the nature of the regulation for each and its placement along the continuum indexing the 
degree to which each represents autonomous motivation. 
SDT says that how the workplace is organised can influence how people are motivated, but 
does not suggest that changing motivations means people have to pass through each stage of 
the model to become fully autonomous. Rather it proposes that under optimum conditions, 
people can fully integrate a task or regulation that is either new or previously only partially 
integrated. Gagne and Deci argue that work climates that promote satisfaction in the three 
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basic psychological needs (competence, autonomy, and relatedness, i.e. an activity relates to a 
personal need) by encouraging full internalisation of extrinsic motivations will result in 
important work outcomes, including: maintained behaviour change; effective performance; 
positive work related attitudes.179 
9.3.2 BAFTA and Self-Determination Theory 
SDT and the concepts of intrinsic and extrinsic motivation may shed some light on why some 
GPs were low recruiters and others managed to enrol more. The theory argues that the more 
autonomous the motivation is for a task, the better that task is carried out. This section will 
examine the reasons that GPs gave for participating to determine whether the high recruiting 
GPs were more autonomous than their lower recruiting counterparts.  To achieve this, the 
reasons given need to be classified according to the self-determination continuum. This is not 
straightforward, as the questions were not asked of GPs with this theory in mind. Therefore, 
some subjective interpretation of motivations cited has to be carried out.  
Only one factor seems to come under the umbrella of inherently intrinsic motivation: interest 
in research. Citing an interest in taking part in research per se implies that there is something 
about the process itself that interests some GPs, and they carry out the tasks required because 
they enjoy them. This is validated somewhat by the fact that GPs giving this as a reason also 
described how they enjoyed the overall experience, and that the processes they followed were 
a refreshing change from their usual work patterns. Only GPs in the high and medium 
recruitment groups cited interest in research as a motivation for participation. 
A number of motivations were given that are categorised as controlled motivation, the most 
controlled form of extrinsic motivation. These include the remuneration available for taking 
part, participation in research because it is beneficial for their career, and the tone of the initial 
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invitation letter: all are based on some form of external reward for participation. GPs citing 
these reasons came from across the recruitment categories, rendering it unclear as to whether 
extrinsic motivations do in fact result in poorer work outcomes. However, when looking at 
these motivations in context, it becomes clear that most GPs gave these reasons in 
conjunction with a variety of other more autonomous reasons, although GPs in the low 
recruitment group gave only extrinsic reasons. 
Other motivations fall into the remaining categories, identified and integrated regulation, but 
are more difficult to categorise between these two groups as specific questions with this in 
mind were not asked during interview.  These include: altruism; personal interest in the topic; 
importance and relevance of the study question; and benefits to the practice or patients of their 
participation. These factors were considered to demonstrate values of GPs, who feel 
responsible for their patients and want to give them the best treatment possible. They place 
importance on and show integration of goals and values. For example, GPs will behave in 
their patients’ best interests because they are driven by keeping their patients as healthy as 
possible, even if they do not find the specific tasks they undertake intrinsically interesting. 
Interest in the study question is distinct from interest in research per se, because it is driven by 
a desire to answer a question that is relevant to their patient care. Similarly, many cited 
benefits to their patients for the same reasons: answering such a pertinent question would 
enable them to ensure the best care for their patients.  
A central part of SDT is that different types of motivations result in different work outcomes: 
more autonomous motivations result in better outcomes. This argument seems to apply in this 
instance. It would be expected that GPs in the low recruitment group would cite fewer 
autonomous and more controlled motivations for participation and it does seem that this is 
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actually the case. GPs in the low recruitment groups gave only controlled reasons for taking 
part, such as a nice invitation letter. GPs in all other groups gave more varied reasons. While 
many said remuneration, benefits for their career, or the tone of the initial invite factored into 
their decision to take part, these were invariably cited as part of a wider variety of reasons. All 
GPs in the higher recruitment groups also gave at least one autonomous motivation, and often 
more. Those in the highest groups cited only autonomous motives, and especially focussed on 
the potential benefits for their patients.   
The discovery of patterns of motivation within the BAFTA interview data is supported both 
by existing literature pertaining to patient recruitment and by theoretical concepts of 
motivation in the workplace. As discussed in section 2.3.3.1, prior research has highlighted 
the fact that motivation was associated with recruitment rates, although it was not clear why 
this was the case. However, BAFTA motivations that relate to recruitment differ slightly from 
those found by De Witt et al;34 they found that interest in the question was not associated with 
recruitment, while BAFTA indicates that those with an interest were in the higher recruitment 
groups. It is possible that De Witt et al did not capture the nuances of interest as they gathered 
their data in a survey; structured questions may not have allowed them to identify different 
reasons underlying interest. GPs may be interested in a question because they have a 
particular interest in that area of medicine, or because they see a lot of patients with the 
condition in question and feel it would benefit them to identify the best form of treatment. 
The reason why GPs find the study question interesting could therefore be an important factor 
that influences their recruitment rates, and this was not identified by De Witt et al.34 
The current findings, together with prior research, indicate strongly that motivation for 
participation does have an impact on recruitment rates. Although BAFTA goes some way to 
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identifying what motivates doctors to take part in research, the evidence so far does not 
explain why motivations may have this effect. However, when related to SDT, the reasons 
why motivation may influence recruitment rates become clearer. SDT theorises that more 
autonomous motivations lead to improved work outcomes, and this supports the BAFTA 
findings; GPs citing only controlled motivations all recruited less well.  
Unfortunately, the evidence so far does not explain how these motivations actually make a 
difference. It may be, as posited in SDT, that intrinsically motivated GPs gain more job 
satisfaction, and so find more time to incorporate the extra workload into their daily schedule. 
It could also impact on how they communicate the trial to their patients. GPs who think that 
the study is important may communicate these feelings during the consent process. It is 
possible that GPs who only participated because they were invited politely were unable to 
convey the benefits of the trial in the same way that their more autonomously motivated 
colleagues could, and this impacted on patient willingness to participate. These findings are 
potentially useful for researchers: identification of what motivates individual GPs to 
participate could enable them to select their sites based on the likelihood that clinicians would 
recruit high proportions of patients. It could also influence the training given by trialists to 
recruiters. Further research needs to be carried out in this area to determine whether or not 
motivations in the context of trial recruitment could be manipulated.  For example, if benefits 
to patients increase intrinsic motivation, a greater part of the training could be devoted to 
highlighting these benefits.  
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9.4 Unanticipated Benefits of Participation in BAFTA 
The majority of GPs described changing attitudes towards the BAFTA trial question over the 
four year recruitment period. (See section 8.5.1.5) Most described how they were less 
concerned about the risks of warfarin in the elderly at the end of the trial than they were at the 
start. In some cases, this was attributed to a general change in attitudes to prescribing 
warfarin. Although the guidelines for prescribing warfarin to this patient population did not 
change during the recruitment period, there was a general increase in willingness to prescribe 
warfarin throughout the medical community. A minority of GPs felt that guidelines had 
changed, and that they were now almost expected to prescribe this drug unless there were 
clear reasons not to. One GP was unsure whether the guidance was underpinned by research, 
and felt that the BAFTA results would be interesting, particularly if they were at odds with 
the NICE Guidance.180 As no new guidelines were published during the recruitment period, it 
is not clear why this changed attitude arose. It is possible that other factors influenced this 
change in attitude. More practices, for example, were involved in warfarin monitoring for 
their patients. A few GPs discussed how they felt that because of this, there were more safety 
procedures in place to ensure that patients took their warfarin correctly towards the end of the 
trial than there were at the beginning, and this gave them the confidence to consider 
prescribing the drug to a wider group of people.  
The interesting finding with regard to this change in attitude over time, however, was the 
perception of a number of GPs that participation in BAFTA had improved their practice. A 
significant minority of doctors during interview described the unexpected benefits of taking 
part. They explained that they felt that their knowledge of AF had developed, enabling them 
to identify more patients with the condition. They also felt that their understanding of how to 
best manage the condition had improved, to the point where, as one GP said, he doesn’t have 
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to think about what to do with these patients, he just knows (Interview 5). A minority of GPs 
described how they felt more confident prescribing warfarin in this age group, sometimes 
because their increased exposure to the drug increased their confidence in prescribing it, or 
because involvement in the trial had underlined the fact that chronological age was less 
important than physical age. One GP explained that participation in the trial had demonstrated 
to her that patients can often incorporate regimes such as warfarin management into their lives 
with few problems, in contrast to her assumption that they would all find it problematic.  All 
GPs discussing this change in attitude felt that this improved knowledge and understanding 
resulted in better care for their patients, and that they had not expected this benefit from the 
trial. This finding has not been discussed in previous research, but does resonate with the 
experience of Stroke Units caring for people with acute stroke. Examination of the 
organisation of acute stroke care found a significant correlation between quality of stroke care 
and research activity. The authors conclude that this suggests that well organised stroke care 
facilitates patient involvement in research, and/or that participation of stroke units in research 
improves services and therefore patient care.170  
This information has the potential to be useful for researchers in a number of ways. Firstly it 
could be used to encourage larger numbers of GPs to incorporate research into their everyday 
workload than currently do.  The majority of successful recruiters cited benefits to their 
patients as a factor influencing their decision to take part in research, and most discussed how 
they felt that their own improved knowledge and understanding resulted in improved care for 
their patients. Researchers and Research Networks may be able to utilise this information to 
encourage more sites to consider involvement, thus reducing the current issues often 
encountered when trying to engage adequate numbers of sites. Initial information given to 
GPs could highlight the specific benefits to the patients of practice participation in a particular 
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study, including the potential benefits to their patients of improved GP knowledge and 
understanding gained through research participation. Further research needs to be carried out 
to determine whether research involvement actually does have a positive impact on service 
provision or quality of care. However, if this were proved, involvement in research could 
potentially be one way of carrying out continuing education for GPs and could result in 
research becoming a mainstream activity that is more central to the role of GP, rather than 
being the domain of those GPs who are interested enough to add research to their already 
demanding workload. 
9.5 Limitations  
One of the limitations of this study is the fact that compromises had to be made in the 
sampling process (See Section 7.2.1). As discussed, these compromises resulted in no 
interviews with GPs from the very small practices (those with one or two GPs). This may 
explain why there appeared to be no differences in attitudes between GPs in smaller practices 
and those in larger practices, despite this being a significant predictor of consent. It is feasible 
that GPs in very small practices have different attitudes to those described in this study. For 
example, they may have better knowledge of their patients. Unfortunately, it was not possible 
to collect data to test this.  
The time constraints that led to compromises in the sampling process also resulted in 
compromises with the analysis (See Section 7.2.2). The data could not be analysed 
concurrently with data collection which meant that unexpected findings from early interviews 
would not be followed up in subsequent interviews. However, as only one researcher carried 
out all interviews, follow up of unexpected findings was carried out in an informal manner. 
For example, the perceived differences between drug company funded trials and those testing 
established drugs were raised by GPs in the early interviews, and the researcher ensured that 
 225 
 
the subject was explored during those that followed. Although formal concurrent analysis in 
theory might have resulted in identification of additional aspects of GP experience, in practice 
subsequent analysis did not identify any areas that should have been incorporated in the later 
interviews. Therefore, it is unlikely that the lack of concurrent analysis had a detrimental 
impact on this study. 
Another potential limitation is the small sample size. Although 19 GPs were interviewed, only 
17 transcripts were included in the analysis. It is possible that more interviews would have 
uncovered opinions that could have better explained the statistical differences identified in 
chapters five and six. However, data saturation was achieved, with no new ideas emerging 
from the data after interview 15.  
The limited time available to some GPs for the interview may have resulted in less rich data. 
Some of the interviews lasted only 30 minutes and it was not possible to cover the whole 
topic guide in any depth in this amount of time. A decision was taken during these interviews 
to cover all areas in less depth rather than focus on a smaller part of the topic guide and probe 
further into responses, unless an individual raised different issues from those already 
identified. Despite the lack of depth, however, some interesting and unexpected findings came 
out of the interview data which add knowledge to the current literature.  
There are a number of issues inherent in this study that may have influenced the nature of the 
data that were collected. Firstly, there was a time lag of approximately 12 months between the 
end of patient recruitment and the start of interviews. This may have resulted in recall bias 
influencing the data, especially when discussing the specific detail regarding trial 
implementation. However, GPs had continued to follow up their patients until approximately 
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three months prior to interview and were therefore still very engaged with the trial. 
Furthermore, large parts of the interview covered generic trial issues, for example, the ethics 
of randomisation, and these were unlikely to have been affected by the time lag. Secondly, the 
interviews were carried out by the BAFTA trial manager, which may have influenced GPs 
willingness to discuss their genuine thoughts regarding the trial. Although this may have 
influenced the discussions in some cases, it is unlikely to have had a significant impact upon 
the data; a number of GPs were explicit about negative aspects of their experience, while 
others stated that they were aware of the interviewer’s role in the trial, but that this would not 
deter them from giving honest responses to the questions. 
It is also possible that these findings relate only to primary care based trials of cardiovascular 
disease in older people. Although qualitative research does not aim to be generalisable in the 
same way as quantitative research, the usefulness of the findings is limited if they apply only 
to such specific circumstances. The findings of this study are only likely to apply when 
considering older patients for trial entry: a number of areas discussed may differ when 
considering younger patients. For example, many GPs described concerns about the ability of 
older patients to understand and accept trial concepts, or discussed worries about the impact 
of co-morbidities or polypharmacy on eligibility. A few also described their feelings of 
responsibility towards their older patients. These concerns may be less acute when 
considering a younger patient population and would need to be researched in trials 
incorporating a different patient group. However, a number of issues raised are likely to apply 
to primary care based trials regardless of their disease area. The influence of motivation for 
participation on recruitment, for example, could equally apply to research looking at other 
conditions. If GPs recruit well because they value the benefits of participation for their 
patients, this is also likely to apply to studies that are not in the field of cardiovascular 
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medicine. Additionally, some of the more generic trial issues raised could also apply to other 
conditions. For example, the ethics of randomisation or the limitations posed by practice 
and/or study workload are not limited to cardiovascular medicine. 
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Chapter 10: Conclusions 
Previous chapters have discussed the findings of the individual projects that make up this 
thesis. This chapter will summarise the key findings from earlier chapters, discuss the extent 
to which the original aims of the thesis (Section 1.3) have been addressed and will bring 
together the earlier findings to provide some overall conclusions. The novel findings from this 
work will also be highlighted. 
10.1 Objective One: What Practice or Practitioner Factors Influence 
the Recruitment of Patients to Primary Care Based RCTs? 
The first aim of this thesis was to conduct a review of the literature pertaining to primary care 
based RCTs to determine what practice or practitioner factors influence patient recruitment, 
and to identify methods that can overcome any identified issues (See Chapter Three). The 
review successfully achieved this aim, providing a comprehensive overview both of factors 
that may affect recruitment, and of approaches designed to overcome difficulties. (See Table 
18, page 225).  Although systematic reviews of recruitment methods have been done 
before,2,3,4,16,35,49 this is the first review that synthesises the literature specific to both primary 
care and practitioner (as opposed to patient) considerations. It provides primary care based 
trialists with a detailed account of difficulties encountered during other RCTs, and the 
approaches that researchers use to alleviate them. It identifies both similarities and differences 
between the issues faced by researchers carrying out trials in a primary care setting and those 
encountered in secondary care. It demonstrates, for example, that recruitment of sites appears 
to be more problematic in primary care than it does in secondary care, and suggests 
approaches trialists can employ to minimise the difficulties, as shown in table 18. It also 
highlights apparent differences in concerns that GPs have when conducting research than 
those held by 
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Table 19: Overview of Factors Affecting Recruitment and Recruitment Approaches 
Factor Problem Solution 
Interest in the study 
question 
Lack of interest discourages site participation Emphasise the relevance and benefits of the trial both 
to the practice and to patients 
Consider different approaches for initial contact with 
practices 
Negative attitude towards 
research 
Not perceived as professionally relevant 
GPs have no responsibility for conducting 
research 
Emphasise the benefits of participation 
Encourage cultural changes to raise the research profile 
Ability to carry out the 
study 
Lack of time 
Lack of suitably trained staff 
Minimise workload 
Maximise flexibility of who can carry out study tasks 
Ensure all staff receive appropriate training 
Personal Relationships Exploitation of personal/professional relationships 
may encourage participation 
Use a ‘local champion’ 
Use of peers to send site invitations 
Participation of academic 
research groups 
The literature is mixed. This may have a positive 
or negative impact on recruitment 
Develop good working relationships 
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specialists, for example, worries about the impact of trial involvement on the doctor/patient 
relationship. However, the review also determined that the existing literature is problematic, 
with much of the evidence being conflicting or unproven in RCTs of recruitment approaches. 
There remains a need for further research in this area (See Chapter 11). 
10.2 Objective Two: Do Patient and/or Practitioner Factors Predict 
the Likelihood of a Patient giving Consent to BAFTA? 
The second objective of this thesis was to identify whether patient and/or practitioner factors 
predicted the likelihood of a patient to give consent to the BAFTA study. Although a number 
of studies examining GP factors influencing recruitment were identified in the systematic 
review, most of these focussed on the referral of patients to trials and it was not clear whether 
referral translated into actual recruitment.25,77 While this may be useful for studies where 
clinicians refer patients to researchers who then complete the recruitment process, it is of less 
use for trials where clinicians are carrying out both identification and recruitment. Only two 
studies considered the influence of GP demographic characteristics on recruitment and neither 
found any association.57,95 However, the analysis of recruitment to BAFTA demonstrated for 
the first time that practice and practitioner factors (GP age; practice size) can predict the 
likelihood of an eligible patient giving their consent to take part in a trial (See Chapter Five).  
It is possible that sample size accounts for the difference between the analysis of BAFTA and 
the previous literature, which surveyed 98 and 186 clinicians as opposed to BAFTA, which 
included 262 GPs. A further difference is that the BAFTA analysis focussed on the 1740 
patients who were considered eligible for the study by their GP.  As described in Chapter 
Five, these patients all attended an appointment with their GP to discuss trial entry,so the 
analysis was able to explicitly explore the direct impact of GP characteristics on the consent 
process.  
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The results have implications for primary care trialists. When recruiting sites, those most 
likely to recruit effectively could be selected, focussing on smaller practices or older GPs, for 
example. However, this would have untoward consequences as it would automatically deny a 
large number of GPs and patients access to research, and may also inadvertently limit trial 
applicability by selecting a non-representative set of sites to participate. Therefore, this is not 
an approach that would be recommended unless future research proves it to be appropriate. 
Despite this, lessons can still be learned from this study. For example, it would be logical to 
assume that larger practices would recruit more patients because they have a larger patient 
pool to begin with, and researchers may be tempted to focus on these sites. However, these 
findings indicate that trialists should use this approach with caution; it may be more sensible 
to ensure that smaller practices are actively encouraged to participate, as they may include a 
more resource effective number of patients.  
10.3 Objective Three: Did Protocol or Procedural Changes in BAFTA 
Influence Patient Recruitment? 
The next aim of the thesis was to use BAFTA to determine whether protocol and procedural 
changes impacted on patient recruitment, or whether the target number of patients was only 
reached because of the increased number of participating sites (See Chapter Six). The 
systematic review identified a number of studies that described how patients were recruited to 
different trials, and explored different strategies for identifying and enrolling patients (See 
Table 6, page 43). Many trialists employ a variety of techniques to improve patient 
recruitment, including minimisation of GP workload,75 simplification of study protocols82 or 
increasing the number of participating sites.18 However, most of the studies were descriptive 
and it is unclear which, if any, of these approaches successfully improved recruitment. The 
analysis of BAFTA data was the first to demonstrate that procedural and/or protocol 
amendments can be associated with improved recruitment rates, lending tangible support to 
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the recruitment guidance given in the literature.17 However, although this is an important 
finding, this analysis does not help trialists to pinpoint which changes were responsible for the 
increased recruitment. Improved understanding of how and why these factors influence 
recruitment would ultimately lead to better trial design, enabling maximisation of recruitment 
from the outset and reducing the need for costly and time consuming amendments.  
10.4 Objective Four: What Were GPs’ Experiences of Recruiting 
Patients to BAFTA? 
Having synthesised the existing literature in this subject area, and identified various factors 
that influenced recruitment to BAFTA (practice and practitioner factors; procedural and 
protocol changes), the next aim was to understand the experience of GPs who recruited to 
BAFTA. It was anticipated that this understanding would provide some explanation for the 
differences identified in the BAFTA analysis. The interview topic guide was based upon the 
findings from the prior work. For example, broad trial questions (i.e. attitudes towards 
randomisation; equipoise or risk; motivations for participation) were informed by the 
systematic review, while BAFTA specific questions (i.e. attitudes towards the training 
sessions; practical aspects of the trial; understanding of trial processes and protocol) were 
informed by the findings of the earlier BAFTA analyses. 
Despite some limitations (See Section 9.5), the interview study did shed some light on the 
earlier findings. As discussed in section 9.1, there was a difference in attitude towards the 
study question between older GPs and their younger counterparts, which may have translated 
into recruitment rates. However, as it is possible that older GPs recruited better because they 
have a different relationship with their older patients than do younger GPs,171 it may be that 
studies with a younger patient population would have different findings. No patterns were 
found in the data when considering the other factors previously found to be associated with 
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recruitment (practice size; year of recruitment), so it remains unclear as to why they 
influenced recruitment.  
Although this study had limited success in providing explanations for the associations 
identified earlier, it did identify other areas that may have important implications for patient 
recruitment. Many interviewed GPs indicated that workload, simplicity of the protocol and 
appropriateness of eligibility criteria were all important considerations that affected their 
ability to carry out the study, lending support to the existing evidence.  
Many BAFTA GPs talked about how improved knowledge and understanding gained through 
participation in BAFTA led to better care for their patients. As discussed in section 9.3, there 
is an argument that taking part in research improves the service offered to patients, and 
therefore improves patient care. The findings of this study imply that benefits to patients of 
participation may be an important factor that influences both a GPs willingness to participate, 
and their subsequent ability to successfully recruit. Whilst this theory has not been proven, the 
information is potentially useful for researchers. GP participation could be encouraged by 
tailoring the initial invitations to emphasise the potential benefits to patients. Recruitment 
could be optimised by exploring the ways in which participation could improve their 
management of the condition in question during clinician training sessions.  
One of the most interesting findings of this interview study relate to the patterns in the data 
that exist between GPs with differing levels of recruitment (See Section 8.6.1). GPs in the low 
recruitment group, for example, had a different perception of risk and responsibility, and more 
concerns about the potential impact on the doctor/patient relationship than their counterparts 
who recruited more successfully. Some of these issues have been discussed in the existing 
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literature, although the focus has tended to be on the impact these considerations have on the 
initial decision to participate (See Table 6, page 43). Only three studies discussed these 
problems in relation to their willingness to recruit or refer patients.77,89,97 However, they did 
not relate their findings to ability to recruit, rather they identified these as potential areas of 
concern. This analysis has demonstrated for the first time that these issues actually affect a 
clinician’s ability to enrol their patients. However, why these perceptions may influence 
recruitment remains unclear. It may be that these feelings influence the informed consent 
discussion. For example, those with a low tolerance for risk may subconsciously impart their 
feelings to patients during the process. Similarly, GPs who perceive the benefits to patients of 
participation could also inadvertently convey these feelings to their patients.  
The impact of motivation to participate on subsequent ability to recruit is another important 
finding of this study. Only one previous study has examined the impact of motivation upon 
recruitment34 and its findings differed slightly from the results of the BAFTA interview study. 
They found that the study question was not associated with recruitment, whilst the findings of 
this interview study suggest that differing attitudes to the study question result in different 
recruitment success rates. However, it is possible that different methodologies account for the 
apparently contradictory findings; De Witt et al carried out a survey of research active 
clinicians.34 Questions were therefore pre-defined, and there was no ability to delve further 
into why the topic under investigation inspired clinicians to participate. In contrast, this study 
was able to uncover the reasons why the trial question promoted involvement. The 
methodology employed here does not allow causation (i.e. importance of the study question 
leads to high recruitment rates) to be proven. However, this is the first study that has 
identified reasons why the question motivates GPs to participate (e.g. the question is 
important because it improves care for my patients), and to relate these detailed motivations to 
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ability to recruit. Furthermore, it is the only study to consider the impact of motivations in 
relation to self-determination theory. This theory provides a potential explanation as to the 
mechanisms that enable motivation to influence outcomes. Consideration of motivation could 
allow researchers to identify those GPs most likely to recruit high numbers of patients. 
However, further research needs to be carried out to identify the most appropriate way to 
utilise this information, and to determine whether motivation is open to manipulation and 
therefore to improved recruitment. 
10.5 Objective Five: How can Patient Recruitment to Primary Care 
Based RCTs be Optimised? 
The final objective was to give recommendations for the optimal recruitment of patients to 
trials in primary care and to identify areas that would benefit from future research. These 
recommendations draw upon all aspects of this thesis, from both the systematic review and 
the original analyses. This objective will be discussed in detail in chapter 11. 
10.6 Conclusions in the Context of Primary Care Trials in 2012 
The BAFTA study completed recruitment in 2006. In the six years since then there have been 
some changes to how primary care trials are conducted. The introduction of the clinical 
research networks has changed, in many cases, how trials are carried out; research network 
nurses often go to participating practices to enrol patients thus removing the need for 
individual GP involvement.  However, some trials still use GPs to identify and consent 
patients, which means that the findings of this thesis are still relevant to trials being carried 
out today. Furthermore, it is possible that many factors that impact on GP recruitment also 
influence network research nurses; there are often differential recruitment rates between 
individual nurses. Future research should take this into account. 
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The regulation surrounding the permissions that are needed to carry out research has also 
increased significantly. It has become more complex, burdensome and time consuming, with 
the result that it is very difficult to implement any protocol or procedural changes in a timely 
manner. The delay caused by the need to gain approvals for these changes has the potential to 
have a significant detrimental effect on a trial’s ability to turn around failing recruitment rates. 
Therefore, it is even more important for trialists to understand which factors in this study had 
an impact on the recruitment rates, and why. This would enable them to ensure that protocols 
were effectively designed in the first instance. 
The primary care clinical environment has also changed since BAFTA was actively 
recruiting. Although disease registers were coming into being during the recruitment phase, 
the introduction of Quality Outcomes Framework  (QoF) in the period since BAFTA ended 
has formalised this process, with practices being paid directly and specifically for managing 
certain elements of their patients’ conditions. Practices actively identify and manage patients 
with a range of usually chronic diseases such as stroke. This has the ability to impact on 
recruitment to trials in different ways. On the one hand, disease registers can make it easier to 
identify the prevalent population of the disease in question. On the other hand, increasing 
workload in primary care more generally including QoF may put increased pressure on the 
time that GPs have available for research. Research participation is not rewarded through 
QoF, so it remains vital to ensure that practices have other motivations for participating. 
Again, the findings of this study surrounding the impact of motivation would be directly 
relevant to this. 
In conclusion, the primary care clinical and research environments have changed dramatically 
since BAFTA was carried out, rendering it even more challenging to carry out RCTs in this 
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arena. As a result of these increased challenges, it is even more important to ensure that trials 
can maximise their potential for recruitment. The findings of this study, therefore, are likely to 
be even more pertinent to 2012 trials than they are to trials carried out in the past. 
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Chapter 11: Optimisation of Recruitment to Primary 
Care Based Randomised Controlled Trials 
This final chapter of the thesis gives recommendations for the optimum recruitment of both 
sites and patients to primary care based RCTs, based on current knowledge. As discussed, 
there remain a number of question marks over the most appropriate approaches to overcome 
the difficulties. There remains a need for a sound evidence base that would enable researchers 
conducting RCTs in primary care to achieve patient recruitment targets in the most cost and 
time effective manner. Therefore, this chapter will also highlight areas which would benefit 
from further study. 
The influences on a trial’s ability to recruit fall into two main areas: site recruitment; and 
patient recruitment. These will be presented in turn. The chapter will then conclude with a 
discussion of areas that would benefit from future research. 
11.1 Guidance for the Recruitment of Sites 
The recruitment of adequate numbers of suitable sites is a challenge faced by many trials. 
This seems to be especially problematic in primary care. The current literature gives advice to 
trialists on the best way to encourage sites to participate in research. This thesis has provided 
evidence that supports the existing literature and has also identified some extra factors that 
have not been considered before. These are summarised in table 19 (Page 233). 
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Table 20: Guidance for Recruiting Research Sites 
Recommendation Reason Literature/thesis 
Minimise practice workload High workload discourages 
participation 
Literature/Thesis 
(Chapter 8) 
Be flexible about which staff are 
able to carry out study specific tasks 
Ability to delegate may enable 
better accommodation of workload, 
therefore encouraging participation 
Literature/Thesis 
(Chapter 8) 
Consider carefully the manner in 
which practices are approached 
Personal contacts may increase site 
recruitment but decrease patient 
recruitment 
Literature 
Give realistic estimations of 
payments and workload 
Enable practices to make informed 
decisions. Practice participation 
may reduce but false expectations 
may result in practice inability to 
carry out the work 
Literature/Thesis 
(Chapter 8) 
Highlight the benefits to patients as 
well as to the practice, of 
participation in the study 
Appreciation of benefits to patients 
may increase site participation and 
have a positive impact on 
subsequent patient recruitment 
Thesis (Chapter 9) 
Many sites decide to participate 
after attending training. Reiterate 
the question relevance and benefits 
of participation during training 
Potentially has a positive impact on 
patient recruitment 
Thesis (Chapter 8) 
 
 240 
 
11.2 Optimisation of Patient Recruitment 
Recommendations for optimising patient recruitment, based both on the evidence in the 
literature and the findings of this thesis are summarised in table 20. 
 
Table 21: Recommendations for the Optimisation of Patient Recruitment 
Recommendation Reason Literature/Thesis 
Consider GP motivations for 
participation. Could motivations be 
amended by giving different 
information to GPs? Could site be 
selected based upon motivation? 
Motivation potentially impacts upon 
the ability to recruit patients. GPs 
who participate because of potential 
benefits to patients may recruit 
more successfully. 
Thesis (Chapter 9) 
Ensure simplicity of trial procedures 
and protocols.  
Keeps workload to a minimum Literature/Thesis 
(Chapter 8) 
Ensure data on non-randomised 
patients is collected carefully. 
Too much concentration on 
collection of this data may detract 
from patient recruitment 
Thesis (Chapter 8) 
Be flexible about which staff are 
able to carry out study specific tasks 
Ability to delegate may enable 
better accommodation of workload, 
therefore encouraging participation 
Literature/Thesis 
(Chapter 8) 
Ensure investigators are equipped 
with the appropriate skills, 
especially with regard to obtaining 
consent 
Inadequate training may have a 
detrimental effect on recruitment 
Thesis (Chapter 8) 
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Problem Solution Literature/Thesis 
Consider Lasagna’s Law. Is the 
disease prevalence lower than 
estimated? 
Increase the number of sites Literature 
Is the study failing to identify 
potentially eligible patients? 
Amend processes to ensure all 
patients are identified 
Literature/Thesis 
(Chapter 6) 
Are the inclusion/exclusion criteria 
too restrictive? 
Amend to protocol to allow more 
patients to be eligible (if it can be 
done without being detrimental to 
the trial) 
Literature 
Are there delays between study 
training and recruitment start up? 
Staff can lose interest or other 
activities take priority if the practice 
is unable to begin when they expect 
to, having a negative impact upon 
recruitment 
Thesis (Chapter 8) 
Can failing sites be supported to 
improve recruitment or would 
resources be better focussed 
elsewhere? 
It is possible that sites that are 
finding it difficult to recruit may be 
unable improve, dependant upon 
their reasons for failure 
Literature/Thesis 
(Chapter 6) 
Many of the approaches taken to improve recruitment are not based on good evidence. No 
RCTs to test the above recommendations have been carried out. Some of the 
recommendations arise from the findings of the interview study described in chapters 7-9, and 
therefore still remain only potential solutions to the problem of patient recruitment. More 
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research needs to be carried out in a number of areas and these will be discussed in the next 
section. 
11.3 Future Research 
As discussed in section 9.3, GPs motivation for taking part in a trial may influence their 
subsequent ability to recruit patients. This raises a number of areas for future research. 
11.3.1 Does Motivation Influence Recruitment? 
Further research needs to determine whether motivation does actually impact on recruitment 
rates. A prospective study to identify why a GP participates could answer this question. This 
study should take into account the potential associations between motivation and recruitment. 
11.3.2 Can Motivations be Manipulated? 
Self-determination theory gives some insight into how motivation may influence recruitment 
(see section 9.3), indicating that intrinsic motivations result in better work outcomes.  The 
ability to manipulate motivations would potentially have many benefits to researchers. Further 
research in a number of areas would be beneficial: 
 A trial that looks at whether motivations can be manipulated may allow trialists to 
optimise patient recruitment; 
 The most appropriate way to successfully manipulate motivations also needs to be 
identified. It may be that the initial contact to the practice needs to reflect these 
considerations; 
 Where it is not possible to change motivations, a study to determine whether it would 
be appropriate to select practices on the basis of the GPs motivation to participate may 
enable optimal patient recruitment. 
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11.3.3 Which Protocol or Procedural Factors Influence Recruitment? 
A trial testing different ways of implementing an RCT would have the potential to identify 
what aspects of protocol or procedural changes actually influence recruitment. This would 
allow trialists to design their trials with the optimum chance of success from the outset. 
11.3.4 Does Involvement in Research Improve Clinical Practice? 
A study demonstrating that involvement in research improves the care for patients would have 
two main benefits for researchers. Firstly it would lend strength to the argument that research 
participation should be an integral part of general practice, potentially increasing site 
recruitment. Secondly it could enhance patient participation, as benefits of improved care for 
patients may potentially be associated with improved patient recruitment. 
11.3.5 What is the Optimum way to Gain Informed Consent? 
When considering the consent process, there are a number of areas that may benefit from 
further research. 
 Previous research demonstrated that the order in which trial arms are presented to 
patients can influence their decision about participation.44 Studies to identify how 
trialists can determine the most appropriate way to describe their trial to patients could 
optimise patient recruitment. 
 Studies to determine whether GPs’ perceptions of risks and benefits colours the 
consent discussion would be beneficial. Further research to identify whether training 
amendments could ensure that these perceptions do not influence way in which the 
trial is explained may increase recruitment rates. 
 Further research to establish whether specific training for GPs on gaining patient 
consent for involvement in research, together with identification of the most 
appropriate format for this training, could have a positive impact on recruitment rates. 
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11.4 Conclusion 
The decision to use mixed methods to address this research question has allowed detailed 
exploration of the question posed by this thesis. As discussed throughout this chapter, each 
approach built on the prior findings of the thesis, and informed the next steps. Taken together 
they have provided a comprehensive overview of the factors that may influence patient 
recruitment and provided a sound basis for future research into a variety of ways to overcome 
the issues raised. Use of a single methodological approach would not have provided such an 
in-depth understanding of this complex subject.  
Although the findings of this thesis do not present researchers with proven solutions to the 
problem of patient recruitment, they do offer useful information that can be taken into account 
when planning trials. Trialists need to achieve a balance between ethical recruitment of 
adequate numbers of patients from a population that appropriately answers the research 
question, and practical aspects of recruitment that will impact on their ability to achieve their 
aims. Athough this thesis has put forward a number of suggestions to optimise recruitment, 
the most appropriate way to accomplish this remains unclear.  
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Appendix One: BAFTA Training Day Agenda 
  
Agenda 2001 Training Session 
Time Content 
1.00 to 1.30 Registration & lunch 
1.30 to 1.45 Overview of practice manual 
1. Contents of the practice manual (investigator/working versions) 
2. Practice proforma 
3. BAFTA team 
4. Protocol  
1.45 to 2.00 BAFTA standard operating procedures 
1. Practice staff roles 
2. Generic SOPS 
2.00 to 2.30 What are CRFs and SOPs? 
DESCRIBING THE PATIENT PATHWAY THROUGH THE STUDY 
1. Identifying patients (case note review & opportunistic screening) 
2. ECG clinic 
3. Randomisation clinic 
4. Patient follow-up 
2.30 till 3.30 
 
Parallel 
sessions 
GP session (1): 
1. Opportunistic screening (CRF2) 
2. Input before randomisation clinic (CRF6) 
3. Randomisation clinic (CRF7b) - study inclusion criteria/exclusion 
4. GP follow-ups (CRF8a-i) 
5. Loss to follow-up (CRF12) 
 
PN SESSION (1): 
1. Opportunistic screening (CRF2) 
2. ECG clinic (CRF3) 
3. Input before randomisation clinic (CRF6, discuss with GP) 
4. Randomisation clinic (CRF7a) 
3.30 till 3.45 Tea 
3.45 to 4.30  Small group work 
GP session (2)  
PN session (2) 
4.30 till 4.45 Summing up - what happens next? 
Getting ready for BAFTA (Section 2) 
BAFTA practice visit to start study running 
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Session Time allocated Time slot 
Registration 30 mins 9.00 to 9.30 
Introduction;    
Rationale & protocol; 
Cardiological input. 
75 mins 9.30 to 10.45 
Coffee break 15 mins 10.45 to 11.00 
MidReC Information 
and GCP 
40 mins 11.00 to 11.40 
HertNet Information 20 mins 11.40 to 12.00 
The practice manual 15 mins 12.00 to 12.15 
Lunch 45 mins 12.15 to 1.00 
Patient consent 30 mins 1.00 to 1.30 
Small group work 
GP session 
Nurse session 
1½ hours 1.30 to 3.00 
  
Agenda 2003 Training Session 
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Appendix Two: Factors Predicting Consent, Family 
Practice Publication 
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Appendix Three: Impact of Study Design on Patient 
Recruitment Family Practice Publication  
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Appendix Four: Topic Guide 
Objectives 
 To identify problems, barriers and facilitators to participation in research from the GP 
perspective  
 To understand how GPs conduct the consent process 
 To explore the reasons for differences between practitioners in the proportions of 
eligible patients who give consent to participation 
Introduction 
 Introduce: self and study; expected length of interview; voluntary and can withdraw at 
any time; explain they have the option to not answer specific questions; 
confidentiality; sign consent form 
Background  
Practice background 
 Number of GPs in the practice 
 Availability of other staff (ie research nurses/receptionists/administrators)  
 Is there a personal list system in operation?  
 Has your practice ever taken part in any research before? 
o What kind?  
Personal background 
 When and where did you qualify? 
 Have you any extra qualifications/training? 
 How long have you been a GP? 
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 How long have you worked in this practice? 
 Have you ever taken part in any research before?  
o What kind, capacity, enjoy? 
BAFTA involvement 
Can you describe the study? 
 What in your view was the study question? 
 What was your view/attitude/feelings towards the study question? 
o How did you feel about the study drugs involved? 
Why did you decide to do the study? 
 How do you feel about research in general 
 What relevance did this question have? 
 Why them as opposed to other GP in the practice 
Patient Recruitment 
Taking part in the study 
 Could you describe your overall experience of taking part 
o How did you find the study procedures? 
o How did you find the study workload? 
o How useful did you find the study manual 
o Was there a time lag between training and recruiting – any impact 
o How do you feel about the reimbursement levels/methods 
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Study training 
 Could you tell me about the initial meeting you attended about the study? 
o What did it involve? 
o Did any parts of the meeting work well? What were they? 
 If no, how do you think it could have been improved? 
o Did any parts of the meeting work not so well? 
 How do you think it could have been improved? 
 If no, was there anything that could have been done differently that 
would have improved it? 
o What do you think this session should have covered that wasn’t included? 
o How do you feel about the session overall? 
 How prepared for taking part did you feel? 
 What affect did it have on your knowledge of the subject? 
 How do you feel about the duration of the training? 
o How would you have felt about DVD/video format training? 
 How would you have felt if you had been sent the studypaperwork 
instead of attending this meeting? 
Specific issues regarding recruitment to BAFTA 
 How did you identify patients who you thought may be eligible for the study? 
o How did the opportunistic screening work? 
o Were all practice staff involved? 
o How did you involve them? 
o How did you identify patients already having AF? 
 How did you choose which patients to invite to randomisation clinic? 
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o Did you invite all eligible patients or only those you know well 
o Did you exclude any specific groups? 
 Why 
 Can you tell me how the consent appointment was done in your practice? 
o Who was involved in the appointment? 
o How long before this appointment did patients receive the information sheet? 
 Can you tell me how you described the study to a patient? 
o How did you explain uncertainty?  
 Did you describe it as personal or community uncertainty? 
 How do you feel about saying to patients ‘I don’t know’ 
o How do you think patients would feel about you saying I don’t know? 
 How did you explain the need for randomisation? 
o What language did you use? 
 How did you explain the randomisation process? 
o What language did you use? 
 Could you tell me what you see as the need for randomisation? 
 How did you describe the relative pros and cons of the study drugs? 
o Did you always describe it in the same way?  
o Did you tailor it to individuals? 
 How did you decide what to say to individuals? 
 Thinking about patient follow up, how did that work? 
o How did you know when they were due to come and see you? 
o How useful were reminders? 
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Broad trial issues 
 Can you tell me about any general feelings you have about involving patients in trials? 
 What do you see as the advantages of using rct design? 
 What do you see as the disadvantages? 
o Could you tell me how you feel about the ethics of RCTs? 
o Some doctors say putting patients in trials may have an influence on the 
doctor\patient relationship. Could you tell me how you feel about that? 
o Some doctors say they feel responsible if patients have event or are on what 
turns out to be inferior treatment. Could you tell me how you feel about that? 
o Some doctors feel that putting patients into trials has an effect on their clinical 
autonomy. Could you tell me you feel about that? 
 Do you have a gut feeling about which treatment will be shown to be best? 
o What do you think results are going to be? 
o What do you hope they will be? 
Further research 
 Would you get involved in similar research in the future? 
o Can you explain why? 
Further comments 
 Do you have any other thoughts or comments about being involved in BAFTA, or 
about trials in general? 
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Appendix Five: Coding Framework Version 3 
1 Risk and Responsibility  
 1.1 BAFTA How GPs feel towards the specific study question 
 1.2 Motivation Why GP/practice took part in BAFTA 
 1.3 Changes in attitude to BAFTA Changes in attitudes throughout the duration of the study (inc outside influences) 
 1.4 Risk Risk and their patients; risk and trials (inc. Direct and indirect reference to risk) 
 1.5 Ethics of Trials How GPs feel about the ethics of RCTs; references to drugs company research 
 1.6 Responsibility GPs feelings of responsibility for their patients/for research 
 1.7 Patients How GPs feel about: putting patients on warfarin/aspirin; putting patients into trials; 
explanation of trials and/or trial drugs 
   
2 GP Experience & Understanding  
 2.1 Overall experience How GPs felt overall about taking part in BAFTA 
 2.2 Practical Issues How OS carried out; how consent clinics were run; study team; usual practice; comments 
on paperwork; workload; how patients chosen; remuneration 
 2.3 Spin offs for the practice Any impact on the practice as a result of the trial but not directly relevant (ie AF registers) 
 2.4 Experience from other studies Discussion of other studies they have participated in; recruitment of different patient groups 
 2.5 Issues affecting recruitment and 
      retention 
Local consultants; existing treatment; recruitment of practices 
 2.6 Suggestions to enhance  
      experience 
Comments on what could be done to improve experience 
 2.7 Understanding of BAFTA Understanding/misunderstanding of: the study question or protocol; trial procedures 
 2.8 Understanding of trials Understanding need for randomisation, primary care evidence etc. 
 2.9 Study team Relationship between study team and practice, ie. trust in the team; support from the team 
 2.10 Training Comments on training given to BAFTA local investigators 
 2.11 Discussion of uncertainty How they feel about discussing treatment uncertainty with their patients 
 2.12 Equipoise Understanding/comments on uncertainty concept 
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3 GP/Patient interaction  
 3.1 Explanation of trial to patients How GPs explain the trial 
 3.2 Description of Uncertainty How GPs explain the uncertainty concept 
 3.3 GP/Patient relationship How trials impact on the doctor/patient relationship 
 3.4 Patient experience GP opinion about what patients think about trials 
 3.5 Patient understanding GP opinion about how well patients understand BAFTA and/or trial concepts; what 
information they wanted and how they wanted to be given it 
 3.6 Patient attitude to study drugs GP thoughts on what patients felt about the study drugs 
 3.7 Clinical Autonomy How GPs feel about clinical autonomy 
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Appendix Six: Involvement of Colleagues in the 
Research 
I was responsible for the design and conduct of the systematic review, with input from 
Professor Jonathan Mant. I was also responsible for the collation and extraction of recruitment 
data from the BAFTA database, for the data checks and for the basic data analysis in chapters 
five and six. Trial statisticians Andrea Roalfe and Roger Holder were responsible for the more 
complex analysis that was requested by the journal at publication (the logistic regression, 
multi-level modelling and the moving F statistic).  I was responsible for the design of the 
interview study, for carrying out all interviews and for all the qualitative data analysis. I 
carried out the transcription of four interviews, and administrative staff were responsible for 
transcribing the remaining interviews. I was also responsible for writing all drafts of all 
publications to have emerged from the thesis (See Appendices 2 and 3). 
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